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ABSTRACT 
 
ELIZABETH SEREX EVANS:  The Impact of Acute Aerobic Exercise on Natural Killer 
Cell, Catecholamine, and Cortisol Responses in Breast Cancer Survivors 
(under the direction of Dr. Claudio Battaglini) 
 
PURPOSE:  The purpose of this investigation was to compare the effect of acute moderate 
intensity aerobic exercise on natural killer (NK) cell, catecholamine, and cortisol responses 
between breast cancer survivors and matched healthy controls.  Additionally, relationships 
between post-exercise changes in NK cell responses and post-exercise changes in 
catecholamines and cortisol were examined.  PARTICIPANTS:  Data were collected from 9 
women who had been treated for Stage I-III invasive breast cancer 3-6 months prior to 
enrollment and 9 healthy sedentary women without a history of cancer treatment.  Subjects 
exercised for 30 minutes on a cycle ergometer at 60% of VO2peak.  Blood samples were 
obtained pre-exercise, immediately post-exercise, 2 hours post-exercise, and 24 hours post-
exercise.  METHODS:  NK cell counts and NK cell cytotoxic activity (NKCA) were 
measured via flow cytometric analysis.  Plasma catecholamines (epinephrine and 
norepinephrine) and cortisol were measured via ELISA techniques.  RESULTS:  Percent 
changes in NK cell counts were similar between groups across time (p > 0.05), although 
absolute cell counts were somewhat lower in breast cancer survivors pre-exercise and 
immediately post-exercise.  NKCA was not significantly different across the study time 
points in the subset of breast cancer survivors (p > 0.05).  Epinephrine levels were 
significantly elevated in the breast cancer survivor group pre-exercise, immediately post-
exercise, and 24 hours post-exercise compared to controls (p < 0.05).   Percent change in 
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epinephrine was somewhat lower in the breast cancer group immediately post-exercise and 
significantly lower in breast cancer survivors at 2 hours post-exercise (p < 0.05).  Cortisol 
levels were somewhat higher in breast cancer patients immediately post-exercise, and percent 
change in cortisol immediately post-exercise increased in breast cancer survivors but 
decreased in controls (p < 0.05).  Change in NK cell counts was only significantly correlated 
with change in cortisol at 2 hours post-exercise in the control group (p < 0.05).  
CONCLUSION:  These results suggest that acute moderate aerobic exercise may have 
similar effects on the immune system in breast cancer survivors and healthy controls, 
whereas it may lead to differing stress hormone responses in breast cancer survivors. Acute 
NK cell responses may be related to other biologic factors yet to be determined. 
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CHAPTER I 
 
INTRODUCTION 
Background 
Breast cancer is the most common cancer among women in the United States, other 
than skin cancer, and it is the second-leading cause of cancer deaths in women, after lung 
cancer (1).  Major treatments for breast cancer include surgery, chemotherapy, and radiation 
therapy, and these treatments can cause significant physical and psychological distress that 
may persist for months or years after the completion of therapy (2).  Fatigue is the most 
common physical distress experienced by breast cancer patients, affecting up to 70% of 
patients during therapy and up to 30% of patients years after the completion of therapy (3).  
This type of fatigue is often severe and may limit activities of daily living; therefore, in the 
past, patients have been advised to rest and reduce their activity levels (3).  However, 
inactivity leads to muscular atrophy and decreased cardiorespiratory function, and prolonged 
rest can actually worsen fatigue, thus contributing to a cycle of further muscular atrophy, 
reduced cardiorespiratory functioning, and a down-regulation of daily activity levels (3-5).   
Over the past 20 years, numerous studies have investigated the impact of exercise 
training on physical functioning in breast cancer patients and survivors (6, 7, 8). Two recent 
reviews by Jones et al. have examined the existing literature pertaining to the impact of 
exercise training on adult patients with breast cancer and other cancer types (6, 7).  The 
primary endpoint of many of the investigations in these reviews is the effect of exercise 
training on cardiorespiratory endurance.   Other outcomes have also been addressed, 
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including changes in muscular strength, body composition, functional quality of life, fatigue, 
anxiety, and self esteem (6).  Many of these “first generation” studies have shown that 
exercise training appears to mitigate many treatment-related side-effects, that patients are 
able to make improvements in cardiorespiratory fitness, and that regular exercise seems to be 
safe, well-tolerated, and associated with few adverse events (6, 7).  Therefore, the results of 
these studies thus far seem promising. 
Physical exercise may also be an attractive adjunct therapy for cancer patients and 
survivors because of its potentially positive influence on biologic systems involved in disease 
protection and anti-cancer defense (9).  In the field of Exercise Immunology, a “J-shaped” 
hypothesis has been postulated describing the inverse relationship between disease 
risk/cancer susceptibility (9, 10).  This hypothesis states that regular, moderate exercise may 
lead to enhanced immune function and therefore a decreased risk of disease and cancer, 
whereas repeated bouts of exhaustive exercise and overtraining could lead to 
immunosuppression, and therefore an elevated risk of disease and cancer (9, 10).   
One particular cellular component of the immune system, the natural killer (NK) cell, 
may be especially characterized by this J-shaped curve in response to exercise.  NK cells are 
part of the body’s innate immune response, which is activated as part of the body’s 
immediate line of defense against pathogens.  They are particularly equipped to target and 
kill virally-infected cells as well as cells that have undergone malignant transformation (10).  
In healthy individuals, both athletic and non-athletic, NK cells are extremely responsive to 
acute exercise.  They follow a profile which typically shows marked elevations in both cell 
number and activity immediately post-exercise, while displaying decreases during the 
recovery period for up to several hours (10-14).  In response to moderate levels of exercise 
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training, resting NK cell numbers and activity may become increased, while in response to 
periods of heavy exercise training, NK cell numbers and activity may become depressed (12-
14).  Although not all studies show entirely consistent outcomes, and the clinical implications 
of exercise-induced changes in NK cell responses are not entirely known, it is thought that 
exercise-related enhancements in NK cell function may confer a protective effect against 
pathogen invasion, while exercise-related decreases in NK cell function may lead to 
increased incidence of viral infection and potential illness (12, 13). 
Research regarding immune system responses to exercise in the cancer patient 
population is limited.  To date, 19 studies have examined the effect of exercise on some 
parameter of immune function (15-33).  Of these, only 3 have examined the effect of exercise 
on NK cell function in the breast cancer patient population, and all were in response to a 
period of exercise training (15, 17, 23).  The results of these 3 studies seem to indicate that 
exercise training either does not affect NK cell function, or may even improve NK cell 
function in breast cancer patients and survivors possibly beyond what is associated with 
normal recovery after cancer therapy, and could possibly be correlated with increased 
disease-free and overall survival (23).  Studies investigating NK cell responses in patients 
with other types of cancer, as well as the studies investigating responses of other immune 
parameters to exercise have shown similar results; that exercise training either does not seem 
to negatively affect immune function in cancer patients and survivors, or may lead to 
improved immune function (16-33).   
While these results seem promising, the limited scope of the existing Exercise 
Immunology literature in the cancer patient/survivor population makes it difficult to draw 
definite conclusions.  For example, comparison of exercise responses between cancer 
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patients/survivors and healthy controls has not been performed.  Also, no study has 
comprehensively examined immune responses to an acute bout of exercise by profiling 
cellular responses pre-exercise, immediately post-exercise, and at multiple time points during 
recovery.  Furthermore, no study in the cancer patient/survivors population has examined the 
relationship between cellular immune parameters and other biologic factors, many of which 
are influenced by exercise and are also important in anti-cancer defense (9).  Knowledge and 
understanding of how cellular immune responses behave pre- to post-exercise and then 
during recovery may help exercise specialists target optimal ranges of exercise intensity, 
frequency, and duration that would ideally strengthen the immune system. Knowledge and 
understanding of how biologic mediators may influence cellular immune system responses 
may help investigators to more fully appreciate the role of exercise in the reduction of cancer 
risk/recurrence/second malignancies and in the increase of survival time post-treatment (9). 
Purposes of the Study 
Breast cancer survivors who are enrolled in exercise rehabilitation programs often 
exercise multiple times per week, usually 3-5 times per week (3-5, 6, 7, 18, 22, 23, 35-39).  
These sessions may occur on alternate days, but occasionally they may occur on consecutive 
days.  Previous studies describing exercise interventions for breast cancer patients have 
generally used moderate-vigorous intensities (50-85% of VO2max, VO2peak, heart rate reserve, 
or maximum heart rate) for durations of one hour or less per session (3-5, 6, 7, 18, 22, 23, 34-
38).  Current guidelines put forth by the American College of Sports Medicine (ACSM) are 
very similar to those for the general population; that individuals affected by cancer should be 
“as physically active as their conditions allow,” to “avoid inactivity,” and that “some 
physical activity is better than none” (39).  With regard to aerobic exercise, the ACSM 
5 
 
supports the physical activity guidelines put forth by the US Department of Health and 
Human Services, stating that individuals should aim for 150 minutes of moderate-intensity 
exercise, 75 minutes of vigorous-intensity exercise, or an equivalent combination, per week 
(39).  As one can see, these exercise prescription guidelines for cancer patients are quite 
general, likely because at this time, not enough research has been performed to completely 
understand the distinct impact of exercise on each physiological system related to every type 
of cancer diagnosis, every type of cancer treatment, and every cancer-related side-effect.  
While previous literature seems to show that aerobic exercise is safe, effective in eliciting 
improved physical fitness, free of significant adverse events, and could potentially be 
associated with improved immune function, it is not yet fully known if a breast cancer 
patient’s immune system responds to and recovers from acute aerobic exercise in a similar 
manner to the immune system of a healthy individual of similar age and physical fitness who 
has never experienced the rigors of major cancer treatment.  More specifically, it is not yet 
known if a breast cancer survivor’s immune response to acute exercise will follow the same 
response profile as typically seen in healthy individuals, or if that response is more or less 
pronounced, compared to a healthy individual.  Additionally, it is not yet understood if the 
recovery period after acute exercise, during which there could be immunosuppression, lasts 
for the same duration in breast cancer survivors and healthy individuals; a finding which 
could significantly impact recommendations for the amount of time a cancer patient/survivor 
should rest post-exercise before engaging in a subsequent bout of exercise.  Furthermore, it is 
not yet clear whether the major factors that mediate immune responses to acute aerobic 
exercise in healthy individuals also influence the exercise-induced immune response in breast 
cancer survivors.  As the research conducted in this field ultimately manifests as exercise 
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prescription guidelines, and in order to construct the most relevant and specific guidelines for 
the cancer patient/survivors populations, researchers and clinicians must understand how 
exercise affects all physiological systems, including the immune system, so that a cancer 
patient or survivor may reap the maximum health benefits of exercise without putting 
themselves at risk for further illness. 
As NK cells are extremely responsive to acute exercise, and they provide the body 
with a first line of defense against pathogens and tumor cells, it is clinically relevant to 
understand how acute aerobic exercise may influence their cytolytic activity, as well as their 
entry into/exit from circulation.  These parameters may give insight to whether the exercise is 
contributing to enhanced immune function or leading to periods of potential 
immunosuppression.  Therefore, the purposes of this investigation were:  1) to compare the 
NK cell response to an acute bout of moderate-intensity aerobic exercise in breast cancer 
survivors and healthy controls, and 2) to compare the relationships between changes in NK 
cell, catecholamine, and cortisol responses to the acute bout of moderate-intensity aerobic 
exercise in breast cancer survivors and healthy controls.   
Definition of Terms 
Major cancer treatment:  surgery, chemotherapy, and radiation therapy. 
Adjuvant hormonal therapy:  drugs used to treat women with breast cancer, particularly in 
tumors that are receptive to the hormone estrogen.  This class of drugs may also be referred 
to as selective estrogen receptor modulators (SERMs).   
Adjuvant trastuzumab therapy:  a drug used to treat women with breast cancer, particularly in 
tumors that over-express the human epidermal growth factor receptor 2 protein (HER2 
protein).   
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Breast cancer survivors:  study group which includes women who have been diagnosed with 
Stages I-III invasive breast cancer and have completed all major cancer treatment 3-6 months 
prior to participation in the study. 
Healthy controls:  study group which includes women who are healthy, sedentary, and have 
never received treatment for cancer of any type.   
Sedentary:  not participating in regular physical activity for at least 1 year prior to enrollment 
in the study.  Regular physical activity is considered as 30-minutes of moderate-vigorous 
activity, 3 days per week. 
VO2peak:  a subject’s peak aerobic capacity, measured during a VO2peak test.  The units of 
VO2peak used in this study are milliliters of oxygen per kilogram of body mass per minute 
(mL/kg/min). 
Moderate intensity aerobic exercise:  aerobic exercise that is performed at an intensity of 40-
60% of VO2peak.   
Aims and Hypotheses 
The purposes of this investigation were addressed by two Research Aims.  Aim #1 
compared the changes in NK cell counts in response to the acute bout of moderate-intensity 
aerobic exercise in breast cancer survivors and healthy controls.  This Aim is addressed in 
Chapter III.  Aim #2 compared the relationships between changes in catecholamine 
responses, cortisol responses, and changes in NK cell counts in breast cancer survivors and 
healthy controls. This Aim is addressed in Chapter V.  Aim #1 was considered the primary 
aim of this investigation and Aim #2 was considered the secondary aim of this investigation.  
Figure 1 below depicts the conceptual model leading to the research design, and how the 
relationships between the variables were addressed in each Research Aim. 
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Figure 1.  Conceptual model leading to research aims. 
 
 
 
Primary and Secondary Aims 
Aim #1:  To examine the effect of one bout of moderate-intensity aerobic exercise on NK 
cell counts in breast cancer survivors and healthy controls 
Hypothesis 1a:  There will be a significant increase in NK cell counts from pre-
exercise to immediately post-exercise in both breast cancer survivors and healthy controls. 
Hypothesis 1b:  There will be no significant difference in NK cell counts from pre-
exercise to 2 hours post-exercise in both breast cancer patients and healthy controls. 
Hypothesis 1c:  There will be no significant difference in NK cell counts from pre-
exercise to 24 hours post-exercise in both breast cancer patients and healthy controls. 
Hypothesis 1d:  There will be no significant differences in NK cell counts between 
breast cancer survivors and healthy controls at any time point (pre-exercise, immediately 
post-exercise, 2 hours post-exercise, and 24 hours post-exercise). 
Aim #2:  To examine the relationships between changes in catecholamine responses, 
cortisol responses, and changes in NK cell counts in breast cancer survivors and healthy 
controls. 
Hypothesis 2a:  Changes in catecholamine levels will be positively correlated with 
changes in NK cell counts from pre-exercise to immediately post-exercise in both breast 
cancer survivors and healthy controls. 
Acute Bout of Moderate 
Intensity Aerobic Exercise 
Δ epinephrine 
Δ norepinephrine 
Δ cortisol 
 
Δ NK cells counts 
 
 
Aim #2 
Aim #1 
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Hypothesis 2b:  Changes in cortisol levels will be positively correlated with changes 
in NK cell counts from pre-exercise to immediately post-exercise in both breast cancer 
survivors and healthy controls. 
Hypothesis 2c:  Changes in catecholamine levels will not be correlated with changes 
in NK cell counts from pre-exercise to 2 hours post-exercise in both breast cancer survivors 
and healthy controls because changes in catecholamine levels and NK cell counts may not be 
significantly different from pre-exercise to 2 hours post-exercise. 
Hypothesis 2d:  Changes in cortisol levels will not be correlated with changes in NK 
cell counts from pre-exercise to 2 hours post-exercise in both breast cancer survivors and 
healthy controls because changes in cortisol levels and NK cell counts may not be 
significantly different from pre-exercise to 2 hours post-exercise. 
Exploratory Analyses 
 In addition to performing the two Research Aims as described above, some 
exploratory analyses were conducted.  These included investigating changes in NK cell 
cytotoxic activity (NKCA) to the moderate intensity aerobic exercise bout in a subset of 
subjects at each study time point (pre-exercise, immediately post-exercise, 2 hours post-
exercise, and 24 hours post-exercise).  This analysis is addressed in Chapter III along with 
Aim #1 as previously described.  Additionally, the effect of the moderate intensity aerobic 
exercise bout on changes in catecholamine and cortisol levels in the breast cancer survivors 
and the healthy controls was examined at each study time point.  This analysis is addressed in 
Chapter IV.  As the investigation of the effect of the exercise bout on these parameters was 
for exploratory purposes, no specific hypotheses were tested. 
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CHAPTER TWO 
 
REVIEW OF LITERATURE 
Introduction 
The purposes of this investigation were to compare the NK cell response to an acute 
bout of moderate-intensity aerobic exercise and to compare the relationships between 
changes in NK cell and stress hormone responses to the acute bout of moderate-intensity 
aerobic exercise in breast cancer survivors and healthy controls.  The following literature 
review begins with a discussion of the role of NK cells in the destruction of pathogens, the 
major immune system factors that mediate the NK cell response and the general NK cell 
response to exercise.  The literature review then focuses on three stress hormones that are 
major mediators of the NK cell response to aerobic exercise:  the catecholamines 
(epinephrine and norepinephrine) and cortisol.  In these sections, the general function of each 
hormone is described, as well as its response to acute aerobic exercise and effect on NK cells.  
Next, the literature review includes a discussion of the major studies which have examined 
the effect of acute aerobic exercise on NK cell function in healthy individuals, both sedentary 
and physically active.  Finally, this literature review concludes with a discussion of the 
current literature investigating the effect of aerobic exercise interventions on immune 
function in the cancer patient population. 
Role of Natural Killer Cells in Destroying Pathogens 
  Natural killer (NK) cells are a major cellular component of the innate branch of the 
immune system.  They are derived from common lymphoid progenitor cells in the bone 
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marrow and are morphologically defined as large granular lymphocytes that do not express T 
cell receptors or surface immunoglobulins (40, 41).  They represent approximately 5-20% of 
mononuclear cells in the blood and spleen and are not commonly found in other lymphoid 
organs (40, 41).  NK cells are classified as lymphocyte subset, and are also referred to by 
their cluster of differentiation (CD) nomenclature as CD3
-
CD16
+
CD56
+
 (42).   
 Functionally speaking, NK cells are able to exhibit spontaneous cytolytic activity 
against a wide variety of virally-infected cells and tumor cells and are able to lyse target cells 
without any apparent previous sensitization (10).  They are able to respond rapidly to a viral 
challenge and can mount a proliferative and cytolytic response days before more specific 
adaptive immune responses can be generated (10, 43).  Once a target cell has been identified, 
NK cells secrete a protein called perforin, which creates pores in the target cell’s membrane 
(41).  Enzymes called granzymes enter the target cell through these pores, thus triggering an 
endogenous pathway of apoptosis (10, 41).   
Major Immune System Mediators of the NK cell Cytolytic Response 
 The proliferative and cytolytic activities of NK cells are mediated by soluble factors 
called cytokines, which are proteins that can regulate and coordinate many of the activities of 
the cellular components of the immune system (44). Cytokines act on other cells through 
transmembrane cell-surface receptors, thus activating intracellular signaling transduction 
pathways to induce gene transcription and synthesis of new cellular proteins (40).  The major 
cytokines that influence proliferation and activation of NK cells are interleukins (IL)-2, 12, 
15, and 18, as well as interferons (IFN)-α and β (41).   
 IL-15 is instrumental in mediating the differentiation and proliferation of NK cells in 
bone marrow (41, 45).  Hematopoietic stem cells develop into NK cell precursors through 
12 
 
sequential acquisition of functional cell surface receptors (45).  Once committed to the NK 
cell lineage, IL-15 stimulates receptors in these NK cell precursors, thus transforming them 
into mature NK cells (45).  IL-2, IL-12, IL-18, IFN-α, and IFN-β, are involved in stimulating 
the activity of NK cells.  In particular, IL-12, which is produced by other immune cells, is a 
powerful inducer of NK cell cytolytic activity, and IL-2 and IL-18 may act to augment the 
effect of IL-12 on NK cells (41).  IFN-α and IFN-β also increase the cytolytic potential of 
NK cells, possibly through upregulation of IL-12 receptor expression, and thus NK cell 
responsiveness to IL-12 (41).  
Once activated, NK cells also secrete a variety of cytokines. In particular, IL-12 
stimulates NK cells to secrete IFN-γ which may then stimulate other immune cells called 
macrophages to kill phagocytosed pathogens (41, 45).  NK cells may also secrete IL-1β, IL-
2, IL-3, IL-4, IL-5, and IL-6; each of which plays its own role in activating inflammatory 
pathways and stimulating proliferation, differentiation and activation of other immune cell 
types (45, 46). 
General NK Cell Response to Acute Aerobic Exercise 
 NK cells are extremely responsive to exercise, and generally produce a response that 
is biphasic in nature, meaning that they display one response profile immediately post-
exercise, and a second response profile during recovery (10).  In the first phase which 
manifests immediately post-exercise, NK cell counts and activity may be dramatically 
elevated over pre-exercise levels by anywhere from 50% to several hundred percent (10).  
However, this post-exercise increase is short-lived.  In the second phase which occurs several 
hours after the completion of  the exercise, NK cell counts and activity return to pre-exercise 
resting levels, and may even decrease below pre-exercise levels before returning to baseline 
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(10).  The magnitude of the NK cell fluctuations relative to baseline are generally related to 
intensity and duration of exercise.  Exercise bouts of higher intensity and/or longer duration 
typically produce a more pronounced biphasic response compared to exercise bouts of lower 
intensity and/or shorter duration (13, 47).  Increases in NK cell counts and activity during 
exercise are primarily associated with increased cardiac output and increased catecholamine 
levels which cause NK cells to be released into circulation from their marginal pools in blood 
vessels, lungs, lymph nodes, spleen, and intestines (10, 42, 48-50). 
 During the recovery period, particularly after exercise of higher intensity (> 60% of 
VO2max) and longer duration (> 1 hour), decreases in NK cell counts and activity below pre-
exercise resting values have been observed, which may persist for up to 4 hours post-exercise 
(42).  These decreases have been associated with several biological factors, including 
increased cortisol levels, alterations in cytokine release, and increased prostaglandin release 
from activated monocytes (10, 51-54).  This potential suppression of NK cell function has 
been incorporated into the “Open Window Theory” by some researchers, which states that 
immunosuppression in the hours following exercise may lead to an increased susceptibility to 
bacterial and viral infection, thus increasing an individual’s chance of acquiring subclinical 
or clinical infection (43, 55).  Researchers have also postulated that individuals who perform 
repeated bouts of acute high intensity/long duration exercise within a period of time without 
sufficient recovery may cause further decreases in an already-suppressed immune system, 
thereby leading to a more chronic form of decreased immune function (43).  However, much 
research is still needed in order to understand the impact of acute and chronic exercise, as 
well as the impact of other physical and psychological stressors, on long-term immune 
function before the open window theory can be fully accepted (55). 
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Catecholamines 
General Function of Catecholamines 
 The catecholamines include the two hormones epinephrine and norepinephrine as 
well as dopamine.  Epinephrine and norepinephrine are secreted from the adrenal medulla 
and released into the blood under stimulation from the sympathetic branch of the autonomic 
nervous system (56, 57).  The ratio of adrenal secretion of epinephrine to norepineprhine is 
approximately 4:1; however the circulating levels of norepinephrine exceeds epinephrine by 
a factor of 5-10, as it is also directly released by sympathetic neurons (56-58).  During times 
of significant physiological stress when the adrenal medulla is highly stimulated, circulating 
epinephrine may increase by 10-20-fold (57).  Epinephrine and norepinephrine function 
together to elicit physiological effects by binding to α and β receptors in tissues; thereby 
activating second messenger systems (56, 57).  The physiological responses caused by the 
catecholamines are often referred to collectively as “fight or flight” responses, which 
generally include increased activity of the cardiovascular, respiratory, muscular, metabolic, 
and thermoregulatory systems with decreased activity of the gastrointestinal and excretory 
systems (56, 57).   
Acute Aerobic Exercise Response of Catecholamines 
 Catecholamine release during acute aerobic exercise is mediated by increases in 
sympathetic nervous system activity and is mostly proportional to exercise intensity and 
duration (56).  During low intensity exercise (< 50% of VO2max), increased plasma 
norepinephrine levels may be observed, which is likely more related to increased sympathetic 
nervous system activity than increased adrenal medulla secretion (57, 59).  In contrast, 
plasma epinephrine may not significantly increase until moderate intensities are reached, 
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when adrenal medulla activity is also increased (57, 59).  Generally speaking, plasma 
catecholamine levels increase significantly when exercise intensity reaches approximately 
40-60% of VO2max (55).  For example, 20 minutes of exercise at 60% of VO2max may cause 
plasma catecholamines to increase 2-3 times pre-exercise levels (57, 59-61). 
In response to high intensity aerobic exercise, plasma catecholamine levels generally 
increase very dramatically.  Twenty minutes of aerobic exercise at 80% of VO2max may elicit 
a 350-500% increase in plasma catecholamines, while exercise at ≥ 100% of VO2max may 
elicit a 1000%-1500% increase in plasma catecholamines (57, 60, 61-63).  Similar increases 
in catecholamine levels can be observed with increasing exercise duration, where 50 minutes 
of moderate intensity exercise (60-70% of VO2max) may elicit a 300-900% increase in 
epinephrine and norepinephrine, while a 90 minute exercise session at the same intensity may 
result in a 10-11-fold increase (57).  When considering an exercise bout at a moderate 
intensity (50% of VO2max) until exhaustion, plasma catecholamines may increase 28-fold (57, 
63-65).  After the completion of exercise, clearance of catecholamines from circulation 
occurs rather quickly with a half-life of approximately 2-3 minutes (58). 
The major physiological systems targeted by the catecholamines during acute aerobic 
exercise are the cardiovascular, skeletal muscle, and metabolic systems, and the major 
actions of these hormones on these systems are to increase cardiac output, increase blood 
flow to working skeletal muscles, and increase breakdown of energy substrates, and 
upregulate metabolic pathways in order to generate ATP from energy substrates.  In the 
cardiovascular system, epinephrine and norepinephrine both stimulate β-adrenergic receptors 
in the heart, leading to increased heart rate and myocardial contractility which leads to 
increased cardiac output (57).  Norepinephrine activates α-adrenergic receptors in the 
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systemic blood vessels to cause generalized vasoconstriction, while epinephrine activates β-
adrenergic receptors in the arterioles of the heart and skeletal muscles to elicit vasodilation, 
the activities of which aim to decrease blood flow to non-essential tissues and increase blood 
flow to the exercising heart and muscles (57).  In the skeletal muscles and other tissues 
associated with metabolism, epinephrine is especially important in the upregulation of 
metabolic processes.  Epinephrine activates β-receptors in adipose tissue to cause the 
breakdown of triglycerides into free fatty acids to be used as energy (57, 59).  Epinephrine 
also has major effects on glucose metabolism and blood glucose maintenance by activating 
β-adrenergic receptors in the liver to increase glycogenolysis and gluconeogenesis (56, 57).  
In the skeletal muscle, epinephrine activates β-adrenergic receptors to increase the activities 
of the enzyme phosphorylase which further upregulates glycogenolysis, as well as 
phosphofructokinase which increases the rate of glycolysis (57).  Additionally, epinephrine 
activates α-receptors in the pancreas to decrease the release of insulin and increase the 
release of glucagon, further contributing to upregulation of glycogen and glucose metabolism 
(56, 57).  Thus, increased catecholamine secretion during increasing exercise intensity and 
duration is essential for increasing cardiac function to deliver blood to working muscles, 
increasing energy usage from lipids (particularly important during prolonged exercise), 
increasing energy usage from carbohydrates (particularly important during high intensity 
exercise), and maintaining blood glucose levels (57, 59). 
The Effect of Catecholamines on NK Cells 
 During acute aerobic exercise, the rise in catecholamine levels is associated with NK 
cell cytosis, and the primary mechanism of action appears to be a catecholamine-induced 
alteration in adhesion molecules that are expressed on NK cells, thus leading to mobilization 
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of NK cells into circulation (11, 13, 66, 67).  The surface density of β-adrenergic receptors is 
high in NK cells, and the density of these receptors is further increased after exposure to 
increased levels of catecholamines (11, 66).  When catecholamines bind to these β-adrenergic 
receptors, a second-messenger system involving the adenyl cyclase system and cAMP is 
activated (66).  Changes in the configurations of one or more adhesion molecules, including 
CD11, CD18, CD31, CD43, CD44, CD62L, sVCAM-1, sICAM-1 and sE-selectin, causes 
reduced expression on the NK cell’s surface, thus leading to demargination of NK cells from 
small venules and the spleen into circulation (66).  This effect is reversed after the cessation 
of the exercise bout.  Falling catecholamine levels are associated with a drop in NK cell 
counts, likely as a result of a decrease in β-adrenergic receptor density, which may return to 
pre-exercise levels within 1 hour post-exercise (66).  A detailed review of the literature 
examining the association between exercise-induced catecholamine response and NK cell 
response is discussed in the section entitled “Acute Aerobic Exercise and NK Cell Response 
in Healthy Individuals.” 
Cortisol 
General Function of Cortisol 
 Cortisol is a glucocorticoid hormone that is released from the adrenal cortex under 
control of the hypothalamic-pituitary-adrenal (HPA) axis.  Physical or emotional stress or 
decreased blood glucose levels stimulate the release of corticotrophin-releasing factor (CRF) 
from the hypothalamus, which in turn stimulates the release of adrenocorticotropin (ACTH) 
from the anterior pituitary (56, 57).  ACTH stimulates adenylate cyclase activity in the cells 
of the adrenal cortex, resulting in the formation of cAMP, which then stimulates the release 
of cortisol (56).  The activity of the HPA axis is controlled through a negative feedback loop 
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mechanism; additionally, ACTH and cortisol levels fluctuate throughout the day due to 
circadian rhythms, eating, and exercise patterns, with the highest levels observed during the 
morning hours (56, 57, 68, 69).   
 Once released, the major targets of cortisol are the liver, skeletal muscle, and adipose 
tissue; i.e., tissues that are crucial in providing energy to the body and maintaining blood 
glucose levels (56, 57).  Cortisol elicits its physiological effects through direct gene 
activation; it penetrates the target cell’s membrane, and binds to a cytoplasmic receptor 
protein (70).  The steroid-receptor complex is then activated and translocated to the target 
cell’s nucleus, where target cell gene expression is modulated by either stimulation or 
inhibition of specific mRNA production, thus manifesting as the cellular response specific to 
the hormone’s action (70).  In the liver, cortisol stimulates gluconeogenesis, which results in 
increased blood glucose levels (57).  In the liver and skeletal muscle, cortisol stimulates 
proteolysis (56, 57).  In the adipose tissue, cortisol acts in conjunction with epinephrine to 
stimulate lipolysis (57).  Additionally, large doses of glucocorticoids may lead to a reduced 
inflammatory response by inhibiting the production of pro-inflammatory cytokines such as 
IL-1, IL-6, and TNF-α, as well as by inhibiting the effects of these pro-inflammatory 
cytokines on target tissues (57, 68). 
Acute Aerobic Exercise Response of Cortisol 
 Similar to the catecholamines, plasma cortisol levels rise proportionally with respect 
to exercise intensity (> 40% of VO2max) and duration (70).  Aerobic exercise activates the 
HPA axis, which causes increased ACTH release from the anterior pituitary and increased 
cortisol output from the adrenal cortex.  Elevation in plasma cortisol levels seems to follow a 
threshold effect, where exercise intensities of > 40% of VO2max appear to elicit increased 
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plasma cortisol concentrations, and intensities below this threshold are either not stressful 
enough, or do not cause significant decreases in blood glucose levels (57).  High intensity 
aerobic exercise seems to elicit a dramatic increase in plasma cortisol levels.  For example, a 
study by Hill et al. (71) observed that 30 minutes of exercise at 80% of VO2max elicited an 
83% increase in cortisol levels in moderately-trained men.  During intense and prolonged 
exercise, plasma ACTH levels rise significantly, resulting in significant secretion or cortisol 
that may become particularly apparent after approximately 60 minutes of exercise (57, 70, 
72). 
 During aerobic exercise activities undertaken by most individuals, the most 
significant effects of cortisol are to stimulate lipolysis in the adipose tissue and 
gluconeogenesis in the liver, thus providing the body with free fatty acids for energy and 
allowing the body to maintain blood glucose levels (57). During very intense and prolonged 
exercise, energy derived from proteins may also become significant, and cortisol-induced 
muscle proteolysis may provide the body with this energy source (56).   
The Effect of Cortisol on NK Cells 
 As reported in the literature, the effect of cortisol on NK cells is mixed and may be 
more relevant during exercise of prolonged duration (42, 72).  Increased plasma cortisol 
levels have been associated with decreased NK cell counts and activity during recovery, and 
the major mechanisms of action are not completely understood, but may be related to 
glucocorticoid-induced apoptosis, inhibited adhesion of effector cells to target cells, and 
altered cytokine responses (13, 42, 43, 73).  In particular, cortisol may suppress production of 
the cytokines IL-2, IL-12, and IFN-γ and upregulate the actions of other cytokines including 
IL-4 and IL-10 which in turn may lead to a decrease in NK cell activity (13, 43, 51, 52).  A 
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detailed review of the literature examining the association between exercise-induced cortisol 
response and NK cell response is discussed in the section entitled “Acute Aerobic Exercise 
and NK Cell Response in Healthy Individuals.” 
Acute Aerobic Exercise and NK Cell Response in Healthy Individuals 
 NK cell response to exercise is commonly quantified using two main measurements:  
NK cell count and NK cell activity (NKCA).  Both are measured from blood samples that are 
usually taken at various points pre-exercise and post-exercise.  To obtain NK cell count for a 
blood sample, two measurements are generally needed:  absolute number of lymphocytes in 
the sample and the proportion of NK cells in the sample (measured using flow cytometry).  
Absolute lymphocyte number and NK cell proportion are multiplied together to determine 
the NK cell count, which is expressed as number of NK cells per unit blood (for example; 1 x 
10
9
cells/L, 1 x 10
6
 cells/mL, etc.).  NKCA can be obtained using several different techniques, 
including a whole-blood or isolated-peripheral blood mononuclear cell (PBMC) radioactive 
chromium-51 (
51
Cr) release assay, fluorescence microscopy, or flow cytometry.  These 
techniques measure the cytolytic capabilities of the NK cells in the sample by mixing NK 
cells (the “effector” cells) with target cells in various ratios, termed effector-to-target ratios 
(E:T ratios).  Cells are radioactively- or fluorescently-labeled depending on the technique to 
be used, and NKCA is determined by measuring differences in radioactivity or fluorescence 
between live cells, dead cells, and control cells.  NKCA is usually expressed as a percentage, 
commonly termed % cytotoxicity or % lysis.   
An examination of the exercise immunology literature describing NK cell response to 
acute aerobic exercise finds that there is not one uniform method of reporting results.  For 
example, some researchers have chosen to report NK cell counts as absolute numbers while 
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others have chosen to report NK cell counts as proportions of peripheral blood mononuclear 
cells (PBMC).  In the case of NKCA, most researchers have expressed results as % 
cytotoxity or % lysis; however, not all researchers have used the same E:T ratios when 
measuring NKCA.  Additionally, some studies have chosen to express NKCA in other units, 
such as lytic units per 10
7 
mononuclear cells, lytic units per L blood, and % lysis per NK cell. 
Furthermore, some researchers choose to report results in table form, while others present 
their results in graphical form only.   
 This section of the literature review describes results for NK cell counts using percent 
changes of the absolute NK cell numbers from baseline whenever possible (i.e., [post-
exercise NK cell count – pre-exercise NK cell count)/pre-exercise NK cell count]*100).  
NKCA will also be described using percent changes from baseline whenever possible (i.e., 
[post-exercise NKCA – pre-exercise NKCA)/pre-exercise NKCA]*100).  The purpose for 
describing NK cell counts and NKCA in this fashion is to make comparisons of results 
between studies easier.  In some cases, authors have directly reported percent changes in NK 
cell counts and NKCA, but in most cases, these have been calculated and estimated using 
data given in tables or graphs.   
This dissertation project was aimed to investigate the effect of acute moderate 
intensity aerobic exercise on NK cell responses in women who are breast cancer survivors 
and women who are healthy age-matched and physical-activity matched controls.  Therefore, 
it is important to note that relatively few studies have examined the effect of acute aerobic 
exercise on NK cell counts and activity in non-athletic populations, and that the majority of 
studies have focused on NK cell responses in elite and recreationally-active endurance 
athletes.  However, the current literature appears to show that regardless of the study 
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population, acute aerobic exercise responses in healthy individuals generally follow the same 
trend, with increases in NK cell counts and activity immediately post-exercise compared to 
pre-exercise levels, and decreases in NK cell counts and activity during the recovery period.  
The magnitude of these changes in NK cell function appears to be largely related to the 
intensity and/or duration of the exercise bout, with moderate intensities and/or shorter 
durations eliciting smaller changes from baseline compared to higher intensities and/or 
longer durations. 
Effect of Acute Aerobic Exercise on NK Cell Count 
Moderate Intensity Exercise and NK Cell Count 
Several studies have exclusively examined the effect of an acute bout of moderate 
intensity aerobic exercise on NK cell counts in healthy individuals, with exercise intensities 
and durations ranging from 60-65% of VO2max and 37 minutes-4 hours, respectively.  All 
studies measured NK cell counts from blood samples taken pre-exercise, immediately post-
exercise, and at various points during the short-term recovery period (0-2 hours).  One study 
measured NK cell counts further into the recovery period, at 24 and 72 hours post-exercise.  
Even at moderate intensities, NK cell counts have been shown to rise significantly 
immediately post-exercise to levels that can be anywhere from 76% to over 200% above pre-
exercise values.  During the recovery period, significant decreases in NK cell counts (usually 
greater than 50% below pre-exercise levels) have been described in some studies, although 
others have not observed significant decreases in NK cell counts.  These decreases in post-
exercise NK cell counts are typically short-lived, and return to near baseline levels within 2 
hours post-exercise. 
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Huang et al. (74) investigated the effect of a short-duration, moderate intensity 
exercise bout on NK cell counts in 8 professional firefighters of sedentary-low fitness levels 
(VO2max = 36.9 ± 5.8 mL/kg/min).  Subjects performed a cycle ergometry ride at 60% of 
VO2max for 37 minutes (an exercise intensity similar to what might be experienced during fire 
suppression activities).  NK cell counts were measured 50 minutes pre-exercise, 30 minutes 
pre-exercise, immediately pre-exercise, immediately post-exercise, and every 15 minutes 
during recovery until 1 hour post-exercise.  When comparing NK cell counts immediately 
pre-exercise and immediately post-exercise, NK cell counts increased significantly by 
approximately 120% (p < 0.001).  At 1 hour post-exercise, NK cell counts were slightly 
below pre-exercise levels by approximately 19%; however, this difference was not 
significant. 
Rhind et al. (49) investigated the effect of a moderate-duration, moderate intensity 
exercise bout on NK cell counts in 9 sedentary men both before and after participating in a 
12-week exercise training program.  Subjects performed a cycle ergometry ride at 60% of 
VO2max for 60 minutes at the beginning of the intervention, and then repeated the same 
exercise bout at the end of the intervention.  NK cell counts were measured pre-exercise, 
immediately post-exercise, 30 minutes post-exercise, and 2 hours post-exercise.  When 
comparing NK cell counts pre-exercise and immediately post-exercise, NK cell counts rose 
1.3-fold before the intervention (p < 0.01) and 1.4 fold after the intervention (p < 0.0001).  
During the recovery period, NK cell count significantly decreased by 56% below pre-
exercise values which persisted throughout the recovery period, from 30 minutes to 2 hours 
post-exercise (p < 0.05).  The magnitude of the post-exercise decrease in NK cells was the 
same both before and after the exercise intervention. 
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Natale et al. (50) and Scharhag et al. (75) investigated the changes in NK cell count in 
response to long-duration, moderate intensity exercise bouts, and although their study 
populations were different, the results were similar.  Natale et al. (50) studied the NK cell 
response to exercise in 8 relatively sedentary healthy men who each performed a 2-hour 
cycle ergometry ride at 60-65% of VO2max.  NK cell counts were measured pre-exercise, 
immediately post-exercise, 3 hours post-exercise, 24 hours post-exercise, and 72 hours post-
exercise.  NK cell counts increased significantly from pre-exercise to immediately post-
exercise by over 200% (p < 0.05).  By 3 hours post-exercise, NK cell counts had returned to 
pre-exercise values, and no further changes in NK cell counts were observed at 24 or 72 
hours post-exercise.  Scharhag et al. (75) examined the NK cell response to exercise in 12 
male competitive triathletes and cyclists who each performed a 4-hour cycle ergometry ride 
at 60% of VO2max.  NK cell counts were measured pre-exercise, immediately post-exercise, 
and during recovery at 1, 2, and 24 hours post-exercise.  NK cell counts increased 
significantly immediately post-exercise by approximately 76% over pre-exercise levels (p < 
0.05).  During the recovery period, NK cell counts decreased significantly below pre-exercise 
levels by approximately 66% at 1 hour post-exercise and 38% at 2 hours post-exercise (p < 
0.05).  At 24 hours post-exercise, NK cell counts had returned to near baseline levels.   
 There are several potential mechanisms which may be associated with the biphasic 
response of NK cell counts to these aerobic exercise bouts.  Increased cardiac output and 
increased sympatho-adrenergic system activation during exercise may be largely responsible 
for the marked NK cell cytosis immediately post-exercise (48-50).  Particularly for exercise 
intensities below 60% of VO2max, the increase in cardiac output may be the major factor 
leading to increases in NK cell counts (48).  However, increased cardiac output during 
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exercise may act synergistically with increased catecholamine levels to affect vascular 
endothelial-lymphocyte adhesion, which would recruit NK cells from their marginal pools 
and other reservoirs (49, 75).  NK cells may be especially responsive to increases in 
catecholamine levels during acute exercise because of their high density of β-adrenergic 
receptors.  Additionally, changes in NK cell response after prolonged exercise may be related 
to changes in inflammatory cytokines, such as IL-6 and TNF-alpha (50).  When comparing 
acute exercise responses before and after exercise training, Rhind et al. (49) explains that the 
increased NK cell response post-intervention may be related to exercise training-induced 
increases in the density of β-adrenergic receptors on NK cells, making them more responsive 
to the effects of catecholamines.  During the recovery period, decreases in NK cell counts 
seem to be related to exercise-induced increases in catecholamines and cortisol; the latter of 
which may be mediated by changes in the inflammatory cytokine IL-6 (75). 
High Intensity Exercise and NK Cell Count 
The vast majority of studies examining the NK cell response to acute aerobic exercise 
have been performed using high intensity exercise, and of these, most have been performed 
using athletes and physically-active individuals.  Many of these studies have exclusively 
examined the effect of an acute bout of high intensity aerobic exercise on NK cell response in 
healthy individuals, with intensities ranging from 70-100% of VO2max, and durations ranging 
from less than 10 minutes to nearly 5 hours.  All studies measured NK cell counts pre-
exercise, immediately post-exercise, and at various points 0-8 hours post-exercise, although a 
few have measured NK cell counts 15-24 hours post-exercise.   
Two studies have examined changes in NK cell counts in response to very short-term, 
high intensity aerobic exercise.  Penkman et al. (76) examined the effect of a simulated 200-
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meter rowing race in 7 female competitive rowers, and Wilson et al. (77) examined the effect 
of a 400-yard race-pace swim in 22 elite high school swimmers.  The duration of the exercise 
sessions were 8.1 ± 0.3 minutes for the rowers and approximately 7 minutes for the 
swimmers.  NK cell counts were measured pre-exercise, immediately post-exercise, and in 
the Penkman et al. (76) study, NK cell counts were also measured 1 hour post-exercise.  
Even though the exercise sessions were quite short, NK cell counts increased significantly 
over pre-exercise values by approximately 629% for the rowing session (p < 0.05) and by 
approximately 373% for the swimming session (p < 0.0001).  At 1 hour post-exercise, NK 
cell counts were decreased below pre-exercise values by approximately 35%, but this 
decrease below the pre-exercise level was not significant. 
Four studies have examined changes in NK cell counts to high-intensity exercise of 
fairly short durations (18 minutes-slightly over 30 minutes).  Moyna et al. (48) examined 
changes in NK cell counts in response to an 18-minute cycle ergometry ride in 32 healthy 
men and women.  Simpson et al. (79) and Campbell et al. (80) investigated changes in NK 
cell counts in response to treadmill runs to volitional fatigue (33.8 ± 12.3 minutes and 24 ±11 
minutes, respectively) in 8 endurance-trained healthy men.  Lastly, Duester et al. (81) 
investigated changes in NK cell counts in response to a 25-minute treadmill run in 22 
healthy, physically-fit men and women.  The exercise intensities for these studies ranged 
between 70-90% of VO2max (47, 78-80).  In all 4 studies, NK cell counts were measured pre-
exercise, and immediately post-exercise, During the recovery period, Simpson et al. (79) and 
Campbell et al. (80) measured NK cell counts at 1 hour post-exercise, and Moyna et al. (48) 
measured NK cell counts at 2 hours post-exercise.  In all 4 studies, NK cell counts were 
significantly elevated immediately post-exercise compared to pre-exercise levels by 
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approximately 53-543% (p < 0.001-0.05).  At 1 hour post-exercise, NK cell counts were 
significantly decreased below pre-exercise resting levels by approximately 50-77% (p < 0.01) 
(79, 80).  At 2 hours post-exercise, Moyna et al. (48) showed that NK cell counts had 
returned to near baseline values. 
Five studies have examined changes in NK cell counts to high intensity exercise of 
slightly longer durations (60-75 minutes).  McFarlin et al. (51, 52) performed two studies 
investigating changes in NK cell counts in response to a 60-minute cycle ergometry ride in 
samples of 13 and 8 endurance-trained men, respectively.   Pedersen et al. (53) examined 
changes in NK cell counts in response to a 60-minute cycle ergometry ride in 6 healthy 
untrained men.  Braun et al. (54) studied changes in NK cell counts in response to a 60-
minute treadmill run in 10 male distance runners.  Lastly, Ronsen et al. (82) examined 
changes in NK cell counts in response to a 75-minute cycle ergometry ride in 9 male 
endurance athletes.  Exercise intensities ranged from 75-85% of VO2max.  In all 5 studies, NK 
cell counts were measured pre-exercise and immediately post-exercise.  During the short-
term recovery period, Ronsen et al. (82) measured NK cell counts at 1 hour post-exercise, 
Braun et al. (54) measured NK cell counts at 1.5 hours post-exercise, and McFarlin et al. (51, 
52) and Ronsen et al. (82) measured NK cell counts at 2 hours post-exercise.  McFarlin et al. 
(51, 52) continued to measure NK cell counts at 4 hours post-exercise, Ronsen et al. (82) also 
measured NK cell counts at 3 hours, 4 hours, and approximately 15 hours post-exercise, and 
Pedersen et al. (53) measured NK cell counts at 24 hours post-exercise.   In all 5 studies, NK 
cell counts were significantly elevated immediately post-exercise compared to pre-exercise 
levels by approximately 82-460% (p < 0.001-0.05).  During the short-term recovery period 
(0-2 hours), Braun et al. (54) and Pedersen et al. (53) reported that NK cell counts were 
28 
 
slightly below pre-exercise levels by 25-35%, but the difference was not significant.  
McFarlin et al. (52) also reported that NK cell counts were near pre-exercise levels at 2 hours 
post-exercise.  However, McFarlin (51) reported a significant decrease in NK cell count at 2 
hours post-exercise of approximately 53% below pre-exercise levels (p < 0.05).  It seems 
though that these short-term decreases in NK cell counts appear to resolve by 4 hour post-
exercise, and that NK cell counts do not seem to undergo further significant alteration 
between 4 and 24 hours post-exercise (50-52, 81).   
Three studies investigated changes in NK cell counts in response to high intensity 
exercise using durations that exceeded 1.5 hours.  Briviba et al. (83) investigated changes in 
NK cell counts in response to running a marathon or half-marathon in 22 recreational 
runners, with race times ranging from 1.5-2.6 hours for the half-marathon and 3.4-4.8 hours 
for the marathon.  Kakanis et al. (84) examined changes in NK cell counts in response to a 2-
hour cycle ergometry ride in 10 elite male cyclists.   Lastly, Nieman et al. (85) studied 
changes in NK cell counts in response to a 2.5-hour treadmill in 13 experienced male and 
female marathon runners.  The quantification of exercise intensity was slightly different 
among the studies.  In the Briviba et al. (83) study, exercise intensity was not explicitly 
stated, but it is likely that subjects were running at an intense race-pace effort.  In the 
Kakanis et al. (84) study, subjects exercised at 90% of the second ventilatory threshold.  In 
the Nieman et al. (85) study, subjects exercised at 75-80% of VO2max.  Additionally, the 
timing of NK cell measurements was slightly different among the studies.  In the Briviba et 
al. (83) study, NK cell counts were measured 10 days pre-race and within 20 minutes post-
race.  In the Kakanis et al. (84) study and the Nieman et al. (85) study, NK cell counts were 
measured pre-exercise and immediately post-exercise.  Kakanis et al. (84) measured NK cell 
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counts during recovery at 2, 4, 6, 8, and 24 hours post-exercise, while Nieman et al. (85) 
measured NK cell counts during recovery at 1.5, 3, and 6 hours post-exercise.  Results were 
varied among the studies.  Briviba et al. (83) found that the proportion of NK cells increased 
pre-race to post-race in both the half-marathoners and the marathoners (17 ± 2% to 24 ± 6% 
and 16 ± 2% to 18 ± 2%, respectively) but the increases were not statistically significant.  
Kakanis et al. (84) found some rather unique results, in that NK cell counts decreased slightly 
immediately post-exercise compared to pre-exercise values by less than 10%, and the 
difference was not statistically significant.  At 4-8 hours post-exercise, NK cell counts had 
decreased significantly below pre-exercise levels, by approximately 40% (p < 0.05).  By 24 
hours post-exercise, NK cell counts were approximately 10% below pre-exercise levels 
(difference not significant), and had therefore returned to near baseline levels.  Nieman et al. 
(85) showed results that were similar to previously-mentioned studies, that NK cell counts 
increased significantly immediately post-exercise by approximately 83% over pre-exercise 
levels (p < 0.05).  At 1.5-3 hours post-exercise, NK cell counts were decreased by 
approximately 50-60% below pre-exercise levels (p < 0.05).  At 6 hours post-exercise, NK 
cell counts were approximately 30% below pre-exercise levels, but the difference was not 
statistically significant. 
Finally, 4 studies have exclusively examined the effect of a graded exercise bout or 
VO2max test on NK cell counts.  Gabriel et al. (86) investigated changes in NK cell counts 
before and after a VO2max test in 10 healthy untrained individuals.  Woods et al. (87) studied 
changes in NK cell counts before and after a VO2max test in 11 sedentary elderly men and 
women enrolled in a 6-month moderate-intensity aerobic exercise intervention.  Van der 
Pompe et al. (88) investigated changes in NK cell counts in 13 healthy post-menopausal 
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women before and after performing a graded cycle ergometry protocol.  Simpson et al. (89) 
investigated changes in NK cell counts in response to a VO2max test in 16 healthy younger 
and older men.  The exercise protocols used for each study were slightly different.  In the 
Gabriel et al. (86) study, subjects performed an incremental graded cycle ergometry protocol.  
In the Woods et al. (87) study, subjects performed a modified Balke treadmill test.  In the van 
der Pompe et al. (88) study, subjects performed a graded cycle ergometry protocol, with 
intensities progressing at 40%, 60%, 80%, and 100% of VO2max.  In the Simpson et al. (89) 
study, subjects performed a walking protocol on the treadmill.  All subjects exercised until 
volitional fatigue.  In all 4 studies, NK cell counts were measured pre-exercise and 
immediately post-exercise.  During the recovery period, van der Pompe et al. (88) measured 
NK cell counts at 5, 15, and 30 minutes post-exercise, while Gabriel et al. (86) and Simpson 
et al. (89) measured NK cell counts at 1 hour post-exercise.  All 3 studies showed significant 
increases in NK cell counts immediately post-exercise compared to pre-exercise levels.  
Gabriel et al. (86) found that NK cell counts increased by approximately 250% over pre-
exercise values (p < 0.025).  Woods et al. (87) found that the proportions of NK cells in 
circulation increased significantly immediately post-exercise both before and after the 6- 
month exercise intervention (~22 ± 3% to ~31 ± 5%, p < 0.05 before the intervention; and 
~17 ± 2% to ~26 ± 2%, p < 0.05 after the intervention).  No differences were observed when 
comparing the magnitude of the NK cell count responses pre-intervention and post-
intervention.  Van der Pompe et al. (88) showed that NK cell counts immediately post-
exercise increased 6-fold over pre-exercise values (p < 0.001).  Simpson et al. (89) showed 
that NK cell response was similar for both younger and older men, in that NK cell counts 
increased significantly immediately post-exercise compared to pre-exercise levels by 
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approximately 286% in the younger group and 297% in the older group (p < 0.001).  At 30 
minutes post-exercise, van der Pompe et al. (88) showed that NK cell counts had returned to 
near baseline value.  At 1 hour post-exercise, Gabriel et al. (86) showed that NK cell counts 
decreased significantly below pre-exercise values by approximately 50% (p < 0.01), while 
Simpson et al. (89) showed that NK cell counts were significantly decreased below pre-
exercise values by approximately 79% in the younger group (p < 0.001) and 70% in the older 
group (p < 0.05).   
The potential mechanisms which may be associated with the biphasic response of NK 
cell counts to these high intensity aerobic exercise bouts are similar to those described for 
moderate intensity aerobic exercise.  The marked rise in NK cell counts immediately post-
exercise is likely associated with increased cardiac output and catecholamines.  Epinephrine 
in particular may induce selective recruitment of NK cells from marginal pools by changing 
the adhesive interaction between endothelial cells and NK cells (48, 53).  During the 
recovery period, cortisol may be a major factor mediating the NK cell cytopenia, possibly 
through alterations in cellular adhesive interactions (53, 84, 85).  This may be of particular 
importance during exercise exceeding 60 minutes in duration, where increases in cortisol 
may overshadow the influence of epinephrine, thus facilitating the egress of NK cells out of 
circulation (85).   
Two studies offered further insight into potential factors which may have lead to their 
observed results.  Briviba et al. (83) observed non-significant increases in NK cell counts in 
response to half-marathon and marathon racing.  The authors suggest that these results may 
be associated with differences in the time at which catecholamines and cortisol were released 
during exercise, as subjects were running the races at different paces, and therefore were 
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exercising for different durations (ranges of 1.5-2.6 hours for the half-marathon, and 3.4-4.8 
hours for the marathon).  Additionally, blood sample timing may have affected results, as 
pre-race NK cell counts were determined from samples taken 10 days pre-race, and post-race 
NK cell counts were determined from samples taken anytime between 0-20 minutes post-
race.  Kakanis et al. (84) did not offer any explanation of why a decrease in NK cell counts 
was observed immediately post-exercise.  However, when the authors examined NK cells 
according to their subsets (CD56
bright
 and CD56
dim
), they observed that the CD56
bright
 NK 
cells significantly immediately post-exercise, compared to pre-exercise levels.  This increase 
in the CD56
bright
 NK cells have implications in enhancing other innate immune responses, 
particularly through inducing increases in TNF-alpha, which can lead to increases in 
neutrophil counts.   
Kakanis et al. (84) also suggests that the NK cell cytopenia observed during the 
recovery period from 0-8 hours post-exercise may possibly support the “open-window” 
theory.  As NK cells are a first line of defense against pathogens, decreased NK cell numbers 
during recovery could provide an opportunity for pathogens to invade the body, thus 
potentially increasing susceptibility for infections such as upper respiratory tract infections 
(URTI).  The observed decrease in NK cell counts 6-8 hours post-exercise may be of 
relevance when considering the implications of repeated bouts of exercise, as performing 
additional exercise bouts when NK cell numbers are suppressed may lead to chronic NK cell 
suppression, thus further increasing the susceptibility to infection (84). 
Studies Comparing Exercise Intensities and NK Cell Count 
The previously described studies have exclusively examined either the effect of 
moderate intensity exercise on NK cells, or the effect of high intensity exercise on NK cells.  
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In this section, seven studies are now discussed which have explored and compared the 
effects of different exercise intensities on changes in NK cell counts.  These studies have 
examined and compared various combinations of exercise intensity, such as comparing the 
effects of low and high intensity, moderate and high intensity, or low, moderate, and high 
intensity. 
Anane et al. (90) and Campbell et al. (91) compared changes in NK cell counts in 
response to short-duration aerobic exercise at low and high intensity in 11 and 13 healthy 
physically-active men, respectively.  In both studies, subjects performed two 20-minute cycle 
ergometry rides, one at 35% of VO2max and one at 85% of VO2max.   Anane et al. (90) 
measured NK cell counts pre-exercise, during the final 2 minutes of exercise, and at 15 
minutes post-exercise.  Campbell et al. (91) measured NK cell counts pre-exercise, 
immediately post-exercise, 15-minutes post-exercise, and 1 hour post-exercise.  In both 
studies, NK cell counts increased significantly at the end of the low-intensity exercise bout 
levels by approximately 156% (p< 0.05) (89) and 158%  (p < 0.001) compared to pre-
exercise levels (91)  Similarly, NK cells increased significantly immediately after high 
intensity exercise in both studies by approximately 829% (p<0.05) (89) and 935% (p < 
0.001) (91).  During the recovery period after low-intensity exercise, Anane et al. (90) 
observed that NK cell counts had returned to slightly above pre-exercise levels at 15 minutes 
post-exercise.  Campbell et al. (91) also observed that NK cell counts returned to slightly 
above pre-exercise levels at 15 minutes post-exercise, where they remained throughout the 1-
hour recovery period.  During the recovery period after high intensity exercise, Anane et al. 
(90) and Campbell et al. (91) observed that NK cell counts were still elevated at 15 minutes 
post-exercise by approximately 100% (p < 0.01).  At 1 hour post-exercise, Campbell et al. 
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(91) found that NK cell counts were decreased below pre-exercise values by approximately 
35%; however, the difference was not statistically significant.  When comparing the 
magnitude of the NK cell responses to the low and high intensity bouts, both studies 
observed marked differences, where the high intensity session produced a greater change in 
NK cell counts immediately post-exercise (156% vs. 829%; p < 0.001, and 158% vs. 935%).  
The studies did not directly compare the NK cell count responses between intensities during 
the recovery period, although it is apparent that NK cell counts returned to near baseline 
levels within 15 minutes post-low intensity exercise whereas they were still elevated after 
high intensity exercise.  At 1 hour into recovery, high intensity exercise had elicited a 35% 
decrease in NK cells, which was not seen after low intensity exercise (91). 
Nieman et al. (92) examined changes in NK cell counts in 10 male runners following 
two 45-minute treadmill runs, one at 50% of VO2max and one at 80% of VO2max.   NK cell 
responses (reported as percentages of lymphocyte counts) were measured pre-exercise, 
immediately post-exercise, and during recovery at 1 hour, 2 hours, and 3.5 hours post-
exercise.  Both exercise bouts elicited significant increases in NK cells during exercise.  In 
response to the moderate intensity bout, the percentage of NK cells in circulation increased 
from 14.0 ± 2.4% pre-exercise to 19.1 ± 2.6% immediately post-exercise (p < 0.0125).  In 
response to the high intensity bout, the percentage of NK cells in circulation increased from 
17.8 ± 3.2% pre-exercise to 26.7 ± 3.2% immediately post-exercise (p < 0.0125).  During the 
recovery period, the percentage of NK cells decreased significantly below pre-exercise 
values in response to both intensities.  In response to the moderate intensity exercise bout, the 
percentage of NK cells was 9.6 ± 2.5%, at 1 hour post-exercise, while at 2 hours post-
exercise, the percentage of NK cells was 8.5 ± 1.7% (p = 0.02 and < 0.003, respectively).  At 
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3.5 hours post-moderate intensity exercise, the percentage of NK cells had risen to 12.7 ± 
1.9%, which was still decreased below pre-exercise values, but the difference was not 
significantly significant.  In response to the high intensity exercise bout, the percentage of 
NK cells was 7.8 ± 1.3% at 1 hour post-exercise, while at 2 hours post-exercise, the 
percentage of NK cells was 9.2 ± 1.4%, (p < 0.003 compared to pre-exercise values).  At 3.5 
hours post-high intensity exercise, the percentage of NK cells was still slightly decreased 
below pre-exercise levels at 12.3 ± 1.9%, but the difference was not statistically significant.  
The only time-point at which changes in NK cell counts statistically differed among the 
moderate and high intensity exercises sessions was immediately post-exercise, where the 
percentage of NK cells was significantly greater for the high-intensity exercise session (26.7 
± 3.2% vs. 19.1 ± 2.6%; p < 0.0125).   
Wang et al. (93, 94) performed two studies investigating changes in NK cell counts to 
moderate intensity exercise and a VO2max test in sedentary men.  In the first study (93), 16 
subjects participated in a cycle ergometry ride at 50% of VO2max for 30 minutes, as well as a 
graded VO2max test on the cycle ergometer.  NK cell counts were measured pre-exercise, 
immediately post-exercise, and during recovery at 2 hours post-exercise.  In response to the 
moderate intensity exercise bout, NK cell counts increased significantly immediately post-
exercise by approximately 50-100% compared to pre-exercise values (p < 0.05).  At 2 hours 
post-moderate intensity exercise, NK cell counts were slightly below pre-exercise values but 
the difference was not statistically significant.  In response to the high intensity exercise bout, 
NK cells also increased significantly immediately post-exercise by approximately 400-500% 
(p < 0.05) compared to pre-exercise values.  At 2 hours post-high intensity exercise, NK cell 
counts decreased significantly below pre-exercise values (p < 0.05).  The authors do not 
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make any direct comparisons between the moderate and high intensity exercise bouts, but it 
is apparent that the magnitude of NK cell increase in response to the high intensity exercise 
bout is markedly greater than the response to the moderate intensity bout.  Likewise, the NK 
cell cytopenia during recovery was greater in response to the high intensity bout compared to 
the moderate intensity bout. 
In the second study by Wang et al. (94), 30 subjects participated in a moderate 
intensity cycle ergometry ride at 60% of VO2max for 40 minutes.  Additionally, subjects 
performed a graded VO2max test on a cycle ergometer, as well as a combination moderate-
high intensity exercise bout where subjects cycled at 60% of VO2max for 20 minutes, rested 
for 30 minutes, and then performed a VO2max test.  NK cell counts were measured pre-
exercise and immediately post-exercise.  In response to the moderate intensity exercise bout, 
NK cell counts increased slightly immediately post-exercise by approximately 13% (not 
statistically significant).  In response to the high intensity and combined moderate-high 
intensity exercise bouts, NK cell counts increased significantly by approximately 403% and 
285%, respectively (p < 0.05).  No direct comparisons were made between exercise bouts, 
but again, it is apparent that the high-intensity and combined moderate-high intensity bouts 
elicited a markedly greater NK cell cytosis compared to the moderate intensity bout. 
 Bruunsgaard et al. (95) investigated the NK cell response to two different exercise 
bouts in 9 recreationally-active men.  Subjects performed a 30-minute cycle ergometry ride at 
65% of VO2max, using normal concentric pedaling, as well as a 30-minute cycle ergometry 
ride using eccentric pedaling at 100-150% of the workload that elicited concentric VO2max.  
NK cell counts were measured from blood samples taken pre-exercise, during minute 20 of 
exercise, immediately post-exercise, and during recovery at 2 hours post-exercise.  NK cell 
37 
 
counts increased significantly immediately post-exercise by approximately 360% compared 
to pre-exercise levels, in response to both types of cycle ergometry rides (p < 0.05).  At 2 
hours post-exercise, NK cell counts decreased below pre-exercise levels by approximately 
23% and 34% for the concentric ride and the eccentric rides, respectively; however, neither 
decrease was significantly different from pre-exercise levels.  NK cell counts were not 
significantly different between the concentric and eccentric exercise bouts pre-exercise, 
immediately post-exercise, or during recovery. 
Lastly, Kendall et al. (96) examined changes in NK cell counts in response to low, 
moderate, and high intensity exercise in 22 healthy young adult men.  Subjects were divided 
into 3 groups based on aerobic fitness.  Eight subjects were classified as low-fit (VO2max < 50 
mL/kg/min), 6 subjects were classified as moderately-fit (VO2max = 50-60 mL/kg/min), and 8 
subjects were classified as highly fit (VO2max > 60 mL/kg/min).  All subjects participated in 
four randomly-ordered cycle ergometry rides of varying intensities and durations:  a low 
intensity ride at 30% of VO2max for 60 minutes, two moderate intensity rides at 65% of 
VO2max for 30 minutes and 120 minutes, and a high intensity ride at 75% of VO2max for 60 
minutes.  NK cell counts were measured 24 hours pre-exercise, immediately pre-exercise, 
immediately post-exercise, 30 minutes post-exercise, 2 hours post-exercise, and 24 hours 
post-exercise.  Changes in NK cell counts were compared within exercise bouts and within 
groups only (i.e., pre-exercise to post-exercise responses for each exercise bout within each 
group), and because of multiple comparisons, the alpha level was set fairly conservatively at 
0.005.  When examining the NK cell response to the low-intensity exercise bout (30% of 
VO2max for 60 minutes), only the highly-fit group experienced a significant increase 
immediately post-exercise compared to pre-exercise levels  (~167%; p < 0.005).  When 
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examining the NK response to the short-duration moderate intensity bout (65% of VO2max for 
30 minutes), only the low-fit group experienced a significant increase immediately post-
exercise compared to pre-exercise levels (~175%, p < 0.005).  When examining the NK cell 
response to the long-duration moderate intensity exercise bout (65% of VO2max for 120 
minutes), the low-fit and high-fit groups experienced significant increases immediately post-
exercise compared to pre-exercise values (~275% and ~533% respectively; p < 0.005).  
Lastly, when examining the NK cell response to the high intensity exercise bout (75% of 
VO2max for 60 minutes), all 3 fitness groups experienced significant increases immediately 
post-exercise compared to baseline values (~275-900%, p < 0.005).   The post-exercise 
increases in NK cell counts were transient for all exercise bouts in all fitness-level groups, 
and all returned to pre-exercise levels by 30 minutes post-exercise with no further changes 
observed throughout the 24-hour recovery period.   
In all 7 of these studies, the magnitude of NK cell response was markedly more 
pronounced for exercise bouts of higher intensities compared to exercise bouts of low and 
moderate intensities.  The mechanisms leading to the observed results are similar to what has 
been described previously.  Increases in NK cell counts during exercise may be associated 
with increases in cardiac output as well as catecholamines, particularly epinephrine, as NK 
cells possess a high number of β-adrenergic receptors, and epinephrine is a potent β-
adrenergic receptor agonist (92).  Furthermore, the density of the β-adrenergic receptors on 
NK cells may also increase in response to high intensity exercise, further contributing to the 
increased magnitude of the NK cell cytosis during high intensity exercise in comparison to 
low and moderate intensity exercise (92, 94).  The NK cell cytopenia that occurs during 
recovery is likely associated with increased cortisol levels particularly in response to 
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prolonged exercise, as corticosteroids can elicit a redistribution of NK cells from the blood to 
other sites in the body (92, 94).   
Two studies offer further explanations pertaining to their specific observed results.  
Campbell et al. (91) noted that during the recovery period after high intensity exercise, NK 
cell counts were decreased by approximately 35% below pre-exercise levels and that this 
decrease was not statistically significant.  While the exercise intensity was quite high (85% 
of VO2max), the duration was rather short (20 minutes).  Therefore, the exercise may not have 
been of sufficient duration in order to elicit a significant NK cell cytopenia during recovery 
(91).  Kendall et al. (96) observed NK cell responses of varying magnitudes to the different 
exercise intensities and durations in the 3 fitness-level groups.  The authors speculate that the 
wide array of responses may be due to differences in absolute exercise workloads rather than 
relative workloads, as well as differences in perceived stress within fitness groups (96). 
Effect of Acute Aerobic Exercise on NKCA 
Moderate Intensity Exercise and NKCA 
Of the four previously described studies that have exclusively examined the effect of 
an acute bout of moderate intensity aerobic exercise on NK cell counts in healthy individuals, 
one also examined the effect of acute moderate intensity exercise on NKCA.  Scharhag et al. 
(75) examined NKCA in 12 male competitive triathletes and cyclists in response to 4 hours 
of cycling at 60% of VO2max.  Whereas NK cell counts were measured at various points pre- 
and post-exercise, NKCA was only measured pre-exercise and immediately post-exercise.  
NKCA was measured using flow cytometric analysis.  Briefly, NK cells were mixed with 
fluorescently-labeled K562 target cells in an effector-to-target cell ratio (E:T ratio) of 50:1.  
NKCA (% lysis) was determined by subtracting the percentage of dead cells in the control 
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sample from the percentage of killed target cells in the test sample, and the number of NK 
cells needed to lyse one target cell were calculated as follows:  needed NK cells = effector 
cells * % NK cells measured by flow cytometry / target cells * % specific lysis.  The authors 
found that the number of NK cells needed to lyse one K562 target cell (i.e., single cell 
NKCA) did increase immediately post-exercise compared to pre-exercise values, but the 
increase was slight and not statistically significant.  However, as described previously, the 
authors did observe a significant increase in NK cell counts immediately post-exercise by 
approximately 76% over pre-exercise levels (p < 0.05).  These findings may indicate that 
significant changes often observed for NKCA in response to aerobic exercise may be more 
related to the numerical redistribution of NK cells rather than of single cell NKCA (75).   
High Intensity Exercise and NKCA 
Eleven studies have exclusively studied the effect of acute high intensity aerobic 
exercise on changes in NKCA in healthy individuals using both short and long duration 
protocols.  The 
51
Cr release assay was the most common method used to determine NKCA, 
either by whole-blood or isolated-PBMC techniques.  However, for three of the more recent 
studies, flow cytometric or calcein-AM fluorescence techniques were used to determine 
NKCA. 
Moyna et al. (48) investigated the NKCA response to an 18-minute cycle ergometry 
ride in 32 healthy men and women, where exercise intensity progressed until 85% of VO2max.  
As was the case for NK cell counts, NKCA was measured pre-exercise, immediately post-
exercise and during recovery at 2 hours post-exercise. NKCA was determined using a whole-
blood 
51
Cr release assay.  Briefly, K562 target cells were labeled with 
51
Cr and then mixed 
with heparinized whole blood in varying concentrations (2.0x10
6 
cells/mL, 1.0x10
6
 cells/mL, 
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0.5x10
6
 cells/mL, and 0.25x10
6 
cells/mL).  NKCA was expressed in cytolytic units, 
calculated using an algorithm that includes the percentage specific lysis and the natural 
logarithm of the concentration of target cells.  The authors found that NKCA increased 
significantly immediately post-exercise by approximately 100% over pre-exercise levels (p < 
0.001).  At 2 hours post-exercise, NKCA had returned to near baseline levels along with NK 
cell count.  Percent change in NK cell count was significantly correlated with percent change 
in NKCA during exercise at 85% of VO2max (r = 0.60; p < 0.001). Percent change in NK cell 
count was also significantly correlated with percent change in NKCA at 2 hours post-
exercise (r = 0.31; p < 0.001).   
Pedersen et al. (53), Braun et al. (54), and McFarlin et al. (51, 52, 97) examined 
NKCA responses to high intensity exercise of 60-75 minutes in duration.   Pedersen et al. 
(53) examined the NKCA response to a 60-minute cycle ergometry ride at 80% of VO2max in 
6 healthy untrained men.  As was the case for NK cell counts, NKCA was measured pre-
exercise, during the last few minutes of exercise, 2 hours post-exercise, and 24 hours post-
exercise.  A 
51
Cr release assay
 
was used to determine NKCA from isolated blood 
mononuclear cells (BMNC).  Briefly, K562 target cells were labeled with 
51
Cr and mixed 
with BMNC in an E:T ratio of 100:1.  NKCA was expressed as % lysis per fixed number of 
mononuclear cells, and was calculated by measuring differences in 
51
Cr release from test 
samples and control samples.  
 
The authors found that NKCA increased significantly during 
exercise by more than 50% above pre-exercise values (p < 0.05), along with a significant 
increase in the percentage of CD16
+
 NK cells (p < 0.05).  During the recovery period, NKCA 
decreased approximately 40% below pre-exercise values, which was significantly decreased 
below the pre-exercise level (p < 0.05), although the percentage of CD16
+
 NK cells had 
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returned to pre-exercise levels.  NKCA returned to pre-exercise levels by 24 hours post-
exercise as did the percentage of CD16
+
 NK cells.   
Braun et al. (54) examined the NKCA response to a 60-minute treadmill run at 85% 
of VO2max in 10 male distance runners. As was the case with NK cell counts, NKCA was 
measured pre-exercise, immediately post-exercise, and 1.5 hours post-exercise.  The authors 
investigated changes in NKCA using 3 different methods:  an isolated-PBMC 
51
Cr release 
assay with E:T ratios of 2.5:1, 5:1, 10:1, and 20:1; a whole-blood 
51
Cr release assay with the 
same E:T ratios; and the whole-blood 
51
Cr release assay with results expressed using an E:T 
ratio of 1:1 (i.e, a “per-cell” NK basis).  The results for changes in NKCA varied somewhat 
based on the method used to determine NKCA.  When using the isolated-PBMC method, 
NKCA (% lysis) increased significantly immediately post-exercise compared to pre-exercise 
levels (8.06 ± 1.39% vs. 22.24 ± 2.76%; p < 0.05).  At 1.5 hours post-exercise, NKCA 
decreased below pre-exercise values but the difference was not statistically significant (8.06 
± 1.39% vs. 5.86 ± 1.06%).  When using the whole-blood method, NKCA also increased 
significantly immediately post-exercise compared to pre-exercise levels (14.04 ± 2.07% vs. 
39.49 ± 2.26%; p < 0.05).  NKCA decreased significantly below pre-exercise levels at 1.5 
hours post-exercise (14.04 ± 2.07% vs. 7.14 ± 1.00%; p < 0.05).  When using the whole-
blood method but expressing NKCA on a “per-NK cell-basis,” NKCA again increased 
significantly immediately post-exercise compared to pre-exercise levels (16.53 ± 2.08% vs. 
38.68 ± 2.89%; p < 0.05).  At 1.5 hours post-exercise NKCA was slightly decreased below 
pre-exercise values, however, the difference was not statistically significant (16.53 ± 2.08% 
vs. 11.31 ± 1.39%). 
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McFarlin et al. (51, 52, 97) performed a series of 3 studies investigating the NKCA 
response to a 60-minute cycle ergometry ride at 70-80% of VO2max in 8-13 trained subjects.  
All 3 studies measured NKCA pre-exercise, immediately post-exercise, and at 2 hours post-
exercise.  Two of the studies (51, 52) also measured NKCA at 4 hours post-exercise.  NKCA 
was determined using two different methods.  McFarlin et al. (51, 52) used a whole-blood 
51
Cr release assay.  McFarlin et al. (97) used a modified method, where whole blood was 
mixed with varying concentrations of K562 target cells which had been labeled with Calcein-
AM fluorescent dye instead of 
51Cr.  NKCA was expressed on a 1:1 E:T ratio (a “per-NK 
cell” basis) for both assays.   All 3 studies showed significant increases immediately post-
exercise by approximately 68-290% compared to pre-exercise levels (p < 0.05).  At 2 hours 
post-exercise, NKCA decreased by approximately 40% (50), 44% (52), and 19% (97); 
however, only the 40% decrease was statistically significant (p < 0.05).  At 4 hours post-
exercise, NKCA had returned to near baseline levels (51, 52). 
Nieman et al. (85), Briviba et al. (83), and Kakanis et al. (84) examined NKCA 
responses to high intensity exercise exceeding 1.5 hours in duration.  Nieman et al. (85) 
examined the NKCA response to a 2.5 hour treadmill run at 75-80% of VO2max in 13 
marathon runners.  As was the case for NK cell counts, NKCA was measured pre-exercise, 
immediately post-exercise, and during recovery at 1.5 hours, 3 hours, and 6 hours post-
exercise.  NKCA was determined using an isolated-PBMC 
51
Cr release assay with E:T ratios 
of 40:1, 20:1, 10:1, and 5:1.  When all NKCA data was combined and expressed as total lytic 
units per 10
7
 mononuclear cells, a significant time effect was observed (p < 001).  NKCA 
increased immediately post-exercise compared to pre-exercise levels, by approximately 34%.  
At 1.5 hours post-exercise, NKCA had decreased to approximately 49% below pre-exercise 
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values, and then increased to approximately 40% below pre-exercise values at 3 and 6 hours 
post-exercise.  When NKCA was expressed on a “per-NK-cell” basis, the time effect was 
erased, and NKCA did not differ significantly from pre-exercise values at any time point 
post-exercise. 
Briviba et al. (83) examined the NKCA to running a marathon or half-marathon in 22 
recreational runners.  As was the case for NK cell counts, NKCA was measured 10 days pre-
race and within 20 minutes post-race.  NKCA was measured using flow cytometric methods.  
Briefly, PBMC cells were isolated and mixed with fluorescently-labeled K562 target cells in 
E:T ratios of 50:1, 25:1, and 12.5:1.  NKCA (% lysis) was determined by examining 
differences in fluorescence for damaged and undamaged target cells.  For individuals 
competing in the half-marathon, NKCA increased significantly pre-race to post-race (61 ± 
6% lysis vs. 69 ± 7% lysis; p = 0.009).  For individuals competing in the full marathon, 
NKCA increased slightly pre-race to post-race, but the difference was not significant (61 ± 
7% lysis vs. 62 ± 5% lysis). 
Kakanis et al. (84) examined changes in NK cell counts in response to a 2-hour cycle 
ergometry ride in 10 elite male cyclists exercising at 90% of their second ventilatory 
threshold.  As was the case with NK cell counts, NKCA was measured pre-exercise, 
immediately post-exercise, and during recovery at 2, 4, 6, 8, and 24 hours post-exercise.  
NKCA was determined using flow cytometric methods with isolated PBMC and an E:T ratio 
of 25:1.  NKCA (% lysis) remained largely unchanged from pre-exercise values for all time 
points post-exercise. 
Finally, Woods et al. (87) and van der Pompe et al. (88) examined NKCA responses 
to graded exercise up to VO2max in 11 elderly individuals before and after a 6-month 
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intervention and 13 post-menopausal women, respectively.  Both studies measured NKCA 
pre-exercise and immediately post-exercise, and van der Pompe et al. (88) also measured 
NKCA at 5, 15, and 30 minutes post-exercise.  Both studies used the 
51
Cr release assay to 
determine NKCA.  Woods et al. (87) used an isolated PBMC assay with E:T ratios of 50:1, 
25:1, and 12.5:1, while van der Pompe et al. (88) used a whole-blood assay.  Woods et al. 
(87) found that for the VO2max test performed before the 6-month intervention, NKCA (25:1 
E:T ratio) increased significantly immediately post-exercise compared to pre-exercise levels 
by approximately 70% (p < 0.05).  In contrast, NKCA increased by only ~10% in response to 
the VO2max test performed after the 6 month intervention (result not statistically significant).  
Similarly, van der Pompe et al. (88) found that NKCA only increased slightly during 
exercise, and NKCA did not change significantly throughout the 30-minute recovery period. 
The mechanisms mediating the changes in NKCA in response to acute exercise are 
generally similar to those previously described for changes in NK cell counts.  Increases in 
catecholamines during exercise may also be associated with increases in NKCA immediately 
post-exercise, while increases in cortisol levels may be associated with decreases in NKCA 
during recovery (53).  Additionally, other biological factors may influence the biphasic 
response of NKCA, which may also be associated with the exercise-induced changes in stress 
hormone levels (51, 52).  During exercise, activated T lymphocytes may release 
inflammatory cytokines such as IL-2 and IFN-γ, which may act to increase NKCA (51).  
During recovery, the number of cytotoxic T lymphocytes producing IL-2 and IFN-γ may 
decrease, thus allowing the actions of other cytokines including IL-4 and IL-10 to prevail, 
which in turn may lead to a decrease in NKCA (51, 52).  Furthermore, prostaglandin release 
from monocytes may also cause a decrease in NKCA during recovery (53, 54). 
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 Some authors have suggested that differences in techniques used to determine NKCA 
may influence results.  Moyna et al. (48), Braun et al. (54), and McFarlin et al. (52, 53) 
suggest that whole-blood techniques may be preferable over isolated-PBMC techniques when 
evaluating NKCA.  When isolated-PBMC assays are performed, cells must be washed and 
are therefore not incubated with other immune and endocrine factors that were present when 
the blood sample was initially obtained, and it is possible that NKCA determined using these 
methods may not completely represent what would actually be occurring in vivo (54). In 
contrast, whole-blood assays do not require washing of cells, so therefore, the “blood borne 
milieu” is retained, and therefore NKCA determined using these methods may more fully 
reflect the in vivo environment (48, 54).  As previously described, Braun et al. (54) compared 
NKCA results using both isolated-PBMC and whole-blood assays, and found that both 
methods resulted in significant elevations in NKCA immediately post-exercise; however, 
only the whole-blood technique resulted in a significant decrease in NKCA during recovery.  
The authors do caution that it can be difficult to compare whole-blood techniques with 
isolated-PBMC techniques because of the inability to establish equivalent E:T ratios (54). 
 In addition to differences in assay techniques, the expression of NKCA as total % 
lysis or % lysis on a “per-NK cell” basis may affect interpretation of results.  Nieman et al. 
(85) suggests that hormone-induced effects on NK cell numbers may affect NKCA by either 
increasing or decreasing the number of NK cells in each assay well, and that is may be 
preferable to express NKCA on a per-cell basis.  As described previously, several studies 
have shown that when NKCA is expressed on a 1:1 E:T ratio or per-NK cell basis, significant 
time effects are removed (54, 85).  This may indicate that changes in NKCA, particularly 
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during recovery, may be more related to a redistribution of NK cell counts rather than an 
impairment in NK cell functionality (54, 75).   
 Several authors give further insight into their specific NKCA outcomes.  Moyna et al. 
(48) observed that the exercise-induced increases in NK cell counts and NKCA were 
markedly different in magnitude; NK cell counts increased by over 500% while NKCA 
increased by only ~100%.  The authors hypothesize that the NK cells that were recruited into 
circulation during exercise may have had decreased cytotoxic function compared to the NK 
cells circulating pre-exercise.  In addition to the variable changes observed in NK cell count 
responses, Briviba et al. (83) also observed variable NKCA responses to the half-marathon 
and marathon runs; likely related to the wide range of race times and therefore time-
dependent effects of catecholamines and cortisol on recruitment and cytotoxicity of NK cells.  
Finally, van der Pompe et al. (88) observed that while NK cell counts increased significantly 
during exercise, NKCA did not.  The exact mechanisms driving this result are not known; 
however, the authors speculate that a component of the signaling pathways triggered by 
agonist stimulation of the β-adrenergic receptors on NK cells may be impaired in post-
menopausal women (88). 
Studies Comparing Exercise Intensities and NKCA 
Nieman et al. (92) examined and compared NKCA responses to moderate and high 
intensity treadmill running in 10 male runners.  Subjects performed two 45-minute treadmill 
runs, one at 50% of VO2max and one at 80% of VO2max.  As was the case with NK cell counts, 
NKCA was measured pre-exercise, immediately post-exercise, and during recovery at 1 hour, 
2 hours, and 3.5 hours post-exercise. NKCA was determined using an isolated-PBMC 
51
Cr 
release assay with E:T ratios of 40:1, 20:1, 10:1, and 5:1.  The authors reported NKCA 
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results using 3 different quantifications:   1) number of lytic units contained in 10
7 
mononuclear cells, where lytic units was defined as the number of effector cells required to 
lyse 20% of 10,000 target cells, 2) lytic units per NK cell x 10
-5, (i.e., NKCA on a “per-NK 
cell” basis), and 3) lytic units per L blood x 1000.  As reported in other studies, observed 
changes in NKCA in response to exercise seemed to vary depending on the quantification 
method used to describe NKCA.  When NKCA was expressed as lytic units per 10
7
 
mononuclear cells (i.e., unadjusted for changes in the proportion of NK cells), NKCA 
increased immediately post-exercise above pre-exercise values, and then decreased below 
pre-exercise resting values in response to both exercise intensities. For the moderate intensity 
exercise bout, NKCA increased by approximately 40% immediately post-exercise (difference 
from baseline not significant), while decreasing by approximately 30% at 1 and 2 hours post-
exercise (difference from baseline not significant).  At 3.5 hours post-exercise, NKCA had 
risen to near baseline levels.  For the high intensity exercise bout, NKCA increased 
significantly by approximately 80% (p < 0.0125), while decreasing by approximately 45% at 
1 hour post-exercise (difference from baseline not significant).  NKCA returned to near 
baseline levels by 2-3.5 hours post-exercise.  Additionally, the pattern of change in NKCA 
over time was not significantly different between exercise intensities.  When NKCA was 
expressed on a “per-NK cell-basis,” very different results were observed.  For the moderate 
intensity exercise bout, NKCA did not significantly differ from pre-exercise values for any 
time point, and the magnitude of change in NKCA over time was slight.  For the high 
intensity exercise bout, NKCA did not change significantly from pre-exercise levels until 2 
hours post-exercise, when NKCA increased by approximately 60% (p < 0.0125).  Again, the 
pattern of change in NKCA over time was not significantly different between exercise 
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intensities.  Lastly, when NKCA was expressed as lytic units per L blood, changes in NKCA 
appeared more similar to the changes in NKCA expressed as unadjusted for the changes in 
proportion of NK cells.  For the moderate intensity exercise bout, NKCA increased 
significantly immediately post-exercise by approximately 47% compared to pre-exercise 
values (p < 0.0125), while at 1-2 hours post-exercise, NKCA decreased by approximately 46-
60% compared to pre-exercise values (p < 0.0125).  At 3.5 hours post-exercise, NKCA had 
returned to near baseline values.  For the high intensity exercise bout, NKCA also increased 
significantly immediately post-exercise by over 200% compared to pre-exercise values (p < 
0.0125), while at 1-2 hours post-exercise, NKCA had decreased by approximately 46-60% 
below pre-exercise values (p < 0.0125).  At 3.5 hours post-exercise, NKCA had once again 
returned to near baseline values.  The pattern of change in NKCA over time was significantly 
different between exercise intensities only immediately post-exercise (p = 0.009). 
The varied results obtained in the Nieman et al. (92) study further support the idea 
that the relationship between NKCA and acute exercise may depend on the type of assay 
used, and how the results are quantified.  This particular study employed an isolated-PBMC 
51
Cr assay to measure NKCA, as have other previously-described studies (53, 54, 85, 87).  In 
this type of assay, at certain E:T ratios, even though the total number of mononuclear cells 
(i.e., effector cells) in the pre- and post-exercise assay wells remain constant, the proportions 
of mononuclear cell subsets (i.e., monocytes, lymphocytes, and lymphocyte subsets) may 
vary considerably (92).  Therefore, increases and decreases in NKCA may depend on the 
actual number of NK cells that are present in each assay well (92).  This may be why 
significant increases during exercise and significant decreases during recovery were observed 
for unadjusted NKCA and NKCA per L blood, as they tend to reflect the increased 
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recruitment of NK cell numbers into circulation during exercise, as well as the egress of NK 
cell numbers out of circulation during recovery.  When the results were normalized to a “per-
NK cell basis,” an increase in NKCA was observed during recovery from high intensity 
exercise, which is somewhat of a novel finding, the mechanisms for which are not entirely 
known (92).   
Bruunsgaard et al. (95) examined and compared NKCA responses to two bouts of 
cycle ergometry exercise in 9 recreationally active men; the first being a 30-minute cycle 
ergometry ride at 65% of VO2max using normal concentric pedaling, and the second being a 
30-minute cycle ergometry ride using eccentric pedaling at 100-150% of the workload that 
elicited concentric VO2max.  As was the case with NK cell counts, NKCA was measured pre-
exercise, during minute 20 of exercise, immediately post-exercise, and during recovery at 2 
hours post-exercise.  NKCA was determined using an isolated-PBMC 
51
Cr release assay with 
E:T ratios of 100:1, 50:1, and 25:1.  In response to the concentric exercise bout, NKCA 
increased significantly immediately post-exercise by approximately 100% compared to pre-
exercise levels (p < 0.05).  At 2 hours post-exercise, NKCA had returned to near baseline 
levels.  Similarly, in response to the eccentric exercise bout, NKCA increased significantly 
immediately post-exercise by approximately 67% (p < 0.05), and at 2 hours post-exercise, 
NKCA had returned to near baseline values.  The pattern of change in NKCA over time was 
not significantly different between exercise bouts at any time.  The authors speculate that the 
return of NKCA to near baseline levels during the recovery period may be consistent with the 
fact that the exercise bouts were of fairly short duration and moderate intensity (94). 
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Correlation between Changes in NK Cell Response with Changes in Catecholamines, and 
Cortisol 
 Four of the studies described in the above sections have examined correlations 
between changes in hormonal parameters and changes in NK cell response to acute aerobic 
exercise.  Kendall et al. (96), Moyna et al. (48), and Scharhag et al. (75) have explored 
correlations between catecholamines and NK cell responses.  Nieman et al. (85) explored 
correlations between catecholamines, cortisol, and NK cell response.  Sharp increases in both 
epinephrine and norepinephrine levels were observed immediately post-exercise in all studies 
(48, 75, 85, 96).  Moyna et al. (48) and Scharhag et al. (75) showed that increases in 
epinephrine levels were significantly correlated with increases in NK cell count (r = 0.30; p < 
0.002 and r = 0.74; p = 0.005, respectively), however, Moyna et al. (48) also found that 
epinephrine was not significantly correlated with NKCA.   Kendall et al. (96) and Scharhag 
et al. (75) observed that increases in norepinephrine levels were significantly correlated with 
increases in NK cell count (r = 0.40; p < 0.0002 and r = 0.65; p = 0.02, respectively).  In 
contrast, Nieman et al. (85) did not observe significant correlations between epinephrine and 
NK cell count or NKCA (r = 0.18; p = 0.34 and r = 0.09; p = 0.64, respectively); however, 
increases in norepinephrine were significantly correlated with changes in NK cell counts (r = 
0.37, p = 0.044).  Nieman et al. (85) also observed that cortisol levels increased sharply 
immediately post-exercise and were elevated at 1.5 hours post-exercise.  Post-exercise 
cortisol levels (average of immediate and 1.5 hr post-exercise levels) were negatively 
correlated with NK cell counts at 3 hrs post-exercise (r = -0.38, p = 0.04). However, no 
significant correlations between cortisol and NKCA were found. 
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 The results of these studies largely support the idea that catecholamines and cortisol 
are related to NK cell responses to acute aerobic exercise.  Increases in catecholamines 
during exercise may be associated with increases in NK cell counts by altering the adhesive 
interactions between NK cells and endothelial cells, thus recruiting them from their marginal 
zones into circulation (48).  Increased cortisol may be associated with decreased NK cell 
counts, possibly through alterations in cellular adhesive interactions (53, 84, 85).   
 It may be important to note that while many of the correlations reported in these 
studies were of statistical significance, their respective strengths were rather weak.  Kendall 
et al. (96) suggests that the relative weakness of these correlations may be related to the 
timing of blood samples taken immediately post-exercise.  Catecholamine levels decrease 
rapidly upon cessation of exercise, and even delaying blood sampling by 2-3 minutes may 
affect results (96).  The non-significant correlations reported by Nieman et al. (85) may be 
due to the fact that the authors tested subjects in two conditions; a placebo condition and a 
carbohydrate-supplemented condition, and correlational analyses were performed for all 
subjects together instead of separately by group.  Additionally, Nieman et al. (85) propose 
that epinephrine may not have been associated with changes in NK cell counts because the 
exercise duration used in their study was longer than 60 minutes, and that for exercise bouts 
of longer durations, the effect of epinephrine may be overtaken by the effect of cortisol on 
diminishing NK cell numbers in circulation. 
Nieman et al. (85) comment that NKCA may not have been significantly correlated 
with cortisol levels because the time of exposure to elevated levels of cortisol may not have 
been long enough.  The authors do suggest that NKCA could have been indirectly affected by 
increased post-exercise cortisol levels, as post-exercise increases in cortisol did influence a 
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decrease in post-exercise NK cell counts, and observed decreases in NKCA were also 
observed (85). 
Aerobic Exercise and Immune Function in Cancer Patients and Survivors 
NK Cell Responses 
 The existing literature describing the effects of aerobic exercise on immune system 
function in cancer patients is limited.  Currently, there are 19 original investigations 
examining the impact of aerobic exercise on some component of immune function in patients 
and survivors of various cancers including breast, lung, gastric, prostate, and leukemia (15-
33), and of these only 3 have performed these investigations using breast cancer patients and 
survivors (15, 17, 23).  Furthermore, only one of these 6 studies investigated the NK cell 
response to an acute bout of aerobic exercise (19).  In the other 5 studies, resting NK cell 
counts and/or NKCA were measured before and after an exercise training intervention in an 
effort to determine whether exercise training could potentially result in enhanced immune 
function in this population of individuals.   
 Shore et al. (19) examined the NK cell response to acute aerobic exercise at anaerobic 
threshold in 6 pediatric cancer patients, mostly treated for acute lymphoblastic leukemia. 
Four of the six patients were currently undergoing chemotherapy.  All 6 subjects participated 
in a cycle ergometry ride at anaerobic threshold for 30 minutes.  NK cell counts and NKCA 
were measured from blood samples were drawn pre-exercise, immediately post-exercise, and 
at 30 minutes post-exercise.  Three of the patients participated in a 12-week exercise training 
intervention that consisted of moderate-vigorous aerobic activities (70-85% of maximum 
heart rate) for 30 minutes per session for 3 sessions per week.  The other 3 patients served as 
a control group.  At the end of the 12-week period, the exercise bout at anaerobic threshold 
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was repeated.  The authors observed that both NK cell counts and NKCA were suppressed in 
the 3 patients who were receiving chemotherapy, compared to the two patients who were not 
receiving chemotherapy as well as to responses seen in healthy children.  However, the 
authors do not describe a detailed NK cell response to the aerobic exercise bouts; i.e, the 
magnitude the change in NK cell counts and activity relative to pre-exercise levels. 
Peters et al. (15), Nieman et al. (17), and Fairey et al. (23) all examined the effect of 
aerobic exercise training on NK cell counts and/or NKCA in breast cancer patients and 
survivors.  Peters et al. (15) examined the effect of a 7-month moderate aerobic exercise 
intervention on NK cell counts and NKCA in 24 breast cancer patients who were at least 6 
months post-surgery, Subjects performed moderate-intensity cycling (60-86% of heart rate 
reserve) for 30-40 minutes per session for 2-5 sessions per week.  Resting NK cell counts and 
NKCA were measured before the intervention, 5 weeks into the intervention, and at 
completion of the intervention.  Resting NK cells increased by approximately 15% from pre-
intervention to post-intervention; however, the increase was not statistically significant.  
Resting NKCA, measured using an isolated-cell 
51
Cr release assay, did significantly increase 
by approximately 83% from pre-intervention to post-intervention (p < 0.05).   
 Nieman et al. (17) investigated the effect of an 8-week moderate aerobic exercise 
intervention on NK cell counts NKCA in 12 breast cancer survivors who were an average of 
3 years post-diagnosis.  Six of the subjects participated in moderate-intensity walking (75% 
of maximum heart rate) for 60 minutes per session for 3 sessions per week.  The other six 
subjects served as a sedentary control group.  Resting NK cell counts and NKCA were 
measured before and after the intervention.  Resting NK cell counts and NKCA did not 
change significantly over the course of the intervention period for either the exercise group or 
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the control group, although subjects in the exercise group were observed to have slightly 
higher NKCA % lysis compared to the control group (p = 0.06).  The authors concluded that 
the exercise intervention may not have been of long enough duration or high enough intensity 
to elicit a change in resting NK cell function, although the safety of having cancer patients 
participate in high-volume, high-intensity exercise training is not yet known.   
 Fairey et al. (23) studied the effect of a 15-week moderate to vigorous exercise 
intervention on multiple immune system parameters including NK cells, in 53 post-
menopausal breast cancer survivors who were an average of 14 months post-treatment.  
Twenty-five subjects participated in moderate to high intensity cycling (50-75% of VO2peak) 
for 15-35 minutes per session for 3 sessions per week.  The other 28 subjects served as a 
sedentary control group. Resting NKCA was measured before and after the intervention 
using a 
51
Cr release assay with 5 E:T ratios ranging from 3.125:1 to 50:1.  Significant 
differences between the exercise group and the control group were observed for changes in 
NKCA pre-intervention to post-intervention at all E:T ratios, where subjects in the exercise 
group experienced increased NKCA and subjects in the control group largely experienced 
decreases in NKCA (p < 0.001-0.41).  The authors found that exercise training improved 
NKCA at all 5 E:T ratios by 6.45%.  Lytic units, the number of NK cells required to lyse 
30% of the target cells, decreased by 2.72 from pre-intervention to post-intervention, 
indicating the NKCA increased on a per-cell basis.   
 Na et al. (20) and Lee et al. (33) both investigated the effect of exercise training on 
NK cell response in gastric cancer patients.  Na et al. (20) examined the effect of a 2-week 
moderate exercise intervention on NKCA in 35 stomach cancer survivors who had recently 
undergone curative surgery.  Seventeen subjects participated in moderate intensity arm and 
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cycle ergometry exercise (60% of maximum heart rate) for 30 minutes twice per day for 5 
days per week.  The other 13 subjects served as a sedentary control group.  Resting NKCA 
was measured on Days 1, 7, and 14 of the intervention using a 
51
Cr release assay with an E:T 
ratio of 50:1.  The authors observed that NKCA did not change from Day 1 to Day 7 for 
either the control group or the exercise group.  From Day 7 to Day 14, NKCA increased in 
the exercise group by approximately 91%, whereas NKCA decreased in the control group by 
approximately 26% (p < 0.05 comparing the changes between groups).  The authors 
suggested that NKCA may have shown significant increases after the exercise intervention 
because NKCA levels were already low at baseline (% lysis = 16.2%).  The low NKCA 
observed for subjects in the study was likely attributed to the recent stress of gastric surgery; 
therefore, sensitivity to exercise-induced immunological change could have been increased.   
 Lee et al. (33) examined the effect of a 24-week light to moderate exercise 
intervention on multiple immune parameters including NK cell counts, in 21 gastric cancer 
survivors who were at least 2 years post-surgery.  Subjects participated in weekly tai chi 
exercise sessions of 50-60 minutes in duration.  Resting NK cell counts were measured 
before and after the intervention.  The percentage of NK cells in circulation did not change 
over the course of the intervention (p = 0.786). 
The NK cell response to chronic aerobic exercise in the cancer patient population has 
shown varied results.  Peters et al. (15), Nieman et al. (17), and Lee et al. (33) did not 
observe statistically significant changes in resting NK cell counts from pre- to post-
intervention.  Similarly, Nieman et al. (17) did not observe significant changes in resting 
NKCA from pre-to post-intervention.  However, Peters et al. (15), Fairey et al. (23), and Na 
et al. (20) did observe marked increases in NKCA over the course of their respective 
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intervention periods.  Reasons for these differences in magnitude and direction of the NK cell 
response to exercise training may result from a variety of factors, including differences in the 
timing of the exercise interventions relative to the amount of time that had elapsed since 
patients had completed treatment, differences in the exercise session intensity, frequency, and 
duration of the interventions, differences in total intervention time, and differences in 
experimental design and patient population (23).  NKCA may also be influenced by other 
biological factors including nutritional state, anti-cancer therapy, circadian rhythm, fatigue, 
and depression, which could have also differed among these studies (20).  For those studies 
which have observed changes in resting NKCA due to exercise training, several mediating 
mechanisms have been proposed, including exercise-induced immune modulation of 
cytokines, activation and changes in signal transduction of NK cells, macrophages, 
neutrophils, and tumor infiltrating lymphocytes, changes in the expression of cell adhesion 
molecules, and alteration in prostaglandins (20).  While the clinical implications of altered 
NK cell responses to exercise are still not completely known, it seems that exercise training 
may improve NKCA beyond what is associated with normal recovery after cancer therapy, 
and this enhanced NKCA may be of great importance because the role of NK cells in the 
destruction of tumor cells and potential correlation with disease-free and overall survival (15, 
23).   
Other Immune System Responses 
 Additional immune system outcomes that have been investigated in the cancer patient 
population include exercise-induced responses of the other cellular components of innate 
immunity (i.e., neutrophils and monocytes), the cellular components of adaptive immunity 
(i.e., T and B lymphocytes), and soluble factors such as inflammatory cytokines and C-
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reactive protein (16-19, 21-33).  As was the case for the studies involving NK cells, these 
other studies have largely examined changes in immune function in response to exercise 
training interventions that were generally of moderate to vigorous intensity for 15-60 minutes 
per session, 3-5 sessions per week for 3 weeks-7 months.  The results of these studies have 
been mixed.  One study has shown that exercise training could lead to decreases in some 
immune parameters (19).  Some studies have shown that exercise training does not seem to 
significantly alter resting immune function in cancer patients or survivors (16, 21, 23, 24, 26, 
28, 29, 32, 33).  Other studies have shown that exercise training may lead to improvements in 
resting immune function, including decreased resting C-reactive protein and inflammatory 
cytokine levels, increased total leukocyte and lymphocyte counts, increased lymphocyte 
activation, increased monocyte phagocytosis, and decreased duration of neutropenia (16, 18, 
22, 24, 30, 31, 33).  The overall conclusions of these studies seem to be that exercise training 
generally does not lead to decreased immune function in cancer patients and survivors, and 
that in some cases, exercise training may lead to improvements in cell counts and activity as 
well as decreases in markers of systemic inflammation.  However, especially when 
considering cancer patients who may have depressed immune system parameters at the 
beginning of an intervention, exercise prescription should proceed with caution (19). 
 There are two studies which have examined the effect of acute aerobic exercise on 
immune parameters other than NK cells, both in pediatric cancer patients.  Along with 
examining the effect of exercise on NK cells, Shore et al. (19) investigated the effect of the 
exercise bout at anaerobic threshold along with the 12-week exercise intervention on 
lymphocyte subsets.  The authors observed that resting immune function, including total 
leukocyte count, total lymphocyte count, helper T lymphocytes, cytotoxic T lymphocytes, 
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and B lymphocytes, were depressed in the 4 patients receiving chemotherapy compared to 
normative data.  In contrast, the resting immune function of the two patients who had 
completed chemotherapy fell within normal ranges.  The authors also observed that the acute 
exercise bout produced similar lymphocyte responses compared to that seen in healthy 
children, with overall leukocyte and lymphocyte counts increasing post-exercise.  However, 
cell counts were significantly lower for the patients undergoing chemotherapy, and there 
were no increases seen in total T lymphocytes, helper T lymphocytes, or cytotoxic T 
lymphocytes.  Lymphocyte activation was also suppressed post-exercise in the patients 
undergoing chemotherapy, whereas it was within normal ranges for the patients who had 
completed chemotherapy.  When examining the effect of the 12-week exercise training 
intervention on resting immune function, the 3 patients undergoing chemotherapy 
experienced even further decreases in resting total T lymphocytes, helper T lymphocytes, and 
cytotoxic T lymphocytes, although cell counts were still above the threshold needed for a 
major increase in susceptibility to infection or spontaneous neoplasia.  Lymphocyte cytolytic 
activity did appear to increase over the course of the intervention period.  The authors 
suggest that the small number of patients in the study may not be sufficient to draw definitive 
conclusions; however, caution should be applied when prescribing exercise in this patient 
population, especially for individuals whose immune systems may already be weakened by 
chemotherapy.   
 Ladha et al. (25) studied the effect of acute moderate-to-vigorous aerobic exercise on 
neutrophil response in 4 pediatric patients with acute lymphoblastic leukemia who were 
receiving maintenance therapy and 6 matched healthy controls.  Subjects participated in a 30-
minute treadmill exercise bout which alternated 10 minutes of running at 85% of VO2peak, 10 
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minutes of walking at 70% of VO2peak, and 10 minutes of running, again at 85% of VO2peak.  
Neutrophil counts and activity were measured from blood samples taken pre-exercise, 
immediately post-exercise, and during recovery at 1 hour and 2 hours post-exercise.  The 
authors observed that absolute neutrophil counts increased significantly from pre-exercise to 
immediately post-exercise by 26% in the patient group and 47% in the control group (p = 
0.011).  At 1 hour post-exercise, neutrophil counts decreased slightly below pre-exercise 
values by 3% in the patient group, whereas neutrophil counts remained elevated above pre-
exercise levels by 33% in the control group.  At 2 hours post-exercise, neutrophil counts 
were slightly above baseline values by 6% in the patient group, while remaining elevated by 
49% in the control group.  There were no significant differences in neutrophil counts 
between the two study groups at any time point.  Neutrophil activity was markedly higher in 
the control group across all time points compared to the patient group by 54-70%, and 
neutrophil activity did not appear to vary considerably across time in either study group.  The 
authors suggest that the decreased neutrophil function observed in the patient group may be 
related to immunosuppressive effects of chemotherapy.  When examining the ratio of active 
neutrophils to resting neutrophils across time, the patient group displayed a considerably 
greater increase in neutrophil oxidative burst compared to the control group (p = 0.048-
0.074).  These results suggest that the patients with acute lymphoblastic leukemia 
experienced a greater per-cell activity compared to the control group upon neutrophil 
stimulation. The physiological significance of this finding is not clear, although it could be in 
part due to the low neutrophil oxidative burst activity observed in the patient group at rest.  
The authors conclude that the pediatric leukemia patients seem to respond in a generally 
similar fashion to the acute exercise bout compared with healthy matched controls, which 
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could be clinically important for a pediatric patient who wishes to engage in sports and 
exercise activities similar to their peers.  As does Shore et al. (19), Ladha et al. (25) caution 
that further research is needed to understand the effects and optimal prescription of acute 
exercise on immune function in the cancer patient population. 
After examining the current exercise immunology literature in the cancer patient 
population, it is apparent that many questions have yet to be answered.  In particular, the 
effect of acute aerobic exercise on cellular immune system responses must be further 
elucidated, as only two studies to date have attempted to examine this particular research 
question in cancer patients.  Additionally, no study has attempted to examine potential 
mediators of the exercise-induced immune response in cancer patients, including 
catecholamines and cortisol.  In order to determine whether exercise in cancer patients and 
survivors may reduce the risk of illness and cancer recurrence/secondary malignancies and 
increase overall survival, researchers and clinicians must understand how exercise affects all 
physiological systems, including the immune system, so that the most relevant and specific 
exercise prescription guidelines can be developed that will hopefully allow cancer patients 
and survivors to reap the maximum health benefits of exercise without putting themselves at 
risk for further illness. 
Conclusion 
 In summary, NK cells are a major component of the innate immune system necessary 
for protecting the body against the invasion of foreign pathogens and for killing tumor cells.  
These immune cells are also extremely responsive to acute aerobic exercise.  They display 
marked increases immediately post-exercise and then returning to pre-exercise levels or 
decreasing below pre-exercise levels during the recovery period.  Many studies have been 
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performed examining the NK cell response to aerobic exercise in healthy individuals, both 
athletic and non-athletic, and it seems that higher intensity and/or longer duration exercise 
produces a more pronounced response compared to exercise of moderate intensity/shorter 
duration.  Additionally, these NK cell responses are associated with exercise-induced 
changes in the stress hormones epinephrine, norepinephrine, and cortisol.  However, the 
literature examining exercise-induced NK cell responses in cancer patients and survivors is 
limited, and no study has examined biological factors that might mediate the immune 
response in this clinical population.  As a result, many questions remain to be answered; such 
as, will the immune system of cancer patients/survivors respond similarly to that of healthy 
individuals when undergoing acute aerobic exercise?  Will similar biological factors be at 
work to mediate the exercise-induced immune response in cancer patients/survivors and 
healthy individuals?  These questions, among others, are addressed in the  
three manuscripts included in this dissertation. 
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CHAPTER III 
 
THE IMPACT OF ACUTE AEROBIC EXERCISE ON NATURAL KILLER CELL 
RESPONSES IN BREAST CANCER SURVIVORS 
 
Summary 
Current research examining the effect of aerobic exercise on immune responses in 
cancer patients and survivors is limited.  The purpose of this study was to examine the effect 
of one acute bout of aerobic exercise on natural killer (NK) cell numbers in breast cancer 
survivors and healthy controls.  For a subset of subjects, NK cell activity (NKCA) was also 
explored.  Participants included 9 women who had completed major treatments for Stage I-III 
invasive breast cancer within 3-6 months of enrollment and 9 sedentary women without a 
history of cancer.  Subjects completed a 30-minute bout of exercise on the cycle ergometer at 
60% of VO2peak.  Whole blood samples were taken pre-exercise, immediately post-exercise, 2 
hours post-exercise, and 24 hours post-exercise.  Complete blood counts were obtained at 
each time point.  Proportions of lymphocytes that carry the NK cell phenotype were obtained 
via flow cytometric analysis.  NK cell activity (NKCA) was assessed for 6 breast cancer 
survivors and 1 control using a whole-blood flow cytometric assay.  In both study groups, 
NK cell counts showed significant increases immediately post-exercise (p < 0.05).  At 2 
hours and 24 hours post-exercise NK cell counts had returned to near pre-exercise levels in 
both groups (p = 0.161-0.381).  Absolute NK cell counts were somewhat lower in breast 
cancer survivors pre-exercise and immediately post-exercise (p = 0.069-0.090), although the 
magnitude of change in NK cell counts was similar between groups across time.  NKCA was 
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not significantly different across the study time points in the subset of breast cancer 
survivors. Although some differences in absolute NK cell counts may exist between the 
groups, recent breast cancer survivors seem to exhibit a normal NK cell response to acute 
moderate intensity aerobic exercise as compared with similar women without a history of 
cancer.  
Introduction 
Breast cancer is the most common cancer among women in the United States, other 
than skin cancer, and it is the second-leading cause of cancer deaths in women, after lung 
cancer (1).  Major treatments for breast cancer, that include surgery, chemotherapy, and 
radiation therapy, can cause significant physical distress that may persist for months or years 
after the completion of therapy (2).  To this end, numerous studies over the past 20 years 
have attempted various strategies to alleviate these complications, with many focusing on 
exercise. Many of these “first generation” studies have shown that exercise training can 
mitigate many treatment-related side-effects, improve physical functioning, and that regular 
exercise seems to be safe, well-tolerated, and is associated with few adverse events (6-8).   
Exercise may be an attractive adjunct therapy for cancer patients and survivors 
because of its potentially positive influence on the immune system (9). One particular 
component of the immune system, the natural killer (NK) cell, is an especially relevant 
because of its ability to target and kill virally-infected cells as well as cells that have 
undergone malignant transformation (10).  In healthy individuals, both athletic and non-
athletic, NK cells are extremely responsive to acute aerobic exercise.  They follow a profile 
which typically shows marked elevations in both cell number and activity immediately post-
exercise, while displaying decreases during the recovery period for up to several hours (10-
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14).  Although not all studies show entirely consistent outcomes, and the clinical implications 
of exercise-induced changes in NK cell responses are not entirely known, it is thought that 
exercise-related enhancements in NK cell function may confer a protective effect against 
pathogen invasion, while exercise-related decreases in NK cell function may lead to 
increased incidence of viral infection and potential illness (12, 13).   
NK cells are extremely responsive to acute exercise, and they provide the body with a 
first line of defense against pathogens and tumor cells, thus, understanding how acute aerobic 
exercise may influence their cytolytic activity, as well as their entry into/exit from circulation 
is clinically relevant.  Examining and understanding NK cell responses to acute aerobic 
exercise in breast cancer survivors is particularly important when considering how to 
prescribe exercise to this population.  Firstly, aerobic exercise prescriptions for cancer 
patients and survivors are largely modeled after those for the general population (39).  While 
much research has been conducted in healthy individuals, immune responses to exercise have 
not been systematically measured in breast cancer survivors.  Since cancer treatments can 
lead to immune system deficiencies which may continue for extended periods of time post-
treatment (23, 24, 98), one could hypothesize that a cancer patient’s weakened immune 
system may not respond to exercise in the same way as that of a healthy individual.  
Secondly, aerobic exercise prescriptions are constructed of an accumulation of multiple acute 
exercise sessions per week.  Therefore, exercise specialists and clinicians need to understand 
how long it takes for a breast cancer survivor’s immune system to recover from one bout of 
aerobic exercise before prescribing the next bout of aerobic exercise.  Current studies 
examining NK cell responses to exercise in breast cancer patients and survivors have shown 
promising results (15, 17, 23).  However, these studies only examined resting NK cell 
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function at the beginning and end of an exercise training period, none examined the acute 
exercise response, and none compared these responses to individuals who had never 
experienced the physiological toll of cancer treatments.  Studying these parameters may 
provide insight to whether the exercise is contributing to enhanced immune function or 
leading to periods of potential immunosuppression.  Therefore, the purpose of this 
investigation was to compare the effect of one acute bout of aerobic exercise on NK cell 
numbers in breast cancer survivors and healthy controls.  For a subset of subjects, the effect 
of the acute bout of aerobic exercise on NK cell activity (NKCA) was also explored. 
Methods 
Subjects 
Subjects were recruited into two study groups:  a breast cancer survivor group and a 
control group.  Subjects in the breast cancer survivor group included women who had been 
diagnosed with Stage I, II, or II invasive breast cancer, had received chemotherapy, and had 
completed all planned surgery, chemotherapy, and radiation therapy 3-6 months prior to 
enrollment.  Subjects in the control included women who did not have a history of cancer 
diagnosis or treatment, were sedentary (i.e., had not participated in regular organized 
physical activity within the past year), and were free from cardiovascular and 
musculoskeletal disease that would render aerobic exercise participation unsafe.  All 
subjects, regardless of study group, were between the ages of 40-70 years, were not regular 
users of anti-inflammatory medications, and were either post-menopausal or had not 
experienced a menstrual period for approximately 1 year prior to enrollment.  Subjects in the 
breast cancer survivor group were recruited from the Medical Oncology clinic at the North 
Carolina Cancer Hospital, the Radiation Oncology clinic at the North Carolina Cancer 
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Hospital, and from the waitlist for the Get REAL and HEEL Breast Cancer Program in the 
Department of Exercise and Sport Science at UNC-Chapel Hill.   Subjects in the control 
group were recruited from the faculty, staff, and student populations at UNC-Chapel Hill, as 
well as from across the Triangle region of North Carolina (Raleigh, Durham, Chapel Hill, 
and surrounding areas). Approval from the Protocol Review Committee in the Lineberger 
Comprehensive Cancer Center and the Institutional Review Boards in the Department of 
Exercise and Sport Science and School of Medicine at UNC-Chapel Hill were obtained 
before proceeding with subject recruitment. 
Overview of Procedures 
Each subject visited the laboratory on three separate occasions.  Prior to each 
laboratory visit, all subjects were asked to refrain from eating for at least 2 hours prior to 
testing, exercise and caffeine for at least 12 hours prior to testing, alcohol use for at least 48 
hours prior to testing, and to maintain adequate hydration.  Visit 1 included an orientation to 
the study, medical and physical screening, and the assessment of peak aerobic capacity on the 
cycle ergometer.  During visit 2, the subject performed a moderate bout of aerobic exercise at 
60% of VO2peak for 30 min on the cycle ergometer.  Blood samples were collected during this 
laboratory visit; immediately prior to exercise, immediately post-exercise, and 2 hours post-
exercise.  Visit 3 was a resting session, during which one blood sample was collected from 
the subject 24 hours post-exercise.  All laboratory visits occurred in the Integrative Exercise 
Oncology Research Laboratory (IEORL) and/or in the Applied Physiology Laboratory (APL) 
in the Department of Exercise and Sport Science at UNC-Chapel Hill.   
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Visit 1:  Medical/Physical Screening and VO2peak test 
During the first visit to the laboratory, subjects received an explanation of the study 
protocol, information regarding the potential risks of participation in the study, and were 
asked to sign the informed consent documents.  All subjects completed a comprehensive 
medical history questionnaire, underwent a 12-lead resting electrocardiogram (ECG) and a 
physical exam by either a physician or other certified professional.  Subjects were screened 
for exclusion based on the criteria put forth by the American College of Sports Medicine 
(ACSM) as contraindications to exercise testing (99). 
Age, race, height (portable stadiometer, Perspective Enterprises, Portage, MI ),  and 
body mass (calibrated balance-beam scale, Detecto, Webb City, MO), were recorded for all 
subjects upon enrollment onto the study.  Height and body mass were used to calculate body 
mass index (BMI).  Percent body fat was assessed using a Discovery Dual Energy X-ray 
Absorption (DEXA) scanner (Hologic, Inc., Bedford, MA).  For subjects in the breast cancer 
survivor group, cancer treatment type was also recorded. 
The final component of visit 1 was an exercise test to measure VO2peak.  The purpose 
of measuring VO2peak was to assess peak aerobic capacity and for estimating the submaximal 
workload that subjects would perform during laboratory visit 2.  The VO2peak test was 
performed on an electronically-braked cycle ergometer (Lode, Gronigen, The Netherlands) 
using the Astrand Cycle Ergometer Maximal Test Protocol (100).  Expired gases were 
collected and analyzed using a TrueMax 2400 Metabolic System (Parvo Medics, Salt Lake 
City, UT). Subjects began the test sitting quietly on the cycle ergometer for 3 minutes while 
resting metabolic data was collected. Subjects then began the first stage of the test by cycling 
at 50 Watts for 3 minutes.  At the end of the 3-min stage, the workload was increased by 25 
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Watts every 3 minutes until volitional fatigue.  Heart rate, rating of perceived exertion or 
RPE (101), expired gases, and 12-lead ECG monitoring were performed throughout the test.  
Heart rate and RPE were recorded at the end of every minute.  The highest VO2 measured by 
the metabolic system during the last stage of the test was recorded at the subject’s VO2peak, 
and the corresponding workload on the cycle ergometer was recorded as the subject’s peak 
workload.  Once the VO2peak test was complete, the subject pedaled at a very low workload 
(<20 Watts), with ECG and blood pressure monitoring continued until they had returned to 
near-baseline levels (102).   
VO2peak was calculated by the metabolic system, while the peak workload (W) was 
the workload at which the subject was exercising when VO2peak was achieved.  From these 
results, the workload (W) at 60% of VO2peak was estimated following the Karvonan 
procedures, by regressing VO2 values for each stage against the corresponding workload for 
that stage.  This intensity was chosen because it is widely used in exercise prescriptions for 
this population (3, 4, 6, 17, 39, 103-108).  .   
Visit 2:  Acute Aerobic Exercise Session 
 During the second visit to the laboratory, subjects performed an acute bout of 
intermittent, moderate exercise on the cycle ergometer at a workload corresponding to 60% 
of the subject’s VO2peak for 30 minutes.  To ensure that all subjects would be able to complete 
the exercise session, a discontinuous protocol was employed such that subjects alternated ten, 
3-minute intervals of exercise with 1.5 minutes of rest, for a total of 30 minutes of exercise in 
a 43.5-minute period.  All subjects started the exercise session between 7:00-10:00 am in 
order to control for daily variations in the study variables. 
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At the beginning of visit 2, subjects rested in the supine position for approximately 20 
minutes while a catheter was inserted into an antecubital vein in the arm for blood sampling. 
For blood sampling a three-stage technique was used.  The first draw was a small amount to 
discard the contents of the catheter.  The second draw contained the sample. The third 
injected a small amount of sterile saline to keep the catheter patent between sampling. A pre-
exercise blood sample was drawn into K3EDTA Vacutainer® tubes which were used for the 
measurement of NK cell counts.  For a subset of subjects, blood was also drawn into a 
sodium heparin Vacutainer® tube and was used for the measurement of NK cell activity 
(NKCA).   
After the pre-exercise blood sample was obtained, subjects sat quietly on the cycle 
ergometer for 3 minutes while resting metabolic data was collected.  Subjects then performed 
a warm-up period, consisting of 4-5 minutes of light pedaling at about 30 Watts on the cycle 
ergometer.  Subjects were also given the opportunity to stretch the lower body in a manner 
that was most comfortable for them.  The subjects then began the 30-minute moderate-
intensity exercise bout at the prescribed workload.  Heart rate and RPE were recorded at the 
end of every 3-minute period of exercise.  Expired gases were monitored during the first, 
third, seventh, and tenth exercise interval.  If necessary, adjustments in workload were made 
to ensure that the subject was exercising as close to 60% of VO2peak as possible.  Immediately 
upon completion of the exercise bout, subjects dismounted the cycle ergometer and returned 
to the supine position.  Blood sampling immediately post-exercise was performed in the same 
manner as described above.   
Subjects were then allowed to rest comfortably in the laboratory.  They were allowed 
to drink water ad libitum; however, no food or other beverage could be ingested.  A final 
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blood sample was obtained at 2 hours post-exercise in the same manner as the other two 
samples.  The catheter was then removed and any necessary bandaging was performed. 
Visit 3:  24-hour Follow-up Session 
 The purpose of the third visit was to obtain a blood sample 24 hours after the 
completion of the aerobic exercise bout.  The blood sample was drawn from an antecubital 
vein using a standard venipuncture technique.   
Determination of Immunological Parameters 
Complete blood counts (CBC) were obtained from all blood samples using a 
COULTER® Ac•T diff ™ Hematology Analyzer (Beckman Coulter, Inc., Brea, CA).  Whole 
blood samples were stained using fluorescently-labeled monoclonal antibodies for the cell 
surface markers CD3, CD16, and CD56.  The specific fluorescent labels were, fluorescein 
isothyocyanate (FITC) for the CD3 marker, phycoerythrin (PE) for the CD16 marker, and 
allophycocyanin (APC) for the CD56 marker.  Fluorescent staining was done in order to 
identify the proportion of lymphocytes that express the CD3
-
CD16
+
CD56
+
 phenotype which 
is characteristic of NK cells.  Stained samples were further prepared for flow cytometric 
analysis according to procedures adapted from protocols made available by Becton 
Dickenson (109).  Samples were fixed in a 1% paraformaldehyde solution and were analyzed 
within 24 hours of preparation using a CyAn 3 laser/9 color flow cytometer (Beckman 
Coulter, Inc., Brea, CA).  Flow cytometry data was viewed and analyzed using Summit 4.3 
software (Dako North America, Inc., Carpinteria, CA).  Absolute NK cell counts were 
calculated by multiplying total lymphocyte counts by the NK cell proportions. 
NK cell activity (NKCA) was determined for a subset of subjects (1 control and 6 
breast cancer survivors) using a whole-blood flow cytometric assay adapted from Fondell et 
72 
 
al. (110).  K562 cells were used as the target cells and were adjusted to a concentration of 
200,000 cells/mL in a complete culture medium (RPMI + penicillin-streptokinase + 10% 
fetal bovine serum).  The following reactions were prepared for each subject:  1) 500 μL 
whole blood + 500 μL whole blood (one tube for each study time point); 2) 500 μL K562 
cells + 500 μL complete culture medium (two tubes); and 3) 500 μL whole blood + 500 μL 
K562 cells (two tubes for each study time point).  The tubes were centrifuged at 200 x g for 1 
minute and then placed in an air incubator at 37°C in 5% CO2 for 2 hours.  Samples were 
then stained for 15 minutes with FITC-labeled anti-CD71 (a fluorescently-labeled 
monoclonal antibody that only stains the K562 target cells). Two mL of 10X BD FACS 
Lysing Solution diluted to a 1X concentration were added to each tube in order to lyse the 
red blood cells, and the samples were incubated for 20 minutes.  The tubes were then 
centrifuged at 500 g for 5 minutes, and the supernatant was removed.  The remaining cell 
pellets were re-suspended in 500 μL of phosphate-buffered saline (PBS).  Samples were 
analyzed within 2 hours of preparation using a CyAn 3 laser/9 color flow cytometer, and data 
was viewed and analyzed using Summit 4.3 software.  NKCA, measured as % NK cytolysis, 
was calculated using the following equation: 
%NK cytotox = 100*[target cells – (mixed cells – effector cells)] / target cells. 
The “target cells” refers to the number of K562 cells measured in the samples with target 
cells only and “mixed cells” refers to the number of remaining K562 cells in the samples 
with a mixture of whole blood and K652 cells.  “Effector cells” refers to cells in the samples 
with whole blood only which may be present in the region for CD71
+ 
K562 cells.   
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Calculation of Plasma Volume Shifts 
Plasma volume shifts (changes in plasma volume due to exercise) were calculated 
according to the equation by Dill and Costill (111). The hematocrit and hemoglobin values 
that were used in these calculations were obtained from the CBC data pre-exercise 
immediately post-exercise, 2 hours post-exercise, and 24 hours post-exercise.  Plasma 
volume shifts were reported in order to estimate the effect that exercise and posture had on 
fluid shifts, which may affect concentrations of leukocytes.   
Statistical Analysis 
All statistical analyses were performed using SPSS Statistics version 18.0.  
Comparison of physical characteristics (age, height, weight, BMI, and percent body fat) 
between the two study groups was performed using independent samples t-tests.  Comparison 
of VO2peak, peak workload, submaximal VO2, and submaximal workload between the two 
study groups was also performed using independent samples t-tests.  Paired-samples t-tests 
were used to compare the estimated submaximal VO2 and workload to the actual submaximal 
VO2 and workload that each study group performed during the acute aerobic exercise bout.  
Plasma volume shifts were compared between groups at the three post-exercise time points 
using independent samples t-tests.  Immune cell counts (total leukocyte, granulocyte, 
monocyte, lymphocyte, and NK cell counts) were compared across the four study time points 
and between the two study groups using 2x4 mixed-model ANOVAs.  NKCA was compared 
across time for the subset of breast cancer survivor subjects using a repeated-measures 
ANOVA.  Pairwise comparisons were made between groups using independent samples t-
tests and within groups across time using repeated-measures ANOVAs.  Percent changes 
were also calculated for NK cell counts and NKCA for both study groups in order to examine 
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how these parameters were changing from pre-exercise to each of the three post-exercise 
time points.  Percent changes were compared between groups using independent samples t-
tests. 
Results 
Subjects 
This study included a total of 18 subjects, with 9 subjects in the breast cancer survivor 
group and 9 subjects in the control group.  Physical characteristics for the 18 subjects are 
presented in Table 3.1.  Descriptive statistics are presented as mean ± standard deviation 
(SD).  Age was the only physical characteristic for which there was a statistically significant 
difference between groups, where the average age of the control group was approximately 9 
years older than age of the breast cancer survivor group (p = 0.002).  Although the BMIs do 
not suggest obesity, the percentage of body fat (~42%) for both groups was very high.  In 
addition, the VO2peak results suggest very low aerobic fitness for both groups. 
All subjects in the breast cancer survivor group received surgery, chemotherapy, and 
radiation therapy and had completed these treatments within 3-6 months prior to enrollment.  
Four subjects underwent mastectomy and five underwent lumpectomy.  Six subjects received 
the chemotherapy combination of Adriamycin, Cytoxan, and Taxol, and one of these subjects 
also received Carboplatin.  One subject received the chemotherapy combination of Cytoxan 
and Taxotere.  Two subjects received the chemotherapy combination of Carboplatin and 
Taxotere.  Six subjects were receiving adjuvant hormonal therapy, with 5 receiving 
Tamoxifen and one receiving Femara.  Two subjects were receiving adjuvant trastuzumab in 
the form of Herceptin.  Lastly, two subjects received additional medications related to their 
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cancer treatments, with one receiving Lapatinib (a protein kinase inhibitor) and one receiving 
Bevacizumab (an angiogenesis inhibitor). 
 
 
Table 3.1.  Subject physical characteristics (mean ± SD) 
Characteristic  
 
Breast Cancer Survivor Group  
(n = 9) 
Control Group  
(n = 9) 
Age (years) 50 ± 6
*
 59 ± 5
*
 
Race (# of women) Caucasian (8) 
African American (1) 
Caucasian (9) 
Height (cm) 164.7 ± 5.8 163.8 ± 5.9 
Weight (kg) 76.9 ± 12.6 77.7 ± 13.3 
Body Mass Index (kg/m
2
) 28.4 ± 5.0 28.9 ± 4.6 
Percent Body Fat (%) 41.6 ± 4.5 42.1 ± 4.0 
VO2peak (mL/kg/min) 18.1 ± 2.7 18.5 ± 5.1 
Peak Workload (W) 107 ± 19 106 ± 17 
*
p < 0.05 for comparing age between groups 
 
Metabolic Responses  
The submaximal VO2 and workloads that were used during the aerobic exercise 
session are presented in Table 3.2.  Estimated submaximal VO2 and workload were 
calculated from the results of the VO2peak test.  Actual submaximal VO2 and workload were 
the subjects actually performed during the exercise session.  Estimated and actual 
submaximal VO2 were similar between groups (p > 0.05) as were estimated and actual 
submaximal workload (p > 0.05).  Within the breast cancer survivor group, actual 
submaximal VO2 was significantly higher than estimated submaximal VO2 (p = 0.016).  
Within the control group, there was no significant difference between estimated and actual 
submaximal VO2 (p = 0.376). 
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Table 3.2.  Metabolic responses during the submaximal aerobic exercise session (mean ± SD) 
Parameter Breast Cancer Survivor 
Group 
Control Group 
Estimated VO2 (mL/kg/min) 10.9 ± 1.6
*
 11.1 ± 3.1 
Actual VO2 (mL/kg/min) 12.1 ± 1.3
*
 11.1 ± 1.8 
Estimated Workload (W) 63 ± 12 66 ± 11 
Actual Workload (W) 59 ± 9 62 ± 11 
*
p < 0.05 for estimated vs. actual VO2 
 
Leukocyte Subset Cell Counts and Plasma Volume Shifts 
 Cell counts for total leukocytes, granulocytes, monocytes, and lymphocytes, as well 
as plasma volume shifts at each study time point are presented in Table 3.3.  As mentioned 
previously, total leukocyte, granulocyte, monocyte, and lymphocyte counts were adjusted to 
reflect the exercise-induced shifts in plasma volume.  In the breast cancer survivor group, 
blood samples were not able to be obtained from one subject immediately post-exercise (0h 
post-exercise) and from one subject at 2 hours post-exercise.  In the control group, NK cell 
count at 24 hours post-exercise was not able to be determined for one subject because of 
difficulty obtaining enough blood for sample preparation and analysis.  Therefore, mean 
substitution was performed to account for these missing data points.  Exercise and recovery 
patterns of plasma volume shifts were similar between breast cancer survivors and controls 
(p > 0.05).  Total leukocyte and leukocyte subset cell counts were significantly elevated 
immediately post-exercise compared with pre-exercise values (p < 0.05).  At 2 hours post-
exercise, total leukocyte, granulocyte, and lymphocyte counts remained significantly elevated 
relative to pre-exercise values in the breast cancer survivor group, while total leukocytes and 
lymphocytes counts remained significantly elevated in the control group (p < 0.05).  When 
comparing groups, monocyte counts were somewhat lower in breast cancer survivors pre-
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exercise (p = 0.059), while lymphocyte counts were consistently lower in the breast cancer 
group across time (p = 0.013-0.090). 
 
Table 3.3.  Immune cell counts and plasma volume shifts across time (mean ± SD) 
Parameter Breast Cancer Survivor Group Control Group 
Total Leukocytes (cells/μL) 
     Pre-exercise 
     0h post-exercise 
     2h post-exercise 
     24h post-exercise 
 
3666.7 ± 1659.1 
4890.9 ± 1833.4
*
 
5239.8 ± 1524.0
†
 
3611.9 ± 1372.7 
 
4377.8 ± 1072.1 
5459.5 ± 1092.6
*
 
5505.6 ± 1173.1
†
 
4251.2 ± 1094.3 
Total Granulocytes (cells/μL) 
     Pre-exercise        
     0h post-exercise 
     2h post-exercise 
     24h post-exercise 
 
2633.3 ± 1320.0 
3554.0 ± 1342.9
*
 
3967.5 ± 1192.6
†
 
2538.4 ± 1068.0 
 
2844.4 ± 610.6 
3517.6 ± 478.2
*
 
3579.0 ± 677.4 
2683.8 ± 736.5 
Total Monocytes (cells/μL) 
     Pre-exercise 
     0h post-exercise 
     2h post-exercise 
     24h post-exercise 
 
255.6 ± 133.3 
364.6 ± 117.4
*
 
307.1 ± 96.8 
306.4 ± 133.0 
 
400.0 ±165.8 
442.5 ± 168.3
*
 
395.8 ± 178.5 
361.7 ± 138.0 
Total Lymphocytes (cells/μL) 
     Pre-exercise 
     0h post-exercise 
     2h post-exercise 
     24h post-exercise 
 
788.9 ± 355.1 
973.0 ± 462.7
*a
 
941.3 ± 430.8
†b 
755.4 ± 309.8
c
 
 
1111.1 ± 401.4 
1508.6 ± 512.5
*a
 
1530.6 ± 649.2
†b 
1195.0 ± 355.4
c
 
NK Cells (cells/μL) 
     Pre-exercise 
     0h post-exercise 
     2h post-exercise 
     24h post-exercise 
 
70.3 ± 37.9 
170.5 ± 110.4
* 
91.8 ± 76.2
 
90.1 ± 57.8
 
 
108.9 ± 51.7 
282.5 ± 132.3
* 
130.1 ± 80.2
 
122.2 ± 57.8
 
Plasma Volume Shifts (%) 
     0h post-exercise 
     2h post-exercise 
     24h post-exercise 
 
-12.0 ± 3.6 
-3.4 ± 6.2 
-7.3 ± 6.7 
 
-11.5 ± 4.6 
-0.1 ± 9.2 
-6.6 ± 7.1 
*
p < 0.05 for pre-exercise vs. 0h post-exercise 
†
p < 0.05 for pre-exercise vs. 2h post-exercise 
a
p < 0.05 for comparing 0h post-exercise between groups 
b
p < 0.05 for comparing 2h post-exercise between groups 
c
p < 0.05 for comparing 24h post-exercise between groups 
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NK Cell Counts  
Cell counts for NK cells are also presented in Table 3.  There was no significant 
group by time interaction effect (p = 0.106).  In both study groups, NK cell counts were 
significantly elevated immediately post-exercise compared to pre-exercise levels (p = 0.006 
and 0.001 for the breast cancer survivor group and the control group, respectively).  At 2 
hours and 24 hours post-exercise, NK cell counts were similar to pre-exercise levels in both 
groups (p = 0.161-0.381).  When comparing groups, NK cell counts were somewhat lower in 
the breast cancer survivor group pre-exercise (p = 0.09) and immediately post-exercise (p = 
0.069).  
Percent changes for NK cell counts between study groups and across the three post-
exercise time points are displayed in Table 3.4.  These are presented in order to more clearly 
appreciate the magnitude of the NK cell response that took place post-exercise, relative to 
pre-exercise values.  Percent change in NK cell counts post-exercise were similar between 
groups (p = 0.651-0.894). 
 
Table 3.4.  Percent change in NK cell counts (mean ± SD) 
Percent change (%) Breast Cancer Survivor 
Group 
Control Group 
     0h post-exercise 
     2h post-exercise 
     24h post-exercise 
165.6 ± 147.6 
26.8 ± 48.0 
31.4 ± 66.3 
179.9 ± 89.3
 
23.3 ± 61.0 
19.3 ± 42.2 
 
NKCA % Cytolysis and Percent Changes 
 NKCA for a subset of 7 subjects (1 control and 6 breast cancer survivors) is presented 
in Table 3.5.  There were no significant differences in NKCA (expressed as % cytolysis in 
500 μL blood) across the study time points for the group of 6 breast cancer survivors (p = 
0.607).   
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Table 3.5.  NK cell activity across time for six breast cancer survivors and one control 
subject (mean ± SD) 
Parameter Breast Cancer Survivors 
(n = 6) 
Control 
(n = 1) 
NKCA (% target cell 
cytolysis in 500 μL blood) 
     Pre-exercise 
 
 
73.6 ± 30.3 
 
 
95.2 
     0h post-exercise 74.4 ± 21.0 95.5 
     2h post-exercise 67.6 ± 12.5 91.4 
     24h post-exercise 60.2 ± 37.1 60.8 
NKCA Percent Change (%) 
     0h post-exercise 
     2h post-exercise 
     24h post-exercise 
 
17.2 ± 47.8 
22.7 ± 95.9 
16.9 ± 128.7 
 
0.4 
-4.0 
-36.1 
 
Discussion 
To the authors’ knowledge, this investigation is the first to examine the effect of acute 
aerobic exercise on any cellular immune parameter in breast cancer survivors.  Absolute NK 
cell counts were consistently lower in the breast cancer survivor group at each study time 
point compared to the control group, and this difference was most notable for the pre-
exercise and immediately post-exercise time points.  This study found that the magnitude of 
change for NK cell counts appears similar across time (0-24 hours post-exercise) when 
comparing the breast cancer survivor subjects and the control subjects, as evidenced by 
similar NK cell count percent changes for both study groups.  Additionally, NKCA did not 
seem to change significantly from pre-exercise to any post-exercise time point in the group of 
6 breast cancer survivors. 
Changes in NK Cell Counts  
As expected, NK cell counts increased significantly immediately post-exercise 
compared with pre-exercise, and then decreased towards pre-exercise levels at 2 hours and 24 
hours post-exercise.  A key finding was that the magnitudes of change in NK cell counts 
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(evidenced by the percent changes) were similar in the breast cancer survivor group and the 
control group.  Immediately post-exercise, NK cell counts increased by an average of 166% 
in the breast cancer survivor group and 180% in the control group.  At 2 hours and 24 hours 
post-exercise, NK cell counts were still approximately 19-31% above pre-exercise levels in 
the two groups.  These findings are encouraging, in that they suggest that the breast cancer 
survivors seemed to experience similar NK cell number recruitment compared to the controls 
during and after 30 minutes of moderate intensity aerobic exercise.  Additionally, neither the 
breast cancer survivors nor the controls appeared to experience below-baseline decreases in 
NK cell counts that are typically seen during the recovery period from exercise (10-14).  
These results are similar to those of previous studies, which have examined changes in NK 
cell counts in response to moderate intensity and moderate duration aerobic exercise in 
healthy men and women of various fitness levels (74, 94-96, 112, 113).   
The current study did not directly explore the effects of potential biologic mediators 
of the NK cell response to the moderate-intensity acute aerobic exercise bout.  However, it is 
still worth noting that there are several biological mechanisms which may be associated with 
the rise and fall of NK cell counts during and after moderate-intensity acute aerobic exercise.  
Increased cardiac output during exercise may act synergistically with increased 
catecholamine levels to affect vascular endothelial-lymphocyte adhesion, which would 
recruit NK cells from their marginal pools and other reservoirs (48-50, 75).  During the 
recovery period, decreases in NK cell counts could be related to exercise-induced changes in 
catecholamines and cortisol; the latter of which may be mediated by changes in the 
inflammatory cytokine IL-6 (75).  In the current investigation it was interesting to note that 
even though absolute NK cell counts were lower in the breast cancer survivor group, the 
81 
 
magnitude of change in NK cell counts was similar between groups.  This suggests that even 
though the cancer treatments may have affected their resting immune counts (9), the exercise 
bout resulted in a response that paralleled the controls who had never experienced cancer 
treatment.    
Changes in NKCA 
 NKCA as observed for the subset of 6 breast cancer survivors did not change 
significantly across the four study time points.  This exploratory finding is interesting, since 
it was expected that NKCA would respond in a similar manner as NK cell counts.  From a 
biological standpoint, the exact mechanisms driving these NKCA results are not clear.  A 
similar result was observed by van der Pompe et al. (88) during and after graded exercise up 
to VO2max in post-menopausal women, in which the authors speculated that a component of 
the signaling pathways triggered by agonist stimulation of the β-adrenergic receptors on NK 
cells may be impaired in this population of subjects (88).  Other authors who have observed  
relatively small changes in NKCA post-exercise despite large changes in NK cell counts 
hypothesized that the NK cells that were recruited into circulation during exercise may have 
had decreased cytotoxic function compared to the NK cells circulating pre-exercise (48). In 
the current study, the sharp increases in NK cell counts post-exercise accompanied by the 
relatively constant NKCA across time may likely be more related increased cardiac output on 
NK cell cytosis rather than β-adrenergic stimulation, especially considering that the exercise 
bout was discontinuous and of moderate intensity and duration.  It is interesting to note that 
NKCA for the group of breast cancer survivors appears quite different from the NKCA 
reported for the one control subject in the subset.  However, no definite conclusions can be 
drawn from this comparison without data from more controls.  Even so, it appears that the 
82 
 
aerobic exercise bout performed in this study did not compromise NKCA in the breast cancer 
survivors. 
The type of assay used in this current investigation to measure NKCA was a whole 
blood flow cytometric assay.  Some authors have suggested that whole-blood techniques may 
be preferable over isolated-PBMC techniques when evaluating NKCA (48, 52-54).  When 
isolated-PBMC assays are performed, cells must be washed and are therefore not incubated 
with other immune and endocrine factors known to have autocrine and paracrine effects on 
immunity, thereby suggesting that NKCA determined using these methods may not 
completely represent what would actually be occurring in vivo (54). In contrast, whole-blood 
assays do not require washing of cells, so therefore, the “blood borne milieu” is retained, and 
therefore NKCA determined using these methods may more fully reflect the in vivo 
environment (48, 54).  Additionally, there may be difficulty in comparing results using 
whole-blood techniques versus isolated-PBMC techniques because of the inability to 
establish equivalent effector to target cell ratios (54).  The assay used in the current study 
could be considered novel, as whole-blood flow cytometric assays for NKCA do not appear 
to be common in the literature.  Further investigation of NKCA in breast cancer survivors 
using other assay techniques may be warranted in order to allow for a more comprehensive 
picture of NK cell function in this population. 
Strengths and Limitations 
 As with any study, there are inherent strengths and limitations.  One strength is the 
homogeneity of the study sample and the inclusion of a comparative control group of 
women.  With the exception of age, the two study groups were matched very closely with 
regard to the other physical characteristics and aerobic fitness.  This study is one of the few 
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to describe immune responses to acute aerobic exercise in the oncology patient population 
and is the only study to investigate the effect of acute aerobic exercise on NK cells in breast 
cancer survivors.  Additionally, this study is one of the few to also include NK cell responses 
to acute aerobic exercise in healthy post-menopausal women, as well as in a study sample 
with a low VO2peak (< 20 mL/kg/min).  One limitation to this study included small sample 
sizes in each group.  Despite this, there was sufficient statistical power at the 0.80 power 
level to detect statistical in the primary outcome variable, which was the difference between 
NK cell count fold change and the null value of 1.0.  Additionally, NK cell count data were 
not available for two cancer survivor subjects (one immediately post-exercise and one 2 
hours post-exercise) and one control subject at 24 hours post-exercise because of difficulties 
obtaining blood samples from those subjects at those times.  Furthermore, NKCA results 
were only available for 6 breast cancer survivors and one control subject, due to the difficult 
nature of measuring this parameter.  As a result, group comparisons for NKCA could not be 
made.  While the control subject for whom NKCA was measured would not have been 
considered an outlier for any other parameter, one cannot necessarily apply her NKCA 
results to the entire control group.  Finally, potential biologic mediators of the NK cell 
response were not explored in this study.  Therefore, biologic mechanisms driving these 
results are largely speculative, especially when concerning results pertaining to the breast 
cancer survivor group. 
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Conclusions 
 In summary, 30 minutes of intermittent, moderate intensity aerobic exercise seems to 
elicit similar changes in NK cell counts in recent breast cancer survivors compared to 
physically similar women without a history of cancer diagnosis or treatment.  Some 
differences in absolute NK cell counts appeared to exist between the groups pre-exercise and 
immediately post-exercise.  NKCA did not appear to change significantly in response to the 
acute exercise bout.  These findings suggest that moderate intensity and duration aerobic 
exercise affected the study groups similarly, and that this type of aerobic exercise is safe to 
include in exercise prescriptions for recent breast cancer survivors. 
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CHAPTER IV 
 
THE IMPACT OF ACUTE AEROBIC EXERCISE ON CATECHOLAMINE AND 
CORTISOL RESPONSES IN BREAST CANCER SURVIVORS 
 
Summary 
The hormones of the adrenal gland are especially sensitive to the effects of acute 
aerobic exercise, and are responsible for eliciting many cardiovascular and metabolic 
responses associated with exercise.  Current literature examining the effect of acute aerobic 
exercise on adrenal gland hormones in the cancer patient population is limited.  Therefore, 
the purpose of this study was to compare the effect of one bout of aerobic exercise on 
catecholamine (epinephrine and norepinephrine) and cortisol responses in breast cancer 
survivors and healthy controls.  Nine women who had completed major treatments for Stage 
I-III invasive breast cancer within 3-6 months of enrollment and 9 sedentary women without 
a history of cancer diagnosis or treatment completed a 30-minute bout of aerobic exercise on 
the cycle ergometer at 60% of VO2peak.  Whole blood samples were taken pre-exercise, 
immediately post-exercise, 2 hours post-exercise, and 24 hours post-exercise.  Plasma 
concentrations of catecholamines and cortisol were measured at each time point using ELISA 
techniques.  Epinephrine increased significantly immediately post-exercise in the control 
group (p < 0.05), but did not change significantly in the breast cancer survivor group.  
Norepinephrine responses were similar between groups (p  > 0.05).  Cortisol decreased 
significantly immediately post-exercise and 2 hours post-exercise in the control group and at 
24 hours post-exercise in the breast cancer survivor group (p < 0.05).  These findings imply 
that catecholamine output from the adrenal medulla and the sympathetic nervous system as 
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well as hypothalamic-pituitary-adrenal (HPA) axis stimulation of cortisol release from the 
adrenal cortex may have been different for breast cancer survivors compared with healthy 
controls.   
Introduction 
 The American Cancer Society estimated that there are over 2.9 million breast cancer 
survivors alive in the United States (1).  However, major cancer treatment can affect virtually 
all of the body’s physiological systems, causing significant physical and psychological 
distress that may persist for months or years after the completion of therapy (2).  Over the 
past two decades, numerous studies have investigated the impact of exercise training on 
physical functioning in breast cancer patients and survivors (6, 7, 8). The primary endpoint of 
many of these investigations was the effect of exercise training on cardiorespiratory capacity.   
Other outcomes have also been addressed, including changes in muscular strength, body 
composition, functional quality of life, fatigue, anxiety, and self esteem (6).   
In recent years, studies examining the impact of aerobic exercise on endocrine 
parameters in cancer patients have begun to emerge as well (27, 28, 30, 34, 114-120).  These 
studies do suggest that positive changes in hormone levels after aerobic exercise training may 
be associated with favorable outcomes including decreased stress and decreased risk for 
developing cardiovascular or metabolic disease (117, 120).  These findings are pertinent, as 
cancer survivors may be at a higher risk for developing comorbid conditions including 
cardiovascular disease as a result of their cancer treatments (27, 120).  Additionally, 
examining the impact of aerobic exercise on the endocrine system in cancer patients and 
survivors may be important because of the role of certain hormones in mediating immune 
responses that are associated with anti-cancer defense (9).   
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 Regarding response to acute aerobic exercise, one set of hormones that may be 
especially important to study are hormones of the adrenal gland, namely the catecholamines 
(epinephrine and norepinephrine) and cortisol.  In healthy individuals, these hormone levels 
rise proportionally with respect to exercise intensity and duration, targeting multiple organs 
including the heart, blood vessels, skeletal muscle, adipose tissue, liver, and pancreas (56, 
57).  Thus, these hormones elicit a wide array of responses involving the cardiovascular and 
metabolic systems. For breast cancer survivors, certain cancer treatments may lead to 
deregulation in adrenal gland hormone release and hypothalamic-pituitary-adrenal (HPA) 
axis function (121-124).  Therefore, it is plausible that their release during acute aerobic 
exercise could be affected as well, although studies examining hormonal responses to acute 
aerobic exercise in breast cancer survivors are scarce. 
Understanding how these hormones respond to and recover from acute aerobic 
exercise will aid researchers and clinicians in constructing the most relevant and specific 
exercise guidelines for cancer patients and survivors; thus allowing a cancer patient or 
survivor to reap the maximum health benefits of exercise.  Furthermore, since current 
exercise guidelines put forth by the American College of Sports Medicine for cancer patients 
and survivors are very similar to those for the general population, it is important to 
investigate and compare physiological responses to exercise between cancer patients and 
survivors and healthy individuals without a history of cancer.  Therefore, the purpose of this 
study was to compare the catecholamine and cortisol responses to an acute bout of moderate-
intensity aerobic exercise in breast cancer survivors and healthy controls.   
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Methods 
Subjects 
 Participants in this study included women breast cancer survivors and healthy women 
who had never been diagnosed with or treated for cancer.  All subjects were between the ages 
of 40-70 years, were not regular users of anti-inflammatory medications, and had not 
experienced a menstrual period for approximately 1 year prior to enrollment.  Inclusion in the 
breast cancer survivor group further required that subjects had been diagnosed with Stage I, 
II, or II invasive breast cancer, had received chemotherapy, and had completed all planned 
surgery, chemotherapy, and radiation therapy 3-6 months prior to enrollment.  Inclusion in 
the control group further required that subjects did not have a history of cancer diagnosis or 
treatment, were sedentary, and were free from cardiovascular and musculoskeletal disease 
that would render aerobic exercise participation unsafe.  Subjects were recruited from the 
University of North Carolina at Chapel Hill (UNC-Chapel Hill) and the surrounding areas.   
General Procedures 
 Study details have been previously discussed in Chapter III.  Briefly, each subject 
completed three laboratory visits during the course of the study.  During visit 1, subjects 
were introduced to the study, received a comprehensive medical and physical screening, and 
completed a VO2peak test on the cycle ergometer to assess maximal aerobic power.  During 
visit 2, subjects completed a 30-minute aerobic exercise bout on the cycle ergometer at a 
workload corresponding to 60% of VO2peak.  Blood samples were obtained immediately pre-
exercise, immediately post-exercise, and 2 hours post-exercise.  During visit 3, one resting 
blood sample was obtained at 24 hours post-exercise.  Before each visit, all subjects were 
asked to follow a set of pre-assessment guidelines which included the following:  no eating 
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for at least 2 hours prior to testing, no exercise for at least 12 hours prior to testing, 
maintaining adequate hydration, no caffeine for at least 12 hours prior to testing, and no 
alcohol use for at least 48 hours prior to testing.  All subject testing took place in the 
laboratory facilities housed within the Department of Exercise and Sport Science at UNC-
Chapel Hill. 
Visit 1:  Medical/Physical Screening and VO2peak test 
Subjects were informed of the study objectives, the potential risks of participation, 
and were asked to sign the informed consent documents previously approved by the 
Institutional Review Board.  Subjects then completed a comprehensive medical history 
questionnaire, underwent a 12-lead resting electrocardiogram (ECG) and a physical exam.  
Subjects were screened for exclusion based on the criteria put forth by the American College 
of Sports Medicine (ACSM) as contraindications to exercise testing (99). 
After subjects were cleared for participation, physical characteristics (i.e., age, race, 
height, body mass, and percent body fat) were recorded.  For subjects in the breast cancer 
survivor group, details of their cancer treatments were recorded to include surgery type, 
chemotherapy medications received, whether or not radiation therapy was received, and the 
use of other medications relevant to the cancer treatment.  Height and body mass were 
measured using a portable stadiometer (Perspective Enterprises, Portage, MI) and a 
calibrated balance-beam scale (Detecto, Webb City, MO).  Body mass index (BMI) was 
calculated from height and body mass.  Percent body fat was assessed using a Discovery 
Dual Energy X-ray Absorption (DEXA) scanner (Hologic, Inc., Bedford, MA).   
Subjects then completed a cardiopulmonary exercise test to measure VO2peak with the 
purposes of assessing peak aerobic capacity and calculating the submaximal workload that 
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subjects would perform during visit 2.  The Astrand Cycle Ergometer Maximal Test protocol 
was performed on an electronically-braked cycle ergometer to assess VO2peak (Lode, 
Gronigen, The Netherlands) (100).  This is a multi-stage protocol, where subjects began by 
pedaling at a workload of 50 Watts for 3 minutes, and then progressed by increments of 25 
Watts every 3 minutes until volitional fatigue.  Resting metabolic data were collected for 3 
minutes immediately before beginning the first stage.   Heart rate and Rating of Perceived 
Exertion (RPE) (101) were recorded at the end of every minute of the test.  Expired gases 
were collected and analyzed using a TrueMax 2400 Metabolic System (Parvo Medics, Salt 
Lake City, UT).  Minute-by-minute heart rates were obtained from 12-lead ECG monitoring 
(GE CASE Cardiosoft V. 6.6 ECG diagnostic system, General Electric, Palatine, IL).  
VO2peak was the highest VO2 measured by the metabolic system during the last stage of the 
test.  Peak workload was the workload on the cycle ergometer that corresponded to the 
subject’s VO2peak.  Once the test was complete, subjects cooled down by pedaling at a very 
light workload (< 20 Watts).  Monitoring continued for at least 5 minutes post-exercise and 
until heart rate and blood pressure had returned to near-baseline levels (102).   
Visit 2:  Acute Aerobic Exercise Session 
 During visit 2, subjects completed a 30-minute bout of moderate intensity aerobic 
exercise at a workload corresponding to 60% of VO2peak.  The 30-minute exercise bout was 
comprised of ten 3-minute exercise intervals alternating with 1.5 minutes of rest.  This type 
of discontinuous protocol was used in order to ensure that all subjects would be able to 
complete the entire 30 minutes of exercise.  All exercise sessions began between 7:00-10:00 
am in order to control for daily fluctuations in the study variables. 
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 Subjects rested in the supine position for approximately 20 minutes so that an 
angiocatheter could be placed in an antecubital vein in the arm for blood sampling.  A pre-
exercise blood sample was drawn into two 3-mL K3EDTA Vacutainer® tubes.  Subjects then 
sat quietly on the cycle ergometer for 3 minutes while resting metabolic data was collected.  
Subjects were then allowed to warm up for 4-5 minutes by pedaling at approximately 30 
Watts for 4-5 minutes on the cycle ergometer, after which they were encouraged to lightly 
stretch the muscles of the lower body in a manner of their choice.  After this was completed, 
subjects performed the 30-minute aerobic exercise bout at the workload which corresponded 
to 60% of VO2peak.  Expired gases were monitored during the first, third, seventh, and tenth 
exercise interval.  Workload was adjusted as needed in order to ensure that subjects were 
exercising as close to 60% of VO2peak as possible.  Heart rate and RPE were recorded every 3 
minutes.  When the exercise bout was complete, subjects immediately dismounted the cycler 
ergometer and returned to the supine position.  An immediate post-exercise blood sample 
was drawn into two 3-mL Vacutainer® tubes. 
 For the remainder of the visit, subjects rested in the laboratory.  Subjects were not 
allowed to ingest any food or beverage with the exception of water.  At 2 hours post-exercise, 
another blood sample was obtained in the same manner as previously described.  The 
angiocatheter was removed and any necessary bandaging was performed. 
Visit 3:  24-hour Follow-up Session 
 Subjects returned to the laboratory in order to obtain a resting blood sample at 24 
hours post-exercise. A standard venipuncture technique was used to draw the blood was into 
two 3-mL K3EDTA Vacutainer® tubes.  Blood was sampled from an antecubital vein in the 
arm.   
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Perceived Stress Scale 
At the beginning of visits 2 and 3, subjects were asked to complete the Perceived 
Stress Scale (PSS).  The PSS is a 10-item questionnaire, where scores may range from 0-40, 
with higher scores denoting higher levels of stress.  The PSS is a widely-used psychological 
instrument used tor measuring the perception of stress (125, 126).  The purpose for 
administering the PSS was to assess subjects’ perceptions of the stressors in their daily life, 
as these stressors could potentially impact resting values of the stress hormone variables in 
this study (epinephrine, norepinephrine, and cortisol). 
Determination of Plasma Levels of Catecholamines and Cortisol 
At the conclusion of laboratory visits 2 and 3, whole blood samples were centrifuged 
at 4°C at 3000 rpm for 10 minutes using an IEC Centra-8R refrigerated centrifuge 
(International Equipment Company, Needham Heights, MA).  The plasma portion was 
isolated and stored in vials at -80°C until the time of analysis.  Catecholamines were 
measured using a competitive binding, single antibody, solid phase 
epinephrine/norepinephrine ELISA kit (Abnova, Tapei City, Taiwan) with analytical 
sensitivities of 10 pg/mL and 50 pg/mL for epinephrine and norepinephrine, respectively.  
The reported mean intra-assay coefficients of variation for epinephrine ranged from 6.9-
15.8%, and the reported mean inter-assay coefficients of variation ranged from 13.2-18.2%.  
The reported mean intra-assay precisions coefficients of variation for norepinephrine ranged 
from 9.8-16.1%, and the reported mean inter-assay coefficients of variation ranged from 8.5-
15.0%.   Samples were run in duplicate, with the exception of two control samples which 
were run in singlet due to limited plasma volume.  Cortisol was measured using a 
competitive binding, double antibody, combination solid and mobile phase ELISA kit 
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(Abnova, Taipei City, Taiwan) with a sensitivity of 0.44 ng/mL.  The reported mean intra-
assay coefficients of variation for cortisol ranged from 6.2-9.4%, and the reported mean 
inter-assay coefficients of variation ranged from 8.6-15.0%.  Samples were run in one batch 
and in duplicate.  
Calculation of Plasma Volume Shifts 
Plasma volume shifts (changes in plasma volume due to exercise) were calculated 
according to the equation by Dill and Costill (111).  Complete blood counts were performed 
at each study time point using a COULTER® Ac•T diff ™ Hematology Analyzer (Beckman 
Coulter, Inc., Brea, CA), which yielded the hematocrit and hemoglobin values that were used 
in these calculations.   Plasma volume shifts were reported in order to indicate the effect that 
exercise may have on fluid shifts, which may affect concentrations of catecholamines and 
cortisol. 
Statistical Analysis 
Age, height, body mass, BMI, percent body fat, VO2peak, peak workload, submaximal 
VO2, and submaximal workload were compared between the two study groups using 
independent samples t-tests.  Submaximal VO2 parameters and submaximal workload 
parameters were compared within the groups using paired-samples t-tests.  Scores from the 
PSS were compared between the two study groups using independent samples t-tests and 
score comparisons within the groups were made using paired-samples t-tests.  Plasma 
volume shifts immediately post-exercise, 2 hours post-exercise, and 24 hours post-exercise 
were analyzed between groups using independent-samples t-tests.  Plasma concentrations of 
catecholamines (epinephrine and norepinephrine) and cortisol were analyzed using a 2x4 
mixed model ANOVA.  Pairwise comparisons were made within and between the groups 
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using repeated-measures ANOVAs and independent samples t-tests, respectively.  Percent 
changes were also calculated for catecholamines and cortisol in order to examine how these 
parameters were changing from pre-exercise to each of the three post-exercise time points.  
Percent changes in hormone concentrations were compared between groups using 
independent samples t-tests.  SPSS Statistics version 18.0 was used to perform all statistical 
analyses. 
Results 
Subjects 
 The 18 subjects were included in this study were equally divided into the breast 
cancer survivor group and the control group.  Although the physical characteristics have been 
previously presented in Chapter III, Table 4.1 presents these for the reader’s edification.  
Similarly, treatment details for the breast cancer survivor group are presented in Table 4.2 
simply for edification.  The control group was significantly older than the breast cancer 
survivor group by an average of 9 years (p = 0.002).  There were no other statistically 
significant physical differences between the groups. 
 
Table 4.1.  Subject physical characteristics (mean ± SD) 
Characteristic  
 
Breast Cancer Survivor 
Group  
(n = 9) 
Control Group  
(n = 9) 
p-value 
Age (years) 50 ± 6 59 ± 5 0.002 
Race (# of women) Caucasian (8) 
African American (1) 
Caucasian (9) -- 
Height (cm) 164.7 ± 5.8 163.8 ± 5.9 0.754 
Weight (kg) 76.9 ± 12.6 77.7 ± 13.3 0.906 
Body Mass Index 
(kg/m
2
) 
28.4 ± 5.0 28.9 ± 4.6 0.817 
Percent Body Fat (%) 41.6 ± 4.5 42.1 ± 4.0 0.823 
VO2peak (mL/kg/min) 18.1 ± 2.7 18.5 ± 5.1 0.847 
Peak Workload (W) 107 ± 19 106 ± 17 0.897 
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Table 4.2.  Details of cancer treatments received by breast cancer survivor group (n = 9) 
Treatment Number of Subjects 
Receiving Treatment 
Surgery 
     Mastectomy 
     Lumpectomy 
 
4 
5 
Radiation Therapy 9 
Chemotherapy 
     Adriamycin 
     Cytoxan 
     Taxol/Taxotere 
     Carboplatin 
 
6 
7 
9 
3 
Hormonal Therapy 
     Tamoxifen 
     Femara 
 
5 
1 
Other  
     Herceptin 
     Lapatinib 
     Bevacizumab 
 
2 
1 
1 
 
Metabolic Responses and PSS Scores 
 Submaximal VO2 and workload were compared to determine if there were any 
differences in exercise intensity between the groups during the aerobic exercise session.  
Estimated submaximal VO2 (i.e., what was calculated as 60% of VO2peak) was similar 
between breast cancer survivors and controls (10.9 ± 1.6 mL/kg/min vs. 11.1 ± 3.1 
mL/kg/min, p = 0.865), as was actual submaximal VO2 (i.e., what was actually performed, 
12.1 ± 1.3 mL/kg/min vs. 11.1 ± 1.8 mL/kg/min, p = 0.261).  Actual submaximal VO2 was 
significantly higher than estimated submaximal VO2 in the breast cancer survivor group (p = 
0.016).  No significant differences existed between the groups for estimated or actual 
submaximal workload, within either group for estimated vs. actual submaximal workload, or 
within the control group for estimated vs. actual submaximal VO2 (p = 0.084-0.626).  
Additionally, there were no statistically significant differences in PSS scores between the 
breast cancer survivor group and the control group for either laboratory visit 2 (15 ± 4 vs. 13 
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± 6, p = 0.511) or laboratory visit 3 (15 ± 5 vs. 12 ± 7, p = 0.305).  Similarly, no significant 
differences existed when comparing PSS scores within the groups for laboratory visit 2 or 3 
(p = 0.261-0.829). 
Plasma Levels of Epinephrine, Norepinephrine, and Cortisol 
 Plasma concentrations of epinephrine, norepinephrine, and cortisol are shown in 
Table 4.3.  As mentioned previously, hormone concentrations were adjusted to reflect shifts 
in plasma volume.  Catecholamine and cortisol concentrations were not able to be determined 
for one breast cancer survivor subject immediately post-exercise and one breast cancer 
survivor subject 2 hours post-exercise because blood samples were not able to be obtained.  
Cortisol concentration was not able to be determined for one control subject 24 hours post-
exercise because of limited plasma volume.  Therefore, mean substitution was performed to 
account for these missing data.  There was a significant Group by Time interaction effect for 
epinephrine (p = 0.040).  Epinephrine levels were significantly elevated immediately post-
exercise in the control group only (p = 0.022).  At 2 hours post-exercise, epinephrine levels 
had somewhat decreased in the breast cancer survivor group (p = 0.053).  When comparing 
groups, epinephrine levels were significantly elevated in the breast cancer survivor group 
pre-exercise, immediately post-exercise, and 24 hours post-exercise compared to the control 
group (p < 0.0005, p = 0.032, and p < 0.0005 respectively).   
In the breast cancer group, plasma norepinephrine levels were somewhat elevated 
immediately post-exercise (p = 0.068) and were significantly elevated at 2 hours and 24 
hours post-exercise compared to pre-exercise levels (p = 0.030 and 0.035, respectively).  
Post-exercise norepinephrine levels were not significantly different from the pre-exercise 
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levels in the control group (p = 0.120-0.363).  Norepinephrine levels were similar between 
groups at each time point (p = 0.203-0.410).  
For plasma cortisol, there was a significant group-by-time interaction effect (p = 
0.018).  In the breast cancer survivor group, cortisol levels at 24 hours post-exercise were 
significantly lower than pre-exercise levels (p = 0.004).  In the control group however, 
cortisol levels were significantly decreased below pre-exercise levels immediately post-
exercise and 2 hours post-exercise (p = 0.003 and 0.013, respectively).  When comparing 
groups, cortisol levels were somewhat higher in the breast cancer survivor group 
immediately post-exercise (p = 0.064).   
 
Table 4.3.  Plasma hormone levels across time (mean ± SD) 
Parameter Breast Cancer Survivor 
Group 
Control Group 
Epinephrine (pg/mL)      
     Pre-exercise 
     0h post-exercise 
     2h post-exercise 
     24h post-exercise 
 
49.7 ± 9.9
a
 
54.5 ± 12.7
b
 
42.8 ± 3.0 
47.9 ± 6.2
c
 
 
27.1 ± 4.9
a 
39.2 ± 14.9
*b 
36.5 ± 15.6 
28.6 ± 6.7
c 
Norepinephrine (pg/mL) 
     Pre-exercise 
     0h post-exercise 
     2h post-exercise 
     24h post-exercise 
 
258.0 ± 109.6 
507.2 ± 395.5
 
524.9 ± 350.7
† 
350.7 ± 105.3
‡ 
 
518.0 ± 555.3 
741.0 ± 728.1 
709.0 ± 485.0 
282.2 ± 147.3
 
Cortisol (ng/mL) 
     Pre-exercise 
     0h post-exercise 
     2h post-exercise 
     24h post-exercise 
 
137.7 ± 73.2 
131.1 ± 77.5 
93.3 ± 64.3
 
84.9 ± 49.8
‡ 
 
147.7 ± 49.2
 
75.3 ± 16.3
* 
85.2 ± 31.2
† 
116.4 ± 61.8
 
*
p < 0.05 for pre-exercise vs. 0h post-exercise 
†
p < 0.05 for pre-exercise vs. 2h post-exercise 
‡
p < 0.05 for pre-exercise vs. 24h post-exercise 
a
p < 0.05 for comparing pre-exercise values between groups 
b
p < 0.05 for comparing 0h post-exercise values between groups 
c
p < 0.05 for comparing 24h post-exercise values between groups 
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Percent Changes in Plasma Hormones 
 Percent changes in plasma epinephrine, norepinephrine, and cortisol for the three 
post-exercise time points are shown in Table 4.4.  These were calculated in order to more 
clearly understand how these parameters changed compared to pre-exercise levels for each 
group.  When comparing groups, percent change in hormone levels after the acute aerobic 
exercise bout were generally similar, with a few exceptions.  Percent change in epinephrine 
was somewhat lower in the breast cancer survivor group immediately post-exercise (p = 
0.081) and significantly lower at 2 hours post-exercise (p = 0.040).  Percent change in 
cortisol was somewhat increased in the breast cancer survivor group immediately post-
exercise and in the opposite direction from the control group (p = 0.054). 
Table 4.4.  Percent change in plasma hormone levels post-exercise (mean ± SD) 
Parameter Breast Cancer Survivor Group Control Group 
Percent change in epinephrine (%) 
     0h post-exercise 
     2h post-exercise 
     24h post-exercise 
 
12.2 ± 30.9 
-11.5 ± 14.7
a 
-1.4 ± 18.7 
 
44.8 ± 42.5 
35.9 ± 57.4
a 
6.0 ± 18.2 
Percent change in norepinephrine 
(%) 
     0h post-exercise 
     2h post-exercise 
     24h post-exercise 
 
101.1 ± 110.5 
111.4 ± 107.6 
56.4 ± 75.5 
 
122.4 ± 172.1 
131.5 ± 136.6 
12.5 ± 103.8 
Percent change in cortisol (%) 
     0h post-exercise 
     2h post-exercise 
     24h post-exercise 
 
19.4 ± 76.4
 
-13.2 ± 66.7 
-36.6 ± 24.8 
 
-40.8 ± 34.0
 
-35.3 ± 30.9 
-16.8 ± 45.0 
a
p < 0.05 for comparing 2h post-exercise values between groups 
 
Discussion 
 To the authors’ knowledge, this is the first study to examine the effect of acute 
aerobic exercise on any hormonal parameter in breast cancer survivors.  Breast cancer 
survivors exhibited significantly higher plasma epinephrine levels compared to controls pre-
exercise, immediately post-exercise and 24 hours post-exercise, as well as somewhat higher 
99 
 
cortisol levels immediately post-exercise.  Compared to pre-exercise levels, plasma 
epinephrine increased significantly immediately post-exercise in the control group, whereas 
plasma norepinephrine significantly increased 2 hours and 24 hours post-exercise in the 
breast cancer survivor group.  Plasma cortisol became significantly decreased in the breast 
cancer survivor group at 24 hours post-exercise, but was significantly decreased immediately 
post-exercise and 2 hours post-exercise in the control group.   
Changes in Plasma Catecholamines 
 There were several novel findings regarding the catecholamine responses to the acute 
aerobic exercise session.  Firstly, absolute plasma epinephrine levels were consistently higher 
in the breast cancer survivor group compared to the control group across time, and this 
difference was significant at the pre-exercise, immediate post-exercise, and 24 hours post-
exercise.  Since the majority of the epinephrine originates in the adrenal gland, this finding 
implies that the breast cancer survivors were experiencing increased adrenal gland activity 
compared to the controls.  It is possible that these elevated epinephrine levels could be 
associated with elevations in pro-inflammatory cytokines (i.e., interleukin 1, 6, and tumor 
necrosis factor alpha); a scenario that is not uncommon in breast cancer survivors who are 
experiencing fatigue, cachexia, depression, and/or pain (127-129).  The current study did not 
ask the breast cancer survivors to report treatment-related side effects, and inflammatory 
cytokines were not measured, but such associations certainly warrant further investigation. 
With regard to metabolism and substrate utilization, Tosti et al. (130) observed that 
breast cancer survivors exhibited elevated blood glucose responses compared to healthy 
controls before and after short duration aerobic exercise sessions at 40-70% of VO2max.  Since 
epinephrine upregulates the process of glycogenolysis in order to release glucose into the 
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bloodstream, the findings of this current study and those of Tosti et al. (130) may be related.  
Blood glucose and lactate measurements were not taken during this study; however, such 
parameters should be investigated further. 
The plasma norepinephrine significantly increased in absolute concentrations from 
pre-exercise to post-exercise time points in the breast cancer survivor group but not in the 
control group.  While the intended intensity of the aerobic exercise session was estimated at 
60% of VO2peak, the breast cancer survivor group’s actual submaximal VO2 was slightly 
higher than 60% of VO2peak (~67% vs. ~61%,  p = 0.016), whereas the control group’s 
estimated and actual submaximal VO2 did not differ.  Therefore, it is possible that by 
working at a higher relative intensity, the breast cancer survivors experienced increased 
sympathetic nervous system activity, and hence significant fluctuations in plasma 
norepinephrine levels.   
Interestingly, the magnitude of catecholamine release during the 30-minute aerobic 
exercise bout was notably lower than what may be typically observed.  For example, it is not 
uncommon for 20 minutes of exercise at 60% of VO2max to cause plasma catecholamines to 
increase 2-3 times pre-exercise levels (57, 59-61).  In the current study, average magnitudes 
of catecholamine increase immediately post-exercise ranged from 12-122% above pre-
exercise levels.  This somewhat “attenuated” response may be most directly related to the 
discontinuous nature of the aerobic exercise bout which alternated 3 minute intervals of 
exercise with 1.5 minute intervals of rest.  Therefore, even though subjects exercised for a 
total of 30 minutes at approximately 60% of VO2peak, the cumulative effect of the exercise 
session may not have elicited the same amount of physiological stress as would 30 minutes 
of continuous exercise at the same intensity, especially for healthy control subjects.  
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Additionally, the submaximal intensity performed during the aerobic exercise session was 
based off the subjects’ VO2peak test results, which may not have been equal to the subjects’ 
true VO2max.   
Taken together, these results indicate that there were some significant differences in 
absolute plasma catecholamine concentration between the breast cancer survivors and 
healthy controls, (i.e., higher epinephrine levels in the breast cancer survivors) but that 
percent changes in catecholamines post-exercise were either notably lower in the breast 
cancer survivors (i.e., epinephrine immediately post-exercise and 2 hours post-exercise) or 
were similar between groups.  After observing some of these group differences, one question 
that arises is whether or not there were any differences in perceived stress of the exercise 
between the groups.  To examine this, an exploratory comparison of heart rate and RPE 
responses between groups was performed.  No significant differences were observed between 
the breast cancer survivors and the controls for either % exercise intensity based on heart rate 
reserve (53.1 ± 14.6% vs. 56.1 ± 15.3%, p = 0.679) or RPE response (12 ± 1 vs. 12 ± 1, p = 
0.536).  Additionally, PSS scores reported by both groups during laboratory visit 2 were 
similar.  This suggests that the higher absolute epinephrine concentrations seen in the breast 
cancer survivor group could be related to some pre-existing condition (i.e., a treatment-
related side effect), but that the relative stress of the exercise on the sympathetic nervous 
system and the adrenal medulla was not necessarily greater. 
Changes in Plasma Cortisol 
 In the control group, plasma cortisol significantly decreased immediately post-
exercise and 2 hours post-exercise, but the reverse occurred in the breast cancer survivor 
group. Additionally, percent change in cortisol immediately post-exercise was somewhat 
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different between groups.  These divergent responses were somewhat unexpected, and the 
exact mechanisms driving these results are not entirely clear.  Elevation in plasma cortisol 
levels seems to follow a threshold effect, where exercise intensities of > 50% of VO2max 
appear to elicit increased plasma cortisol concentrations, and intensities below this threshold 
are either not stressful enough, or do not cause significant decreases in blood glucose levels 
(57).  The fact that the breast cancer survivors exercised at a slightly higher relative intensity 
during the exercise trial may have led to increased activation of the hypothalamic-pituitary-
adrenal (HPA) axis, thus resulting in higher plasma cortisol release during exercise. Although 
HR and RPE response and relative output of catecholamines were largely similar between 
groups, the exercise seemed to place a greater amount of stress on the HPA axis of the breast 
cancer survivors, thus yielding greater plasma cortisol concentrations.  Additionally, the 
discontinuous nature of the aerobic exercise session may not have elicited the same amount 
of physiological stress as would a continuous aerobic exercise session of the same intensity 
and duration.  For the control group, this could mean that the exercise may not have reached 
the threshold that is necessary for eliciting an increase in plasma cortisol concentration, and 
that the decreases in plasma cortisol may have occurred because the rate of removal exceeded 
the rate of secretion (57).   
Strengths and Limitations 
 As with all studies, there were strengths and limitations inherent to this study.  One 
strength was that breast cancer survivors and controls were very closely matched regarding 
aerobic fitness (VO2peak), and body composition.  This study is one of the few to describe 
endocrine responses in a study sample of women who are of very low aerobic fitness (< 20 
mL/kg/min), and it is the first to describe endocrine responses to acute aerobic exercise in 
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breast cancer survivors at multiple time points post-exercise.  One limitation of this study 
may be the average age difference between the study groups.  While all attempts were made 
to match subjects closely on all physical characteristics, the control group was older than the 
breast cancer survivor group by an average of 9 years.  Previous studies have also observed 
post-exercise decreases in cortisol in healthy older females (131-132).  Additionally, this 
study employed a relatively small sample size, and there may not have been adequate 
statistical power to detect all within- or between-group differences in all hormone 
parameters.  Furthermore, some data points were not available for all subjects because of 
limited availability of blood samples, or the inability to obtain blood samples.  As a result, 
mean substitution was performed to account for these missing data points. Lastly, while all 
subjects had fasted for at least 2 hours prior to all Laboratory Sessions, it is likely that some 
subjects had fasted for a longer period of time than others; a factor which could affect 
epinephrine and cortisol release.   
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Conclusions 
 In summary, 30 minutes of moderate intensity aerobic exercise seems to elicit 
generally similar changes in plasma epinephrine concentrations in recent breast cancer 
survivors compared to physically similar control women without a history of cancer 
diagnosis or treatment.  Some differences in absolute plasma epinephrine levels were 
measured between groups, which could be related to underlying physiological differences 
specifically associated with cancer and its treatments.  Plasma cortisol responses during the 
exercise session differed between breast cancer survivors and controls, possibly due to 
differences in age and exercise intensity.  These findings suggest that acute aerobic exercise 
may have a more pronounced or “stressful” effect on the adrenal glands in recent breast 
cancer survivors compared to healthy women without a history of cancer, even though other 
measures of exercise intensity (i.e., HR and RPE) are similar.   
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CHAPTER V 
 
THE RELATIONSHIPS BETWEEN CHANGES IN NATURAL KILLER CELL 
NUMBERS, CATECHOLAMINES, AND CORTISOL AFTER ACUTE AEROBIC 
EXERCISE IN BREAST CANCER SURVIVORS 
 
Summary 
Current research examining the endocrine factors that mediate immune responses in 
cancer patients and survivors is limited.  The purpose of this study was to investigate the 
relationships between changes in NK cell, catecholamine, and cortisol responses to the acute 
bout of moderate-intensity aerobic exercise in nine breast cancer survivors (3-6 months post-
treatment for Stage I-III invasive breast cancer) and nine healthy controls.  Subjects 
performed 30 minutes of discontinuous aerobic exercise on the cycle ergometer at 60% of 
VO2peak.  NK cell counts and plasma concentrations of epinephrine, norepinephrine, and 
cortisol were determined from blood samples taken pre-exercise, immediately post-exercise, 
and 2 hours post-exercise.  Changes in NK cell counts were correlated with changes in 
epinephrine, norepinephrine, and cortisol concentrations using Spearman Rank Correlations.  
Changes in NK cell counts were not significantly correlated with changes in catecholamines 
or cortisol in the breast cancer survivor group (r = -0.417-0.433, p = 0.244-0.831).  Change in 
NK cell count was significantly correlated with change in cortisol concentration in the 
control group at 2 hours post-exercise (r = 0.767, p = 0.016).  These results suggest that 
exercise-related changes in NK cell counts may not be related to the hormones of the adrenal 
gland in breast cancer survivors, but rather to other biologic factors yet to be examined. 
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Introduction 
 The American Cancer Society estimates that at this time, there are more than 2.9 
million breast cancer survivors in the United States (1).  The increase in breast cancer 
survival rates over recent years is encouraging; however, many of these survivors are left to 
deal with treatment-related side effects which may persist for months or years (2).  In 
addition to their effects on the cardiopulmonary and musculoskeletal systems, cancer 
treatments can compromise the immune system which may continue for extended periods of 
time beyond treatment completion (23, 24, 98).  Since immune function and disease-free 
overall survival are positively related, exploring complementary therapies that may boost or 
suppress a breast cancer survivor’s immune system is of particular importance (9, 23). 
Aerobic exercise is an attractive adjunct therapy for cancer patients and survivors 
because of its potentially positive influence on biologic systems involved in disease 
protection and anti-cancer defense (9).  In particular, natural killer (NK) cells are an 
especially relevant parameter to study because of their ability to destroy virally-infected cells 
and tumor cells, as well as their extreme responsiveness to acute aerobic exercise (10-14).  
NK cells are thought to be associated with multiple biologic factors including hormones of 
the adrenal gland, and in particular, the catecholamines (epinephrine and norepinephrine) and 
cortisol.  Catecholamines affect NK cell numbers through upregulating the surface density of 
β-adrenergic receptors on the NK cells themselves, thus causing changes in the 
configurations of adhesion molecules, which lead to demargination of NK cells from small 
venules and the spleen into circulation (11, 66).  Cortisol affects NK cell numbers, possibly 
through glucocorticoid-induced apoptosis, inhibited adhesion of effect or cells to target cells, 
and altered cytokine responses (13, 42, 43, 73).  During acute aerobic exercise, plasma 
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concentrations of both catecholamines and cortisol increase; therefore, increased 
catecholamines are often associated with increased NK cell numbers during exercise, 
whereas increased cortisol is often associated with decreased NK cell numbers during 
recovery (11, 13, 42, 43, 66, 67, 73). 
To date, no study has examined associations between exercise-induced immune 
responses and endocrine mediators in the breast cancer patient population.  Cancer and its 
treatments may be associated with chronic inflammation, altered hypothalamic-pituitary-
adrenal axis and sympathetic nervous system function, and immune system deficiencies (23, 
24, 98, 121-124, 127-129).  Understanding how exercise affects the relationships between 
these parameters may help investigators devise exercise prescriptions that increase 
functioning in both the endocrine and immune systems, with the ultimate goals of reducing 
cancer risk/recurrence/second malignancies and increasing survival time post-treatment.  
Therefore, the purpose of this investigation was to compare the relationships between 
changes in NK cell, catecholamine, and cortisol responses to the acute bout of moderate-
intensity aerobic exercise in breast cancer survivors and apparently healthy controls.   
Methods 
Subjects 
 Participants included 9 breast cancer survivors and 9 apparently healthy controls.  All 
were women 40-70 years of age, were not regular users of anti-inflammatory medications, 
and had experienced amenorrhea for approximately 1 year prior to enrollment.  The breast 
cancer survivor group had been diagnosed with Stage I-III invasive breast cancer, had 
received chemotherapy, and had completed all planned surgery, chemotherapy, and/or 
radiation therapy within 3-6 months prior to enrollment.  The control group had never 
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experienced cancer treatment or diagnosis, was sedentary, and was free from any disease that 
would pose as a contraindication to aerobic exercise participation.   
Laboratory Visits 
Study procedures for the laboratory visits were previously described in Chapter III.  
Briefly, subjects reported to the laboratory facilities in the Department of Exercise and Sport 
Science at UNC-Chapel Hill on two separate occasions.  Prior to each laboratory visit, 
subjects were asked to refrain from 1) eating for at least 2 hours prior to testing, 2) exercise 
and caffeine for at least 12 hours, and 3) alcohol for at least 48 hours.  Visit 1 included an 
introduction to the study, assessment of baseline physical characteristics (age, race, height, 
weight, and body composition), a comprehensive medical and physical screening, and a 
VO2peak test using the Astrand Cycle Ergometer Maximal Test Protocol to assess VO2peak 
(100) and extrapolate to a workload equal to 60% of VO2peak.  During the VO2peak test, 
oxygen uptake was determined using a Parvo Medics TrueMax 2400 Metabolic System 
(Parvo Medics, Salt Lake City, UT).  Heart rate and Rating of Perceived Exertion or RPE 
(101) were recorded at the end of every minute of the test.  ECG monitoring was performed 
continuously using a GE CASE Cardiosoft V. 6.6 ECG diagnostic system (General Electric, 
Palatine, IL).    
Visit 2 began between 7:00-10:00 am in order to control for daily variations in the 
study variables.  Upon arrival, subjects completed the Perceived Stress Scale (PSS) in order 
to assess how subjects perceived stress in daily life, as such stress could impact the resting 
values of epinephrine, norepinephrine, and cortisol.  Subjects rested for 3 minutes on the 
cycle ergometer while resting metabolic data was collected.  Subjects then performed a 
warm-up on the cycle ergometer, followed by light stretching of the muscles of the lower 
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body.  Subjects then performed the 30 minute aerobic exercise bout at a workload which 
corresponded to 60% of VO2peak.  Since all subjects were sedentary, the exercise was divided 
into ten 3-minute intervals with1.5 minutes of rest.  Metabolic data was collected during 
intervals 1, 3, 7, and 10, and workload was adjusted as needed in order to maintain the 
exercise intensity as close to 60% of VO2peak as possible.  Heart rate and RPE were recorded 
at the end of each 3-minute exercise interval.  
Blood Sampling 
Blood samples were taken through a catheter placed in an antecubital vein.  Blood 
samples were obtained using the three-syringe technique (waste, sample, saline) pre-exercise 
before the warm-up, immediately post-exercise, and 2 hours post-exercises.  Subjects were 
not allowed to ingest any food or beverage with the exception of water, as these could 
potentially affect study variables.  At the conclusion of the laboratory session, whole blood 
samples were centrifuged at 4°C for 10 minutes at 3000 rpm using an IEC Centra-8R 
refrigerated centrifuge (International Equipment Company, Needham Heights, MA).  The 
plasma portion was aliquoted and stored at -80°C.   
Determination of NK Cell Counts  
 Routine complete blood counts (CBC) were performed for the blood samples taken at 
each time point using a COULTER® Ac•T diff ™ Hematology Analyzer (Beckman Coulter, 
Inc., Brea, CA).  From these, the numbers of total lymphocytes were obtained.  To determine 
NK cell counts, blood samples were stained to identify the subset of lymphocytes which 
express the CD3
-
CD16
+
CD56
+
 phenotype.  Whole blood samples were fluorescently stained 
using fluorescein isothyocyanate (FITC) for the CD3 marker, phycoerythrin (PE) for the 
CD16 marker, and allophycocyanin (APC) for the CD56 marker.  Samples were further 
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prepared using procedures made available by Becton Dickenson (109).  Within 24 hours of 
sample preparation, flow cytometric analysis was performed using a CyAn 3 laser/9 color 
flow cytometer (Beckman Coulter, Inc., Brea, CA).  Summit 4.3 software (Dako North 
America, Inc., Carpinteria, CA) was used to view and analyze flow cytometry data.   
Determination of Plasma Catecholamine and Cortisol Concentrations  
Epinephrine and norepinephrine were assayed using a commercially available ELISA 
kit (Abnova, Tapei City, Taiwan) which has sensitivities of 10 pg/mL and 50 pg/mL for 
epinephrine and norepinephrine, respectively.  The reported mean intra-assay coefficients of 
variation for the epinephrine ELISA was 6.9-15.8%, and the reported mean inter-assay 
coefficients of variation was 13.2-18.2%.  The reported mean intra-assay coefficients of 
variation for the norepinephrine ELISA was 9.8-16.1%, and the reported mean inter-assay 
coefficients of variation was 8.5-15.0%.  All samples were run in duplicate except for two 
control samples which were run in singlet due to limited plasma volumes.   
Cortisol was also assessed using a commercially available ELISA kit (Abnova, Taipei 
City, Taiwan) that has a sensitivity of 0.44 ng/mL.  The reported mean intra-assay 
coefficients of variation for the cortisol ELISA was 6.2-9.4%, and the reported mean inter-
assay coefficients of variation ranged from 8.6-15.0%.  All samples were run in duplicate.   
Statistical Analysis 
 All analyses were performed using SPSS Version 18.0.  Subject characteristics, VO2 
(peak and submaximal), workload (peak and submaximal), and PSS scores were compared 
between groups using independent samples t-tests.  Submaximal VO2 and workload data 
were also compared within groups using paired-samples t-tests.  Absolute lymphocyte counts 
(and therefore NK cell counts), epinephrine, norepinephrine, and cortisol concentrations were 
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adjusted for plasma volume changes due to exercise using the method by Dill and Costill 
(111).  Fold changes for NK cell counts, catecholamine, and cortisol concentrations at each 
post-exercise time point (immediately post-exercise and 2 hours post-exercise) were 
calculated by dividing the post-exercise value by the pre-exercise value and were compared 
to a null value of 1.0 using one-sample t-tests.  Between-group comparisons of fold changes 
for each parameter were made using Wilcoxon Rank Sum tests. Relationships between fold 
changes in NK cell counts and fold changes in epinephrine, norepinephrine, and cortisol were 
evaluated at each post-exercise time point using Spearman Rank correlations. 
Results 
Subject Characteristics, VO2, workload, and PSS Scores 
Between-group comparisons of subject characteristics, VO2, workload, and PSS 
scores (mean ± standard deviation [SD]) are shown in Table 5.1.  The control group was 
older than the breast cancer survivor group by an average of 9 years (p = 0.002).  All other 
comparisons regarding physical characteristics, VO2, and workload were similar (p = 0.261-
0.906).  Additionally, PSS scores between groups were similar (p = 0.511). 
Subjects in the breast cancer survivor group had been treated for Stage I, II or III 
invasive breast cancer and had completed all planned surgery, chemotherapy, and radiation 
therapy 3-6 months prior to enrollment.  Surgery type included mastectomy (n = 4) and 
lumpectomy (n = 5).  Chemotherapy agents included Adriamycin (n = 6), Cytoxan (n = 7), 
Taxol/Taxotere (n =9), and Carboplatin (n = 3).  Hormonal therapies included Tamoxifen (n 
= 5) and Femara (n = 1).  Other cancer treatment-related medications included Herceptin (n = 
2), Lapatinib (n = 1), and Bevacizumab (n = 1).  All subjects received radiation therapy. 
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Table 5.1.  Comparison of subject characteristics, VO2, workload, and PSS scores (mean ± 
SD) 
Characteristic  
 
Breast Cancer Survivor Group  
(n = 9) 
Control Group  
(n = 9) 
Age (years) 50 ± 6
*
 59 ± 5
*
 
Race (# of women) Caucasian (8) 
African American (1) 
Caucasian (9) 
Height (cm) 164.7 ± 5.8 163.8 ± 5.9 
Weight (kg) 76.9 ± 12.6 77.7 ± 13.3 
Body Mass Index (kg/m
2
) 28.4 ± 5.0 28.9 ± 4.6 
Percent Body Fat (%) 41.6 ± 4.5 42.1 ± 4.0 
VO2peak (mL/kg/min) 18.1 ± 2.7 18.5 ± 5.1 
Peak Workload (W) 107 ± 19 106 ± 17 
Estimated Submaximal VO2 
(60% of VO2peak, mL/kg/min) 
10.9 ± 1.6
†
 11.1 ± 3.1 
Actual Submaximal VO2 
(mL/kg/min) 
12.1 ± 1.3
†
 11.1 ± 1.8 
Estimated Submaximal 
Workload at 60% of VO2peak 
(W) 
63 ± 12 66 ± 11 
Actual Submaximal 
Workload (W) 
59 ± 9 62 ± 11 
PSS Score 15 ± 4 13 ± 6 
*
p < 0.05 for comparing age between groups 
†p < 0.05 for comparing calculated and actual submaximal VO2 in the breast cancer survivor 
group 
  
Changes in NK Cell Counts, Plasma Catecholamines, and Cortisol 
 Pre-exercise values and fold changes for NK cells, plasma epinephrine, 
norepinephrine, and cortisol are shown in Table 5.2.  In the breast cancer survivor group, 
blood samples were not able to be obtained from one subject immediately post-exercise and 
from one subject 2 hours post-exercise; therefore, mean substitution was performed to 
account for these missing data points.  Plasma volume shifts did not differ significantly 
between groups and were as follows:  -12.0 ± 3.6% vs. –11.5 ± 4.6% immediately post-
exercise and -3.4 ± 6.3% vs. -0.1 ± 9.2% 2 hours post-exercise for the breast cancer survivor 
group and control group, respectively.  Although plasma volume shifts were similar between 
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groups, cell counts and hormone concentrations were adjusted to account for shifts in plasma 
volume due to exercise. In the breast cancer survivor group, pre-exercise NK cell counts 
were somewhat lower, whereas pre-exercise epinephrine concentration was significantly 
higher compared to the control group (p = 0.090 and < 0.0005, respectively). 
Within the breast cancer group, NK cell counts and norepineprhine displayed 
significant increases (i.e., fold changes significantly greater than 1.0) immediately post-
exercise relative to pre-exercise values (p = 0.010 and 0.025 respectively).  At 2 hours post-
exercise, epinephrine was significantly decreased (p = 0.047), while norepinephrine remained 
significantly elevated relative to pre-exercise values (p = 0.018).  Within the control group, 
NK cell counts and epinephrine were significantly elevated immediately post-exercise (p < 
0.0005 and p = 0.013, respectively, while norepinephrine was somewhat elevated (p = 
0.065).  At 2 hours post-exercise, epinephrine was somewhat elevated (p = 0.098), while 
norepinephrine remained significantly elevated relative to pre-exercise levels (p = 0.023.  
Cortisol was significantly decreased (i.e., fold change significantly less than 1.0) relative to 
pre-exercise levels immediately post-exercise and 2 hours post-exercise (p = 0.007 and 0.009 
respectively).  All other fold changes were not significantly different from the null value of 
1.0. 
When comparing groups, the control group showed a significantly larger magnitude 
of increase in epinephrine 2 hours post-exercise (p = 0.005).  All other comparisons were 
similar between groups. 
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Table 5.2.  NK cell counts, plasma catecholamine, and cortisol concentrations at baseline 
(pre-exercise) and fold changes across time (baseline to immediately post-exercise [0h post-
exercise] and baseline to 2 hours post-exercise [2h post-exercise]) 
Parameter Breast Cancer Survivor Group 
(mean ± SD) 
Control Group 
(mean ± SD) 
NK Cells 
     Pre-exercise (cells/μL) 
     Fold change      
          0h post-exercise 
          2h post-exercise 
 
70.3 ± 37.9 
 
2.7 ± 1.5
† 
1.3 ± 0.5 
 
108.9 ± 51.7 
 
2.8 ± 0.9
†
 
1.2 ± 0.6 
Epinephrine 
     Pre-exercise (pg/mL) 
     Fold change      
          0h post-exercise 
          2h post-exercise 
 
49.7 ± 9.9
* 
 
1.1 ± 0.3 
0.9 ± 0.1
†‡ 
 
27.1 ± 4.9
* 
 
1.4 ± 0.4
† 
1.4 ± 0.6
‡
 
Norepinephrine  
     Pre-exercise (pg/mL) 
     Fold change      
          0h post-exercise  
          2h post-exercise 
 
258.0 ± 109.6 
 
2.0 ± 1.1
†
 
2.1 ± 1.1
† 
 
518.0 ± 555.3 
 
2.2 ± 1.7
 
2.3 ± 1.4
†
 
Cortisol  
     Pre-exercise (ng/mL) 
     Fold change      
          0h post-exercise 
          2h post-exercise 
 
137.7 ± 73.2 
 
1.2 ± 0.8 
0.9 ± 0.7 
 
147.7 ± 49.2
 
 
0.6 ± 0.3
† 
0.8 ± 0.5
† 
*
p < 0.05 for comparing pre-exercise values between groups 
†
p < 0.05 when compared to the null value of 1.0 
‡
p < 0.05 when comparing the fold change at 2 hours post-exercise between groups 
 
Correlations between Changes in NK Cell Count, Catecholamine, and Cortisol 
 The correlations between changes in NK cell counts and changes in catecholamines 
and cortisol immediately post-exercise and 2 hours post-exercise are shown in Table 5.3.  In 
the breast cancer survivor group, changes in NK cell counts were not significantly correlated 
with changes in epinephrine, norepinephrine, or cortisol concentrations.  In the control group, 
changes in NK cell counts were not correlated with fold changes in epinephrine or 
norepinephrine concentrations.  Changes in NK cell counts were not correlated with fold 
changes in cortisol levels immediately post-exercise.  However, fold changes in NK cells 
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were significantly correlated with fold changes in cortisol at 2 hours post-exercise (r = 0.767, 
p = 0.016).  
 
Table 5.3.  Spearman correlations (p-values) between fold changes in NK cell counts, 
epinephrine, norepinephrine, and cortisol immediately post-exercise and 2 hours post-
exercise 
 Epinephrine Norepinephrine Cortisol 
NK cell counts immediately post-exercise 
     Breast Cancer Survivor Group 
     Control Group 
 
0.083 (0.831) 
-0.033 (0.932) 
 
0.233 (0.546) 
-0.367 (0.332) 
 
0.433 (0.244) 
0.483 (0.187) 
NK cell counts 2 hours post-exercise 
     Breast Cancer Survivor Group 
     Control Group 
 
0.350 (0.356) 
0.167 (0.662) 
 
-0.417 (0.265) 
0.150 (0.700) 
 
0.183 (0.637) 
0.767 (0.016) 
 
Discussion 
The key findings of this study were that no significant relationships were observed 
between post-exercise changes in catecholamines and NK cell counts, and that a significant 
relationship was observed between post-exercise changes in cortisol and NK cell counts in 
the control group only.  It was initially hypothesized that for both groups immediately post-
exercise, there would be significant positive correlations between changes in catecholamines 
and cortisol with changes in NK cell counts.  Additionally, it was hypothesized that for both 
groups at 2 hours post-exercise, there would be no significant correlations between changes 
in catecholamines and cortisol with changes in NK cell counts because hormone 
concentrations and NK cell counts would have returned to near pre-exercise levels.  
Therefore, these findings were somewhat unexpected. 
Other investigators have examined the relationship between exercise-induced changes 
in NK cell counts and catecholamines, showing results that are reflective of what was 
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hypothesized for this study.   Moyna et al. (48) and Scharhag et al. (75) showed that increases 
in NK cell counts were significantly correlated with increases in epinephrine levels (r = 0.27-
0.74, p ≤ 0.005).  Scharhag et al. (75) and Kendall et al. (96) have also shown that increases 
in NK cell counts were significantly correlated with increases in norepinephrine levels (r = 
0.40-0.65, p ≤ 0.02).  However, it should be noted these studies were performed in healthy 
men and women with substantially higher VO2peak than the subjects in the current 
investigation.  Additionally, these studies included exercise protocols that were continuous 
rather than discontinuous (as the latter was done in the current study), and the exercise 
intensities and durations tended to be notably greater than that of the current study.  
Therefore, the differences in subject population and type of exercise performed between 
these studies and the current investigation may certainly lead to differing results.   
Increases in plasma catecholamines during acute aerobic exercise generally occur 
when the intensity reaches approximately 40-60% of VO2max (55).  In relation to NK cells, 
the rise in catecholamine levels has been associated with increases in circulating NK cells, 
the primary mechanism of action appearing to be a catecholamine-induced alteration in 
adhesion molecules that are expressed on NK cells thus recruiting them from their marginal 
zones into circulation (11, 13, 48, 66, 67).  Weak or non-significant correlations between NK 
cell counts and catecholamines may be related to the timing of the blood samples taken 
immediately post-exercise.  Catecholamine levels decrease rapidly upon cessation of 
exercise, and even delaying blood sampling by 2-3 minutes may affect results (96).  
Additionally, plasma concentrations of catecholamines do not always indicate what is 
occurring at the tissue level (96).  In the current study, increases in NK cell counts may have 
been more closely related to increases in cardiac output rather than increases in 
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catecholamines, as the discontinuous nature of the aerobic exercise session might have 
elicited an attenuated catecholamine response compared to a continuous exercise bout.   
The current study found that changes in NK cell counts were correlated with changes 
in cortisol concentrations in the control group only. Similar to the catecholamines, plasma 
cortisol levels rise proportionally with respect to exercise intensity and duration (70).  
Increased plasma cortisol levels are typically thought to be associated with decreased NK cell 
counts and activity during recovery from acute aerobic exercise, particularly after longer 
duration or more intense exercise.  In the current study, cortisol levels decreased from pre-
exercise to immediately post-exercise and remained below baseline 2 hours post-exercise.  In 
contrast, NK cell counts increased from pre-exercise to immediately post-exercise and 
remained 2 hours post-exercise.   
Strengths and Limitations 
 As is the case with all studies, this investigation possessed some inherent strengths 
and limitations.  With the exception of age, the study groups were extremely similar with 
respect to physical characteristics and aerobic fitness level.  The small sample size (n = 9 per 
group) may not have provided enough statistical power to adequately analyze all 
relationships between study variables.  Additionally, mean substitution had to be performed 
for two subjects (once immediately post-exercise and once at 2 hours post-exercise) as blood 
samples were unable to be obtained from them at these times.  Furthermore, the current study 
employed a discontinuous exercise protocol at only one intensity, whereas comparing the NK 
cell response and stress hormone response at multiple intensities may be needed in order to 
provide a more conclusive view of the relationships between these parameters. 
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Conclusions 
 In summary, the exercise-induced changes in plasma catecholamines do not seem to 
be associated with changes in NK cell counts in breast cancer survivors, similar to normal 
healthy women.  In contrast, changes in NK cell counts were not associated with plasma 
cortisol in the breast cancer survivor group, but were in the control group.  These findings 
suggest that other biologic mechanisms might be playing a more significant role in directing 
exercise-induced NK cell responses, particular in breast cancer survivors.   
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CHAPTER VI 
 
RESEARCH SYNTHESIS 
 
Major Findings 
 These investigations have revealed several key findings regarding the impact of acute 
aerobic exercise on NK cell, catecholamine, and cortisol responses in breast cancer survivors.  
NK cell counts were somewhat lower in breast cancer survivors pre-exercise (70.3 ± 37.9 
cells/μL vs. 108.9 ± 51.7 cells/μL, p = 0.09) and immediately post-exercise compared with 
healthy controls (170.5 ± 110.4 cells/μL vs. 282.5 ± 132.3 cells/μL, p = 0.069).  Breast 
cancer survivors and healthy controls displayed similar magnitudes of change in NK cell 
counts immediately post-exercise (165.6 ± 147.6% vs. 179.9 ± 89.3%, p = 0.807), 2 hours 
post-exercise (26.8 ± 48.0% vs. 23.3 ± 61.0%, p = 0.894), and 24 hours post-exercise (31.4 ± 
66.3% vs. 19.3 ± 42.2%, p = 0.651).  NKCA was similar across time in the subset of 6 breast 
cancer survivors (pre-exercise:  73.6 ± 30.3%, immediately post-exercise:  74.4 ± 21.0, 2 
hours post-exercise:  67.6 ± 12.5, 24 hours post-exercise:  60.2 ± 37.1, p = 0.607).  These 
results suggest that despite some slight differences in absolute cell concentrations, the 
moderate intensity aerobic exercise elicits similar changes in NK cell counts in recent breast 
cancer survivors compared to physically similar women without a history of cancer diagnosis 
or treatment. 
Second, the aerobic exercise bout led to some interesting differences in catecholamine 
and cortisol responses between the two groups.  Absolute plasma epinephrine levels were 
significantly higher in the breast cancer survivor group compared to the control group pre-
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exercise (49.7 ± 9.9 pg/mL vs. 27.1 ± 4.9 pg/mL, p < 0.0005), immediately post-exercise 
(54.5 ± 12.7 pg/mL vs. 39.2 ± 14.9 pg/mL, p = 0.032), and 24 hours post-exercise (47.9 ± 6.2 
pg/mL vs. 28.6 ± 6.7 pg/mL, p < 0.0005).  Percent changes in epinephrine were somewhat 
lower in the breast cancer survivor group compared to the control group immediately post-
exercise (12.2 ± 30.9% vs. 44.8 ± 42.5%, p = 0.081) and significantly lower at 2 hours post-
exercise (-11.5 ± 14.7% vs. 35.9 ± 57.4%, p = 0.040).  Absolute plasma norepinephrine 
concentrations and post-exercise percent changes were similar between groups (p = 0.203-
0.759).  Plasma cortisol levels were somewhat higher in the breast cancer survivor group 
compared to the control group immediately post-exercise (131.1 ± 77.5 ng/mL vs. 75.3 ± 
16.3 ng/mL, p = 0.064).  Lastly, the percent change in cortisol was positive in the breast 
cancer group and negative in the control group (19.4 ± 76.4% vs. -40.8 ± 34.0%, p = 0.054).  
These results demonstrate that the exercise session could have led to a greater stress hormone 
response in the cancer survivors, even though HR and RPE responses were similar between 
groups.  It should be noted however, that although absolute concentrations of epinephrine 
and cortisol were significantly elevated in the breast cancer survivors at various time points 
relative to the controls, the magnitude of the percent change in epinephrine and cortisol was 
somewhat blunted in breast cancer survivors. 
Third, no significant correlations were observed for changes in NK cell count with 
changes in epinephrine or norepinephrine in either study group post-exercise (r = -0.017-
0.400, p = 0.286-0.966) .  Similarly, no significant correlations were observed for changes in 
NK cell count with changes in cortisol in the breast cancer survivor group post-exercise (r = -
0.417-0.350, p = 0.265-0.932).  Change in NK cell count was not correlated with change in 
cortisol in either group immediately post-exercise or in the breast cancer survivor group at 2 
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hours post-exercise (r = 0.183-0.483, p = 0.187-0.637) but was significantly correlated at 2 
hours post-exercise in the control group (r = 0.767, p = 0.016).  These results suggest that 
exercise-induced changes in catecholamines and cortisol may not be principal biologic 
factors driving exercise-induced changes in NK cell counts, particularly in the breast cancer 
survivors.   
Significance of the Study and Implication of Results 
 The American Cancer Society estimates that there are currently more than 2.9 million 
breast cancer survivors living in the United States (1).  Many of these survivors may 
experience immune system dysfunction and adrenal gland hormone dysfunction which may 
be related to the stress of cancer and its treatments (23, 24, 98, 121-124, 127-129).  Exercise 
has already been shown to improve physiological and psychological outcomes including 
cardiorespiratory endurance, body composition, muscular strength, functional quality of life, 
fatigue, anxiety, and self esteem (6).  While a few previous studies have examined NK cell 
responses to aerobic exercise training in the breast cancer patient population (15, 17, 23), The 
current study adds valuable cross-sectional data to the literature, as it is the only study to date 
that has examined acute aerobic exercise responses of any immune or hormonal parameter in 
these individuals.  Additionally, it compares these exercise responses of the breast cancer 
survivors to those of healthy women who have never experienced the physical toll of cancer 
and its treatments.  The latter point is particularly noteworthy because exercise prescriptions 
for the cancer patient population are largely modeled after those for the general population 
(39).  Therefore, if exercise specialists are to continue to apply guidelines that exist for 
healthy individuals to cancer survivors, then it must be determined whether or not exercise 
affects these population groups similarly.  This investigation focused on the effect of acute 
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moderate intensity aerobic exercise on NK cell, catecholamine and cortisol responses, both as 
separate parameters and in correlation with each other. 
 One of the major findings of this investigation was that acute moderate aerobic 
exercise led to similar NK cell count responses in the breast cancer survivors and the 
controls, and that neither group experienced post-exercise decreases in NK cell counts 
relative to pre-exercise values.  This is an important finding, as it suggests that this type of 
exercise, which is commonly used in exercise prescriptions for breast cancer survivors, 
caused a typical response as previously seen in other healthy individuals (74, 94-96, 112, 
113).  Additionally, NK cell counts had returned to near pre-exercise levels by 24 hours post-
exercise.  Furthermore, the exercise did not seem to significantly affect NKCA in the subset 
of breast cancer survivors.  These results imply that 30 minutes of discontinuous moderate 
intensity aerobic exercise is safe for breast cancer survivors, and that 24 hours of recovery 
appears sufficient for NK cell counts to return to pre-exercise values. 
 The investigation also found that the breast cancer survivors had significantly higher 
absolute concentrations of epinephrine and cortisol at several time points, but that the 
magnitude of change between groups was only significantly different for epinephrine at 2 
hours post-exercise .  This is an important finding, as it suggests that breast cancer survivors 
may be experiencing higher levels of stress hormone output as an effect of their cancer 
treatments.  It also suggests that the adrenal medulla and the adrenal cortex may each respond 
to the stress of exercise differently in breast cancer survivors, compared to healthy controls.  
For example, there were no significant differences in post-exercise percent changes in 
norepinephrine when comparing the study groups.  However, breast cancer survivors 
experienced a somewhat attenuated magnitude in their epinephrine response immediately 
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post-exercise, and a significantly attenuated magnitude in their epinephrine response at 2 
hours post-exercise.  Additionally, breast cancer survivors experienced a positive percent 
change in cortisol immediately post-exercise whereas the controls experienced a negative 
percent change.  These findings indicate that particularly for cortisol, the exercise intensity 
may have reached the threshold needed to elicit increased HPA axis activation and increased 
cortisol secretion in the breast cancer survivors, but that this threshold had not been reached 
for the controls.  This finding is noteworthy, as it suggests that exercising at similar relative 
intensities in breast cancer survivors and healthy individuals may actually lead to different 
physiological responses between these groups.  This could be important for exercise 
specialists working with breast cancer survivors, as prescribed exercise intensities may 
actually lead to physiological responses that are more pronounced than what might be seen in 
the general population, even when other markers of exertion (i.e., HR and RPE) are similar. 
 Regarding the relationships between changes in NK cells and changes in 
catecholamines and cortisol, the current study found no correlation between these 
parameters.  Change in cortisol was found to correlate with change in NK cell counts in the 
control group.  The general lack of correlation between NK cells and stress hormones in this 
study may have occurred because of the discontinuous nature of the moderate exercise 
session, and so changes in NK cell counts may have related more to changes in cardiac 
output, which can demarginalize NK cells into circulation (10, 42, 48-50).  This possibility 
was explored, by relating changes in absolute VO2 during the exercise (VO2 is proportional 
to cardiac output) to changes in NK cell counts immediately post-exercise, although in this 
case too, no significant association was found.  These findings suggest that while a 
discontinuous exercise bout may lead to significant changes in NK cell counts and some 
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stress hormone parameters independently, it may not provide enough of a physiological 
stimulus to cause both the hormonal and NK cell parameters to vary together, or that the 
perturbations in the stress hormone parameters were not of a sufficient quantity to drive the 
perturbations in the NK cell counts. 
Summary of Research Hypotheses 
Hypothesis 1a:  There will be a significant increase in NK cell counts from pre-
exercise to immediately post-exercise in both breast cancer survivors and healthy controls.  
Result:  Supported. 
Hypothesis 1b:  There will be no significant difference in NK cell counts from pre-
exercise to 2 hours post-exercise in both breast cancer patients and healthy controls.  Result:  
Supported 
Hypothesis 1c:  There will be no significant difference in NK cell counts from pre-
exercise to 24 hours post-exercise in both breast cancer patients and healthy controls.  Result:  
Supported. 
Hypothesis 1d:  There will be no significant differences in NK cell counts between 
breast cancer survivors and healthy controls at any time point (pre-exercise, immediately 
post-exercise, 2 hours post-exercise, and 24 hours post-exercise).  Result:  Supported. 
Hypothesis 2a:  Changes in catecholamine levels will be positively correlated with 
changes in NK cell counts from pre-exercise to immediately post-exercise in both breast 
cancer survivors and healthy controls.  Result:  Rejected. 
Hypothesis 2b:  Changes in cortisol levels will be positively correlated with changes 
in NK cell counts from pre-exercise to immediately post-exercise in both breast cancer 
survivors and healthy controls.  Result:  Rejected 
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Hypothesis 2c:  Changes in catecholamine levels will not be correlated with changes 
in NK cell counts from pre-exercise to 2 hours post-exercise in both breast cancer survivors 
and healthy controls because changes in catecholamine levels and NK cell counts may not be 
significantly different from pre-exercise to 2 hours post-exercise.  Result:  Supported. 
Hypothesis 2d:  Changes in cortisol levels will not be correlated with changes in NK 
cell counts from pre-exercise to 2 hours post-exercise in both breast cancer survivors and 
healthy controls because changes in cortisol levels and NK cell counts may not be 
significantly different from pre-exercise to 2 hours post-exercise.  Result: Rejected. 
Strengths and Limitations 
 This is the first study to investigate acute aerobic exercise responses regarding NK 
cells and stress hormones in breast cancer survivors, and it is one of only a few studies that 
have investigated acute exercise responses in any immune parameter in oncology patients 
(19, 25).    
This study included a very homogeneous sample with regard to race, body composition, and 
aerobic fitness.  Additionally, this study is one of the few to compare NK cell and stress 
hormone responses of the breast cancer survivors to those of healthy post-menopausal 
women.  Further, this study examined these physiological responses in individuals who had a 
very low average aerobic fitness (< 20 mL/kg/min), as most investigations tend to examine 
responses in athletic and physically active individuals.   
One limitation to this study included small sample sizes in each group which may 
have made it difficult to detect all within- or between-group differences in the parameters 
measured. Second, there was a significant difference in mean age between the study groups, 
which could have affected some hormonal parameters.  Also, the study employed a 
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discontinuous protocol at only one exercise intensity, Additionally, some data were not 
available for two cancer survivor subjects (one immediately post-exercise and one 2 hours 
post-exercise) and one control subject at 24 hours post-exercise, either because blood 
samples could not be obtained, or because of limited plasma volume available from the 
sample.  NKCA was only measured in 6 breast cancer survivors, and so comparisons with the 
control group could not be made.  Furthermore, the period of time that elapsed between the 
cessation of the exercise bout and the immediate post-exercise blood draw was longer than 2-
3 minutes in some subjects, which could have affected the measured catecholamine response 
at that time point.  Lastly, while all subjects had fasted for at least 2 hours prior to all 
Laboratory Sessions, it is likely that some subjects had fasted for a longer period of time than 
others; a factor which could affect epinephrine and cortisol release, and therefore the 
measurement of those parameters. 
Future Research 
 Exercise immunology and endocrinology research in oncology patients is still a 
relatively young field, and so there are many opportunities to expand and improve upon the 
current research.  Exploring acute exercise response in individuals with cancer other than 
breast cancer, oncology patients of varying ages (pediatric, adult, and geriatric), recent 
survivors vs. long-term survivors, as well as patients undergoing treatment vs. patients who 
are post-treatment would be useful in order to determine if significant differences in exercise 
responses exist.  These findings could ultimately lead to developing more specific exercise 
prescription guidelines based on cancer and treatment type, patient age, and the amount of 
time that has elapsed since the patient completed treatment.  Examining acute exercise 
responses in immune parameters other than NK cells as well as investigating relationships 
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between exercise-induced immune responses and other biologic factors is relevant, as there 
are a multitude of biologic factors that contribute to anti-cancer defenses which can also be 
modified by exercise (9).  Comparing the effect of continuous vs. discontinuous exercise of 
the same total duration may elucidate whether rest periods within an exercise session could 
lead to attenuated responses.  As all exercise oncology research ultimately manifests as 
exercise prescription guidelines, future research should strive to understand how exercise can 
affect the immune and endocrine systems, so that cancer patients and survivor can reap the 
maximum health benefits of the exercise without putting themselves at risk for further illness 
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APPENDIX A 
EXTENDED METHODS 
Subjects 
 Subjects were recruited into two study groups:  a breast cancer survivor group and a 
control group.  Subjects in the breast cancer survivor group included women who had 
completed all planned surgery, chemotherapy, and radiation therapy in the treatment of their 
disease.  Subjects in the control included women who did not have a history of cancer 
diagnosis or treatment, were sedentary (i.e., had not participated in regular organized 
physical activity within the past year), and were free from cardiovascular and 
musculoskeletal disease that would render aerobic exercise participation unsafe.  Subjects in 
the breast cancer survivor group were recruited from the Medical Oncology clinic at the 
North Carolina Cancer Hospital on the campus of the University of North Carolina at Chapel 
Hill (UNC-Chapel Hill), the Radiation Oncology clinic at the North Carolina Cancer 
Hospital at UNC-Chapel Hill, and from the waitlist for the Get REAL and HEEL Breast 
Cancer Program in the Department of Exercise and Sport Science at UNC-Chapel Hill.   
Subjects in the control group were recruited from the faculty, staff, and student populations at 
UNC-Chapel Hill, as well as from across the Triangle region of North Carolina (Raleigh, 
Durham, Chapel Hill, and surrounding areas).  Potential subjects were made aware of the 
study through fliers and mass email communication. Additionally, physicians and nurse 
navigators assisted in subject recruitment by speaking to potential subjects about the study 
and by passing along the contact information of a member of the research team. 
 The inclusion criteria for participation in the breast cancer survivor group are 
presented below: 
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1.  Confirmed diagnosis of Stage I, II, or III invasive breast cancer; 
2. Received chemotherapy; 
3. Completed the final treatment of surgery, chemotherapy, and/or  radiation therapy 
within 3-6 months prior to enrollment; 
4. Patients receiving adjuvant hormonal therapy or adjuvant trastuzumab were eligible; 
5. No presence of metastatic disease; 
6. Female, between 40 and 70 years of age; 
7. Post-menopausal, or had not experienced a menstrual period for approximately 1 year 
prior to enrollment; 
8. Not a regular user of anti-inflammatory medications. 
The inclusion criteria for participation in the control group are presented below: 
1.  Female, between 40 and 70 years of age; 
2. No history of cancer diagnosis or treatment; 
3. Not involved in regular organized physical activity for at least 1 year prior to 
enrollment; 
4. Post-menopausal (i.e., had not experienced a menstrual period) for approximately 1 
year prior to enrollment;  
5. Not a regular user of anti-inflammatory medications. 
All subjects in both the breast cancer survivor group and the control group were 
required to complete a comprehensive medical history questionnaire, a physical screening by 
either a physician or other certified professional, and a 12-lead resting electrocardiogram 
(ECG).  Subjects were screened for exclusion based on the criteria put forth by the American 
College of Sports Medicine (ACSM) as contraindications to exercise testing (99). 
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Research Design 
 This was a prospective cohort study with the primary goal of examining changes in 
NK cell count after an acute bout of moderate intensity aerobic exercise.  The secondary goal 
was to examine the relationship between changes in NK cell count, catecholamine 
(epinephrine and norepinephrine), and cortisol responses after and acute bout of moderate 
intensity aerobic exercise.  Subjects were recruited into two groups; a breast cancer survivor 
group and a control group as described above.  Each subject visited the laboratory on three 
separate occasions.  Laboratory Visit 1 included an orientation to the study, medical and 
physical screening, and the assessment of peak aerobic capacity through a VO2peak test on the 
cycle ergometer.  Physical characteristics including age, race, height, weight, and percent 
body fat over the past year were obtained during this visit as well.  During Laboratory Visit 
2, the subject performed a moderate bout of aerobic exercise on the cycle ergometer, the 
intensity and duration of which was approximately 60% of VO2peak and 30 minutes, 
respectively.  Blood samples were collected during this laboratory visit; immediately prior to 
exercise (baseline), immediately post-exercise, and 2 hours post-exercise.  Laboratory Visit 3 
was a resting session, during which one blood sample was collected from the subject 24 
hours post-exercise.  The outcome (dependent) variable for this study was NK cell count.  
The predictor (independent) variables for this study were catecholamines (epinephrine and 
norepinephrine) and cortisol.  Each outcome and predictor variable was measured from the 
blood samples collected at the various time points outlined in Laboratory Visits 2 and 3.  All 
Laboratory Visits occurred in the Integrative Exercise Oncology Research Laboratory 
(IEORL) and/or in the Applied Physiology Laboratory (APL) in the Department of Exercise 
and Sport Science at UNC-Chapel Hill.  Approval from the Protocol Review Committee in 
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the Lineberger Comprehensive Cancer Center and the Institutional Review Boards in the 
Department of Exercise and Sport Science and School of Medicine at UNC-Chapel Hill were 
obtained before proceeding with subject recruitment and testing.  Figure 2 illustrates a 
summary timeline of the major events that occurred during the Laboratory Visits. 
 
Figure 2.  Timeline of study events. 
 
 
 
 
 
 
 
 
 
 
 
 
Instrumentation 
 The following equipment was used during Laboratory Visit 1 and 2 to measure 
physical characteristics, to perform the medical and physical screening, and to assess 
cardiorespiratory function during the VO2peak assessment and aerobic exercise session: 
Within 2 weeks 
Laboratory Visit 1:  
Medical/Physical Screening and 
VO2peak Assessment 
 Collect signed informed 
consents 
 Collect completed medical 
history questionnaire 
 Record physical 
characteristics 
 Perform DEXA scan 
 Perform resting ECG 
 Perform physical 
screening 
 Perform VO2peak 
assessment 
Laboratory Visit 2: Aerobic 
Exercise Bout 
 Complete 
Psychological Stress 
Scale 
 Collect blood sample 
at baseline 
 Perform 30 minute 
moderate intensity 
aerobic exercise bout 
 Collect blood sample 
immediately post-
exercise 
 Collect blood sample 
2 hours post-exercise 
Laboratory Visit 3:  
24-hour Follow-up 
 Complete 
Psychological 
Stress Scale 
 Collect blood 
sample at 24 
hours post-
exercise 
24 hours 
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1.  Portable stadiometer (Perspective Enterprises, Portage, MI) to measure height to the 
nearest 0.01 cm; 
2. Mechanical scale (Detecto, Webb City, MO) to measure body mass to the nearest 0.1 
kg. 
3. Discovery Dual Energy X-Ray Absorption (DEXA) scanner (Hologic, Inc., Bedford, 
MA) to assess percent body fat. 
4. GE CASE Cardiosoft V. 6.6 ECG diagnostic system (General Electric, Palatine, IL) 
to assess cardiac function during rest and exercise; 
5. Littmann® Stethoscope (3M, St. Paul, MN) to ascultate the heart and lungs during the 
physical screening, as well as for the measurement of blood pressure during rest and 
exercise; 
6. Sphygomomanometer (American Diagnostics Corporation, Hauppage, NY) to 
measure blood pressure during rest and exercise; 
7. Lode electronically-braked cycle ergometer (Lode, Gronigen, The Netherlands) as the 
mode of the VO2peak test and the aerobic exercise session will be cycling; 
8. Parvo Medics TrueMax 2400 Metabolic System (Parvo Medics, Salt Lake City, UT) 
to measure respiratory gases and oxygen uptake (VO2); 
9. Polar telemetry system (Polar Electro Inc., Lake Success, NY) to measure heart rate; 
10. Borg’s 6-20 Rate of Perceived Exertion (RPE) scale to measure RPE; 
The following equipment was used during the blood sampling procedures during Laboratory 
Visits 2 and 3, as well as for the measurement of NK cell counts, NKCA, catecholamines, 
and cortisol: 
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1. K3EDTA and Sodium Heparin Vaccutainer® tubes for the collection of whole blood 
samples; 
2. IEC Centra-8R refrigerated centrifuge (International Equipment Company, Needham 
Heights, MA) to isolate the plasma component of the whole blood samples; 
3. Sorvall Biofuge Primo R centrifuge (Thermo Fisher Scientific,  Waltham, MA) to 
spin whole blood samples during the preparation of samples for flow cytometric 
analysis; 
4. COULTER® Ac•T diff ™ Hematology Analyzer (Beckman Coulter, Inc., Brea, CA) 
to measure complete blood count and differential white blood cell count; 
5. CyAn 3 laser/9 color flow cytometer (Beckman Coulter, Inc., Brea, CA) to determine 
NK cell proportions and NKCA; 
6. Enzyme-linked immunosorbant assay (ELISA) kits (Abnova, Taipei City, Taiwan) to 
measure plasma catecholamines (epinephrine and norepinephrine) and cortisol;  
7. Bio-tek ELX800 microplate reader (BioTek U.S., Winooski, VT) to read ELISA 
assays. 
Data Collection Procedures 
Laboratory Visit 1:  Medical/Physical Screening and VO2peak Assessment 
 During the first visit to the laboratory, the subject received an explanation of the 
study protocol as well as information regarding the potential risks of participation in the 
study.  Prior to arriving to the laboratory, all subjects were asked to follow a set of pre-
assessment guidelines, presented below.  Subjects were also asked about their adherence to 
these pre-assessment guidelines during the laboratory visit. 
1.  No eating for at least 2 hours prior to testing; 
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2. No exercise for at least 12 hours prior to testing; 
3. Subjects should maintain adequate hydration status; 
4. Subjects should refrain from caffeine use at last 12 hours prior to testing; 
5. Subjects should refrain from alcohol use at least 48 hours prior to testing; 
6. Subjects should wear clothing (including shoes) that is comfortable for exercise. 
Once the subject had had all questions answered regarding study participation, the 
informed consent documents were signed. The subject then underwent a medical and 
physical screening to determine if she was free of any contraindication to performing an 
exercise test as described previously.  During the medical and physical screening, the 
following procedures were performed: 
1.  Completion of a comprehensive medical questionnaire (Appendix B); 
2. 12-lead resting ECG; 
3. Auscultation of carotid, radial, and pedal pulses; 
4. Auscultation of heart and lungs; 
5. Assessment of resting blood pressure in the supine, sitting, and standing positions. 
 Upon clearance to participate in the study, the subject’s physical characteristics were 
measured and/or recorded.  Height, weight, and percent body fat were assessed using 
equipment housed in the laboratory, as described in the above section.  Age and race were 
obtained by verbally asking the subject.  Other physical characteristics such as menopausal 
status, physical activity participation, and cancer treatment type (for subjects in the breast 
cancer survivor group) were assessed from the subject’s responses to the comprehensive 
medical questionnaire. 
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 The final component of Laboratory Visit 1 included a cardiopulmonary exercise test 
to measure VO2peak.  The purpose of measuring VO2peak was to assess peak aerobic capacity 
and to determine the workload that the subject would perform during Laboratory Visit 2.   
The VO2peak test was performed on an electronically-braked cycle ergometer, using 
the Astrand Cycle Ergometer Maximal Test Protocol (100) (Appendix C).  The protocol is a 
multi-stage protocol with incremental increases in workload after every 3 minutes.  The 
subject was seated on the cycle ergometer and fitted with the mask that was connected to the 
metabolic system, through which expired gases were collected and analyzed.  The subject sat 
quietly on the cycle ergometer for 3 minutes while resting metabolic data was collected. The 
subject began the first 3-minute stage of the test by cycling at 50 Watts.  At the end of the 
stage, the workload was increased by 25 Watts every 3 minutes until volitional fatigue.  
Heart rate, Rating of Perceived Exertion (RPE) (101), expired gases, and 12-lead ECG 
monitoring were performed throughout the test.  Heart rate and RPE were recorded at the end 
of every minute.  The test was administered by three individuals, one of whom was an 
exercise physiology faculty member of the Department of Exercise and Sport Science at 
UNC-Chapel Hill.   
 The highest VO2 measured by the metabolic system during the last stage of the test 
was recorded at the subject’s VO2peak, and the corresponding workload on the cycle 
ergometer was recorded as the subject’s peak workload.  Once the VO2peak test was complete, 
the subject entered an active cool-down period where the subject pedaled at a very low 
workload (<20 Watts) on the cycle ergometer.  The subject was allowed to remove the mask, 
drink fluids ad libitum, and dismount the cycle ergometer.  ECG monitoring continued for at 
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least 5 minutes post-exercise and until heart rate and blood pressure had returned to near-
baseline levels (102).   
Laboratory Visit 2:  Acute Aerobic Exercise Session 
 Laboratory Visit 2 occurred within 2 weeks after Laboratory Visit 1.  During 
Laboratory Visit 2, the subject performed 1 acute bout of moderate aerobic exercise on the 
cycle ergometer at a workload corresponding to 60% of the subject’s VO2peak for a duration 
of 30 minutes.  The purpose for choosing an intensity of 60% of VO2peak and a duration of 30 
minutes was twofold.  Firstly, 30-minute exercise bouts at 60% of VO2peak are commonly 
used in many studies examining the effects of aerobic exercise on physical functioning in 
breast cancer patients, and therefore represent an intensity and duration widely used in 
exercise prescriptions for this population (3, 4, 6, 17, 39,102-107).  Secondly, an exercise 
intensity of 50-60% of VO2peak and a duration of 30 minutes is necessary in order to elicit a 
response in cortisol, which is one of the independent variables in this study (57).  
Additionally, previous pilot testing in the laboratory with breast cancer survivors newly 
enrolled in an exercise and recreation therapy rehabilitation program demonstrated that 
exercising for 30 minutes at an intensity of 60% of VO2peak is feasible.  However, to ensure 
that all subjects will be able to complete the exercise session, a discontinuous protocol was 
employed such that the subject alternated ten 3-minute intervals of exercise with 1.5 minutes 
of rest, for a total of 30 minutes of exercise in a 43.5-minute period.  Two individuals 
supervised the exercise session and all subjects started the exercise session between 7:00-
10:00 am in order to control for daily variations in the study variables. 
 As was the case with Laboratory Visit 1, subjects were asked to follow the set of pre-
assessment guidelines before arriving for Laboratory Visit 2.  Upon arrival to the laboratory, 
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the subject was asked about adherence to the pre-assessment guidelines.  The subject was 
then asked to complete the Perceived Stress Scale (PSS), which is a widely-used 
psychological instrument used tor measuring the perception of stress (125, 126) (Appendix 
D).  The purpose for administering the PSS was to assess the subject’s perception of the 
stressors in her daily life, as these stressors could potentially impact resting values of the 
stress hormone variables in this study (epinephrine, norepinephrine, and cortisol).  After 
completing the PSS, the subject rested in the supine position for approximately 20 minutes 
while a catheter was inserted into an antecubital vein in the arm for blood sampling.  Catheter 
insertion was performed by an individual who was trained in phlebotomy techniques.  Blood 
was drawn into two 3-mL K3EDTA Vacutainer® tubes.   For a subset of subjects, blood was 
also drawn into a 3-mL sodium heparin Vacutainer® tube.  The blood that was drawn into 
the K3EDTA Vacutainer® tubes was to be used for the measurement of NK cell counts, 
catecholamine, and cortisol levels.  The blood that was drawn into the sodium heparin 
Vacutainer® tube was to be used for the measurement of NKCA.  This blood sample was 
drawn before the exercise session (pre-exercise). 
The subject performed a warm-up period, consisting of 4-5 minutes of light pedaling 
at about 30 Watts on the cycle ergometer.  The subject then dismounted the cycle ergometer 
and was given the opportunity to stress the lower body in a manner that was most 
comfortable for the subject.  The subject re-mounted the cycle ergometer and was fitted with 
the mouthpiece that was connected to the metabolic system, through which expired gases 
were collected and analyzed.  The subject sat quietly on the cycle ergometer for 3 minutes 
while resting metabolic data was collected.  The subject then began the exercise bout, which 
involved cycling at the prescribed workload for 30 minutes.  As described previously, a 
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discontinuous protocol was employed such that the subject alternated ten 3-minute intervals 
of exercise with 1.5 minutes of rest.  Heart rate and RPE were recorded at the end of every 3-
minute period of exercise.  Expired gases were monitored during the first, third, seventh, and 
tenth exercise interval.  If necessary, adjustments in workload were made to ensure that the 
subject was exercising at 60% of VO2peak.  Immediately upon completion of the exercise 
session, the subject dismounted the cycle ergometer and returned to the supine position.  
Blood sampling immediately post-exercise was performed in the same manner as described 
for the pre-exercise sample.   
The subject was then allowed to rest comfortably in the laboratory.  The subject was 
allowed to drink water ad libitum; however, no food or other beverage could be ingested.  A 
final blood sample was obtained at 2 hours post-exercise in the same manner as the previous 
two samples.  The catheter was then removed and any necessary bandaging was performed. 
Laboratory Visit 3:  24-hour Follow-up Session 
 Laboratory Visit 3 occurred 24 hours after Laboratory Visit 2.  As was the case for 
Laboratory Visits 1 and 2, the subject was asked to follow the pre-assessment guidelines 
before arriving to the laboratory.  Upon arrival to the laboratory, the subject was asked about 
adherence to the pre-assessment guidelines.  The subject was allowed to use the restroom if 
needed.  The subject will sat quietly in a phlebotomy chair and a blood sample was drawn 
from an antecubital vein in the arm using a standard venipuncture technique by an individual 
trained in phlebotomy techniques.  The blood was drawn into the Vaccutainer® tubes in the 
same manner as was done for the previous three blood samplings.  The timing of the blood 
draw occurred as close as possible to 24 hours after completion of the moderate aerobic 
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exercise session.  However, a window of 30 minutes before or after the 24-hour post-exercise 
mark was deemed acceptable. 
Data Processing and Reduction 
Oxygen Uptake (VO2) and Metabolic Data 
 Oxygen uptake (VO2) and metabolic data was collected during Laboratory Visits 1 
and 2, using the Parvo Medics TrueMax 2400 Metabolic System. The subject breathed into a 
mask which was connected to the metabolic system via plastic tubes.  Since the metabolic 
system is computerized, the computer software was able to analyze a variety of parameters 
including the fraction of expired oxygen (FeO2), fraction of expired carbon dioxide (FeCO2), 
minute ventilation (VE), oxygen uptake (VO2), carbon dioxide output (VCO2), and 
respiratory exchange ratio (RER).   Data were recorded continuously, but was displayed as 
15-second averages.  These data were printed from the computer in text form, which was 
then transcribed into a Microsoft Excel workbook for easier manipulation. 
Calculation of VO2peak and Exercise Workload 
 Peak oxygen consumption (VO2peak) was determined from data collected during 
Laboratory Visit 1.  VO2peak was calculated by the metabolic system, and was simply the 
highest VO2 value recorded during the Astrand Cycle Ergometer Maximal Test Protocol.  
The peak exercise workload was the workload on the cycle ergometer at which the subject 
was exercising when she achieved VO2peak.   
 During Laboratory Visit 2, the subject exercised at approximately 60% of VO2peak.  
This intensity was taken as 60% of the value that corresponded to the subject’s VO2peak (i.e., 
if the subject’s VO2peak was 20 mL/kg/min, then a 60% exercise intensity would be 12 
mL/kg/min).  The workload corresponding to 60% of VO2peak was determined from a 
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regression analysis where VO2 values for each stage of the VO2peak test were averaged and 
plotted against the workload for that stage.  Figure 3 shows the regression analysis for one 
subject as an example of how the workload corresponding to 60% of VO2peak was calculated.   
 
Figure 3.  Example regression for determining workload corresponding to 60% of VO2peak. 
 
Determination of NK Cell Counts 
Complete blood count (CBC) and differential white blood cell count were obtained 
from the whole blood samples collected at each of the four study time points into the 
K3EDTA Vacutainer® tubes.  These blood samples were analyzed using a COULTER® 
Ac•T diff ™ Hematology Analyzer.  Total lymphocyte count was noted for each subject at 
each time point, as NK cells are a subset of lymphocytes. 
The whole blood samples were stained using fluorescently-labeled monoclonal 
antibodies for the cell surface markers CD3, CD16, and CD56.  The specific fluorescent 
labels used in this study were fluorescein isothyocyanate (FITC) for the CD3 marker, 
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phycoerythrin (PE) for the CD16 marker, and allophycocyanin (APC) for the CD56 marker.  
Fluorescent staining was done in order to identify the lymphocytes that express the CD3
-
CD16
+
CD56
+
 phenotype which is characteristic of NK cells.  Stained samples were further 
prepared for flow cytometric analysis according to procedures adapted from protocols made 
available by Becton Dickinson (109).  The specific procedures used in this study to prepare 
stained blood samples for flow cytometric analysis of NK cell counts are listed in Appendix 
E.  Samples were analyzed within 24 hours of preparation. 
 The percentage of NK cells in the lymphocyte population was acquired from these 
blood samples using a CyAn 3 laser/9 color flow cytometer.  For each subject, a total of 8 
samples were prepared:  one unstained control sample, 3 single color control samples (anti-
CD3-FITC, anti-CD16-PE, and anti-CD56-APC), and the stained samples for each study 
time point (baseline, immediately post-exercise, 2 hours post-exercise, and 24 hours post-
exercise).  The unstained control sample and single color control samples were used to adjust 
the voltage settings on the flow cytometer so that individual cell populations would be in 
view, as well as to identify the positive and negative cell populations for each of the 3 cell 
surface markers.  A region was drawn around the overall lymphocyte population on the side-
scatter (SS) vs. forward-scatter (FS) plot, which was used to set a gate on the SS vs. anti-
CD3-FITC plot.  This was done in order to specifically identify which lymphocytes from the 
SS vs. FS plot were negative for the CD3 cell surface marker (CD3
-
) and which lymphocytes 
were positive for the CD3 cell surface marker (CD3
+
).  A region was then drawn around the 
CD3
-
 lymphocyte population in the SS vs. anti-CD3-FITC plot, which was then used to set a 
gate on the anti-CD56-APC vs. anti-CD16-PE plot.  This was done in order to specifically 
identify which CD3
-
 lymphocytes from the SS vs. anti-CD3-FITC plot were either positive 
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and/or negative for the CD16 and CD56 cell surface markers.  Auto-compensation of the 
single color control samples was performed in order to mathematically eliminate spectral 
overlap between fluorophores.  Flow cytometry data was viewed and analyzed using Summit 
4.3 software (Dako North America, Inc., Carpinteria, CA). 
Figure 4 (Panels 4a-4c) shows the flow cytometry output for one subject’s sample as 
a means to illustrate how these cell populations appear.  Panel 4a shows the region R1 
highlighting the overall lymphocyte population on the SS vs. FS plot.  Panel 4b shows the 
region R2 highlighting the CD3
- 
lymphocytes on the SS vs. anti-CD3-FITC plot.  Panel 4c 
shows the region R3 highlighting the CD3
-
 lymphocytes that are positive for the CD16 and 
CD56 cell surface markers.  By convention, cell populations that are negative for a cell 
surface marker plotted on the x-axis appear on the left side of the plot, while cell populations 
that are positive for that cell surface marker appear on the right.  Similarly, cell populations 
that are negative for a cell surface marker plotted on the y-axis appear on the bottom of the 
plot, while cell populations that are positive for that cell surface marker appear on the top.   
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Figure 4.  Illustration of the overall lymphocyte, CD3, CD16, and CD56 cell populations 
using flow cytometry.  
 
 
 
NK cell count was determined by multiplying the total lymphocyte count by the 
proportion of NK cells in the lymphocyte population.  Proportion of NK cells was 
determined by multiplying the proportion of CD3
- 
lymphocytes (denoted as % Hist of R2 in 
Panel 4b) by the proportion of CD16
+
CD56
+
) lymphocytes (denoted as % Hist of R3 in Panel 
4c).    
Determination of NK Cell Activity 
NKCA was determined for a subset of subjects (1 control and 6 breast cancer 
survivors) using a whole-blood flow cytometric assay adapted from Fondell et al. (110).  The 
specific protocol used in this study for sample preparation is listed in Appendix F.  K562 
human erythroleukimic cells were cultured in a medium containing 89% Iscove’s Dulbecco’s 
Medium, 10% fetal bovine serum, and 1% penicillin-streptomycin.  The cell culture was kept 
in an air incubator at 37°C and 5% CO2.  Culture medium was changed every 2-3 days and 
cell density was maintained between 10
5
 and 10
6
 cells per mL.  The K562 cells were used as 
the target cells in the NKCA assay. 
Figure 4a.  Lymphocyte 
population on the SS vs. FS plot 
Figure 4b.  CD3 lymphocytes on 
the SS vs. anti-CD3-FITC plot 
Figure 4c.  CD3
-
 lymphocytes 
with the CD16
+
CD56
+ 
phenotype 
on the anti-CD56-APC vs. anti-
CD160PE plot 
Lymphocyte 
Population 
CD3
-
 
Lymphocytes 
CD16
+
CD56
+
 
Lymphocytes 
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For each subject, 14 samples were prepared:  two samples with target cells only, four 
samples with whole blood only (one for each study time point), and eight tubes with target 
cells and whole blood mixed together (two for each study time point).  Samples were stained 
with FITC-labeled anti-CD71, as this fluorescently-labeled monoclonal antibody only stains 
the K562 target cells.  Samples were acquired by within 2 hours of preparation using a CyAn 
3 laser/9 color flow cytometer, and data was viewed and analyzed using Summit 4.3 
software.  NKCA, measured as % NK cytolysis, was calculated using the following equation: 
 
%NK cytotox = 100*[target cells – (mixed cells – effector cells)] / target cells 
 
where the “target cells” refers to the number of K562 cells measured in the samples with 
target cells only and “mixed cells” refers to the number of remaining K562 cells in the 
samples with a mixture of whole blood and K652 cells.  “Effector cells” refers to cells in the 
samples with whole blood only which may be present in the region for CD71
+ 
K562 cells. 
Calculation of Plasma Volume Shifts 
Plasma volume shifts (changes in plasma volume due to exercise) were calculated 
according to the equation by Dill and Costill (111). The hematocrit and hemoglobin values 
that were used in these calculations were obtained from the CBC data at baseline, 
immediately post-exercise, 2 hours post-exercise, and 24 hours post-exercise.   Plasma 
volume shifts were reported in order to indicate the effect that exercise may have on fluid 
shifts, which may affect concentrations of white blood cell populations (lymphocytes, 
monocytes, and granulocytes), catecholamines and cortisol. 
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Determination of Plasma Levels of Catecholamines and Cortisol 
Catecholamines (epinephrine, norepinephrine) and cortisol were measured from 
stored plasma via enzyme-linked immunosorbent assay (ELISA) procedures.  All samples 
were measured in duplicate to ensure quality control, except for two control subject samples 
which were run in singlet due to limited plasma volume.  Catecholamines were measured 
using a competitive binding, single antibody, solid phase epinephrine/norepinephrine ELISA 
kit with analytical sensitivities of 10 pg/mL and 50 pg/mL for epinephrine and 
norepinephrine, respectively.  Cortisol was measured using a competitive binding, double 
antibody, combination solid and mobile phase ELISA kit with a sensitivity of 0.44 ng/mL.  
The reported mean intra-assay coefficients of variation for epinephrine range from 6.9-
15.8%, and the reported mean inter-assay coefficients of variation range from 13.2-18.2%.  
The reported mean intra-assay precisions coefficients of variation for norepinephrine range 
from 9.8-16.1%, and the reported mean inter-assay coefficients of variation range from 8.5-
15.0%.  The reported mean intra-assay coeffcients of variation for the cortisol ELISA range 
from 6.2-9.4%, and the reported mean inter-assay coefficients of variation range from 8.6-
15.0%.   
 Concentration of plasma levels of catecholamines in samples were calculated using a 
calibration curve, constructed from plotting the natural log of the standard concentrations 
against the corresponding absorbance readings Second-order polynomial regression models 
were used to fit the standard curve, the equation from which was used to calculate the 
concentrations of plasma epinephrine and norepinephrine.  Concentrations of plasma levels 
of cortisol were calculated in the same manner. 
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Data Analysis 
Sample Size Estimation 
 The primary purpose of this study was to examine the effect of the moderate intensity 
aerobic exercise bout on changes in NK cell counts from baseline to post-exercise in breast 
cancer survivors and healthy controls.  The secondary purpose of this study was to examine 
the relationships between changes in catecholamines and cortisol with changes in NK cell 
counts from baseline to post-exercise in response to the moderate intensity acute aerobic 
exercise bout in breast cancer survivors and healthy controls.  Exploratory analyses of this 
study aimed to examine the effect of the moderate intensity aerobic exercise bout on changes 
in catecholamine and cortisol levels from baseline to post-exercise in breast cancer survivors 
and healthy controls, and to examine the effect of the moderate intensity aerobic exercise 
bout on changes in NKCA from baseline to post-exercise in breast cancer survivors and 
healthy controls. 
The sample size estimation was based on the primary purpose of evaluating the 
change in NK cell count from pre-exercise to immediately post-exercise in the breast cancer 
survivor group.   For this study, the desired sample size was the number of subjects per group 
needed to detect statistical significance when the percent difference between NK cell counts 
at baseline and immediately post-exercise was at least 50%.  To determine this, the fold 
change was calculated (NK cell count immediately post-exercise divided by the NK cell 
count at baseline) and tested to see if it was significantly different from 1.  A one group t-test 
with a two sided 0.05 significance level has 80% power to detect a difference between a null 
hypothesis of 1 and an alternative hypothesis of 1.5, assuming a standard deviation of 0.5 
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with 10 patients.  To allow for similar analyses, 10 controls were to be enrolled as well, 
bringing the total goal sample size to 20 subjects for this study.   
Statistical Analysis 
All statistical analyses were performed using SPSS Statistics version 18.0.    The 
alpha level was set a priori at 0.05. 
Aim #1:  Evaluation of Changes in NK Cell Counts 
Hypotheses 1a:  There will be a significant increase in NK cell counts from pre-
exercise to immediately post-exercise in both breast cancer survivors and healthy controls.   
Hypothesis 1b:  There will be no significant difference in NK cell counts from pre-
exercise to 2 hours post-exercise in both breast cancer patients and healthy controls.   
Hypothesis 1c:  There will be no significant difference in NK cell counts from pre-
exercise to 24 hours post-exercise in both breast cancer patients and healthy controls.   
Hypothesis 1d:  There will be no significant differences in NK cell counts between 
breast cancer survivors and healthy controls at any time point (pre-exercise, immediately 
post-exercise, 2 hours post-exercise, and 24 hours post-exercise). 
A 2x4 mixed model ANOVA was used to compare NK cell concentrations between 
the two study groups across the four time points.  Pairwise comparisons between groups were 
made using independent samples t-tests.  Percent changes in NK cell counts calculated as 
[(post-exercise NK cell count – pre-exercise NK cell count) / pre-exercise NK cell 
count)]*100 were compared between groups for each of the three post-exercise time points 
using independent samples t-tests. 
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Aim #2:  Evaluation of Correlations between Changes in Catecholamine and Cortisol 
Responses with Changes in NK Cell Counts 
Hypothesis 2a:  Changes in catecholamine levels will be positively correlated with 
changes in NK cell counts from pre-exercise to immediately post-exercise in both breast 
cancer survivors and healthy controls.  The fold changes in catecholamine responses from 
baseline to immediately post-exercise were correlated with the fold changes in NK cell count 
from baseline to immediately post-exercise using Spearman’s Rank Correlation coefficients.  
This analysis was performed for both the breast cancer survivor group and the healthy control 
group. 
Hypothesis 2b:  Changes in cortisol levels will be positively correlated with changes 
in NK cell counts from pre-exercise to immediately post-exercise in both breast cancer 
survivors and healthy controls.  The fold changes in cortisol responses from baseline to 
immediately post-exercise was correlated with the fold changes in NK cell count from 
baseline to immediately post-exercise using Spearman’s Rank Correlation coefficients.  This 
analysis was performed for both the breast cancer survivor group and the healthy control 
group. 
Hypothesis 2c:  Changes in catecholamine levels will not be correlated with 
changes in NK cell counts from pre-exercise to 2 hours post-exercise in both breast cancer 
survivors and healthy controls because changes in catecholamine levels and NK cell 
counts may not be significantly different from pre-exercise to 2 hours post-exercise. The 
fold changes in catecholamine responses from baseline to 2 hours post-exercise were 
correlated with the fold changes in NK cell count from baseline to 2 hours post-exercise 
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using Spearman’s Rank Correlation coefficients.  This analysis was performed for both the 
breast cancer survivor group and the healthy control group. 
Hypothesis 2d:  Changes in cortisol levels will not be correlated with changes in 
NK cell counts from pre-exercise to 2 hours post-exercise in both breast cancer survivors 
and healthy controls because changes in cortisol levels and NK cell counts may not be 
significantly different from pre-exercise to 2 hours post-exercise.  The fold changes in 
cortisol responses from baseline to 2 hours post-exercise were correlated with the fold 
changes in NK cell count from baseline to 2 hours post-exercise using Spearman’s Rank 
Correlation coefficients.  This analysis was performed for both the breast cancer survivor 
group and the healthy control group. 
Exploratory Analyses 
 Statistical procedures for the exploratory analyses of this study were the as those 
described above for Research Aim #1.  Catecholamine levels and cortisol levels were 
compared between the groups across the four study time points using 2x4 mixed model 
ANOVAs, and pair-wise comparisons were made between groups using independent samples 
t-tests  NKCA was examined across the four study time points using a repeated-measures 
ANOVA.  Percent changes in post-exercise catecholamines, cortisol, and NKCA were also 
compared between the groups using independent samples t-tests. 
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APPENDIX B 
MEDICAL HISTORY QUESTIONNAIRE 
Department of Exercise and Sport Science 
Medical History 
 
Subject: __________________________ ID: ___________  Telephone:______________ 
 
Address:________________________________________________________________ 
 
Occupation:___________________________________  Age:______________________ 
 
Race:________________________________________ 
 
          YES NO 
Patient History 
1. How would you describe your general health at present? 
Excellent______ Good_______ Fair______ Poor______ 
2.   Do you have any health problems at the present time?   _____ _____ 
3.  If yes, please describe:         
             
4.  Have you ever been told you have heart trouble?    _____ _____ 
5.  If yes, please describe:         
             
6.  Do you ever get pain in your chest?     _____ _____ 
7.  Do you ever feel light-headed or have you ever fainted?   _____ _____ 
8.  If yes, please describe:         
             
9.  Have you ever been told that your blood pressure has been elevated? _____ _____ 
10.  If yes, please describe:         
             
11.  Have you ever had difficulty breathing either at rest or with exertion? _____ _____ 
12.  If yes, please describe:         
             
13.  Are you now, or have you been in the past 5 years, under a doctor’s care for any reason?
          _____ _____ 
14.  If yes for what reason?         
           
 _____________________________________________________________________ 
15.  Have you been in the hospital in the past 5 years?   _____ _____ 
16.  If yes, for what reason?         
             
17.  Have you ever experienced an epileptic seizure or been informed that you have epilepsy?
          _____ _____ 
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18.  Have you ever been treated for infectious mononucleosis, hepatitis, pneumonia, or 
another infectious disease during the past year?    _____ _____ 
19.  If yes, name the disease:          
20.  Have you ever been treated for or told you might have diabetes? _____ _____  
21.  Have you ever been treated for or told you might or low blood sugar? _____ _____ 
22.  Do you have any known allergies to drugs?    _____ _____ 
23.  If so, what?          
             
24.  Have you ever been “knocked-out” or experienced a concussion? _____ _____ 
25.  If yes, have you been “knocked-out” more than once?   _____ _____ 
26.  Have you ever experienced heat stroke or heat exhaustion?  _____ _____ 
27.  If yes, when?          
             
28.  Have you ever had any additional illnesses or operations? (Other than childhood 
diseases)           
          _____ _____ 
29.  If yes, please indicate specific illness or operations:     
          _____________
 _____________________________________________________________________
_____________________ 
30.  Are you now taking any pills or medications?    _____ _____ 
31.  If yes, please list:          
 _____________________________________________________________________ 
32.  Have you had any recent (within 1 year) difficulties with your: 
 a.  Feet        _____ _____ 
 b.  Legs        _____ _____ 
 c.  Back        _____ _____ 
 
Family History 
33.  Has anyone in your family (grandparent, father, mother, and/or sibling) experienced any 
of the following? 
 a.  Sudden death       _____ _____ 
 b.  Cardiac disease       _____ _____ 
 c.  Marfan’s syndrome      _____ _____ 
 
Mental History 
34.  Have you ever experienced depression?     _____ _____ 
35.  If yes, did you seek the advice of a doctor?    _____ _____ 
36.  Have you ever been told you have or has a doctor diagnosed you with panic disorder, 
obsessive-compulsive disorder, clinical depression, bipolar disorder, or any other 
psychological disease?       _____ _____ 
37.  If yes, please list condition and if you are currently taking any medication. 
Condition      Medication 
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 __________________ 
 
Bone and Joint History 
34.  Have you ever been treated for Osgood-Schlatter’s disease?  _____ _____ 
35.  Have you ever had any injury to your neck involving nerves or  
vertebrae?         _____ _____ 
36.  Have you ever had a shoulder dislocation, separation, or other injury of the shoulder that 
incapacitated you for a week or longer?     _____ _____ 
37.  Have you ever been advised to or have you had surgery to correct a shoulder condition?
          _____ _____ 
38.  Have you ever experienced any injury to your arms, elbows, or wrists?_____ _____ 
39.  If yes, indicate location and type of injury:      
             
40.  Do you experience pain in your back?     _____ _____ 
41.  Have you ever had an injury to your back?    _____ _____ 
42.  If yes, did you seek the advice of a doctor?    _____ _____ 
43.  Have you ever been told that you injured the ligaments or cartilage of either knee joint?
          _____ _____ 
44.  Do you think you have a trick knee?     _____ _____ 
45.  Do you have a pin, screw, or plate somewhere in your body as the result of bone or joint 
surgery that presently limits your physical capacity?    _____ ____ 
46.  If yes, indicate where:         
            
47.  Have you ever had a bone graft or spinal fusion?   _____ _____ 
 
Activity History 
48.  During your early childhood (to age 12) would you say you were: 
 Very active ____ Quite active____ Moderately active____ Seldom active____ 
49.  During your adolescent years (age 13-18) would you say you were: 
 Very active ____ Quite active____ Moderately active____ Seldom active____ 
50.  Did you participate in: 
a. Intramural school sports?      _____ _____ 
b. Community sponsored sports?     _____ _____ 
c. Varsity school sports?      _____ _____ 
d. Active family recreation?      _____ _____ 
51.  Since leaving high school, how active have you been? 
 Very active ____ Quite active____  Active____  Inactive____ 
52.  Do you participate in any vigorous activity at present?   _____ _____ 
53.  If yes, please list: 
Activity  Frequency   Duration  Intensity 
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54.  How would you describe your present state of fitness? 
Excellent_____ Good_____ Fair_____ Poor_____ 
55.  Please list the type(s) of work you have been doing for the previous ten years: 
Year  Work    Indoor/Outdoor Location (city/state) 
            
            
Menstrual Cycle History 
56.  Have you been post-menopausal for the past year, in that you have not experienced a 
menstrual period for at least 1 year?      _____ _____  
Emergency Contact Information  
57.  Whom shall we notify in case of emergency? 
 Name:            
 Phone: (Home)     (Work)     
 Address:           
58.  Name and address of personal physician:      
            
             
 
FOR SUBJECTS IN THE BREAST CANCER SURVIVOR GROUP ONLY 
59.  Please indicate which type(s) of treatment you received/are receiving for your cancer 
Surgery____ Chemotherapy____   Radiation Therapy____  Hormonal Therapy____ 
Trastuzumab_____ 
 
60.  How long ago did you finish receiving surgery, chemotherapy, and/or radiation therapy? 
___________________________________________________________________________ 
 
61.  If you received surgery, which type did you receive? 
Mastectomy ____  Lumpectomy____ 
 
62.  If you received chemotherapy, please list the names of the drugs that were included in 
your treatment. 
___________________________________________________________________________
___________________________________________________________________________ 
 
63.  If you are receiving hormonal therapy, please list the names of the medications that you 
are taking and how long you have been taking them. 
___________________________________________________________________________
___________________________________________________________________________ 
 
64.  If you are receiving trastuzumab, please list how long you have been taking this 
medication. 
___________________________________________________________________________ 
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65.  Please list any other medication(s) that you have taken/are currently taking that is/are 
directly related to your cancer treatment. 
___________________________________________________________________________
___________________________________________________________________________ 
 
All of the above questions have been answered completely and truthfully to the best of my 
knowledge. 
 
Signature:        Date:     
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APPENDIX C 
ASTRAND CYCLE ERGOMETER MAXIMAL TEST PROTOCOL 
Instructions: 
1. Attach 12-lead ECG to subject. 
2. Adjust cycle ergometer seat to the appropriate height for subject. 
3. Fit subject with mask while subject is seated on cycle ergometer. 
4. Collect resting metabolic data (Test Stage:  Rest) 
5. Start VO2peak test (Test Stage:  1). 
a. Test Stage 1 workload is 50 Watts. 
b. Each Test Stage lasts for 3 minutes. 
c. Increase workload by 25 W from Test Stage 1 to 2.  Use this same 
increment for all subsequent increases in workload as the test progresses. 
d. Monitor ECG and expired gases continuously. 
e. Record HR and RPE at the end of each minute. 
f. Record BP at the end of Minute 2 of each stage. 
6. Subject will progress through test until volitional fatigue or symptom-limited 
indication*.   
7. Record VO2peak as the highest VO2 reached during the test. 
8. Record Peak Workload as the highest workload used during the test. 
9. Record total test time. 
10. Allow subject to cool down on cycle ergometer (pedal at very light workload).  
Subject may remove mask and drink fluids during this time. 
11. Continue ECG monitoring for at least 5 minutes (longer if needed). 
12. Assessment is concluded when HR, ECG, and BP return to pre-test levels. 
13. Disconnect ECG leads and remove electrodes from subject. 
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Test Stage Stage 
Duration 
Workload 
(Watts) 
HR (bpm) RPE BP (mmHg) 
Rest 3 minutes NA NA NA NA 
1 3 minutes 50 Min 1: 
Min 2: 
Min 3: 
Min 1: 
Min 2: 
Min 3: 
 
Min 2: 
2 3 minutes 75 Min 1: 
Min 2: 
Min 3: 
Min 1: 
Min 2: 
Min 3: 
 
Min 2: 
3 3 minutes 100 Min 1: 
Min 2: 
Min 3: 
Min 1: 
Min 2: 
Min 3: 
 
Min 2: 
4 3 minutes 125 Min 1: 
Min 2: 
Min 3: 
Min 1: 
Min 2: 
Min 3: 
 
Min 2: 
5 3 minutes 150 Min 1: 
Min 2: 
Min 3: 
Min 1: 
Min 2: 
Min 3: 
 
Min 2: 
 
VO2peak ______________ 
Peak workload _________________ 
Total test time ___________________ 
Have HR, BP, and ECG returned to pre-assessment levels before leaving lab? YES NO 
 HR _____________ 
 BP _____________ 
 
*Symptom-limited indications for stopping a VO2peak test 
1. Drop in systolic blood pressure of  >10 mmHg from baseline blood pressure, despite 
an increase in workload; 
2. Hypertensive response, characterized by systolic blood pressure >250 mmHg and/or a 
diastolic blood pressure of  >115 mmHg; 
3. Moderately severe angina (defined as 3 on standard scale) or increasing chest pain; 
4. Wheezing, shortness of breath, leg cramps, dizziness, or near syncope; 
5. Signs of poor perfusion, such as cyanosis or pallor; 
6. Arrrythmias including sustained ventricular tachycardia, multifocal PVCs, triplets of 
PVCs, supraventricular tachycardia, heart block, or bradyarrhythmias; 
7. Development of bundle branch block or intraventricular conduction delay that cannot 
be distinguished from ventricular tachycardia; 
8. ST elevation (+1.0 mm) in ECG leads without diagnostic Q-waves (other than V1 or 
aVR) 
9. ST or QRS changes such as excessive ST depression (> 2 mm horizontal or 
downsloping ST-segment depression) or marked axis shift. 
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APPENDIX D 
PERCEIVED STRESS SCALE (PSS) 
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APPENDIX E 
SAMPLE PREPARATION FOR NK CELL COUNTS 
The following are the procedures for preparing whole blood samples for flow cytometric 
analysis of NK cell counts.  This protocol is adapted from Becton Dickinson’s protocol for 
direct immunofluorescence staining of whole blood using a lyse/wash procedure: 
(http://www.bdbiosciences.com/support/resources/protocols/stain_lyse_wash.jsp) 
 
Materials 
1.  FITC Mouse Anti-Human CD3 Antibody (BD Catalog # 555339) 
2.  PE Mouse Anti-Human CD16 Antibody (BD Catalog # 555407) 
3.  APC Mouse Anti-Human CD56 Antibody (BD Catalog # 555518) 
4.  10X FACS Lysing Solution (BD Catalog # 349202) 
5.  Dulbecco’s PBS (pH = 7.2 ± 0.2; not containing calcium, magnesium, or phenol red 
(Invitrogen Catalog # 14190-136) 
6.  Paraformaldehyde solution (Invitrogen Catalog # FB001) 
7.  0.2 μm filter (Fisher Scientific Catalog #09 740 24A) 
8.  K3EDTA Vacutainer tubes 
9.  12x75 mm polypropylene test tubes (BD Catalog # 352063)* 
 
*The specific type of tube is of importance depending on which type of flow cytometer is 
being used.  The CyAn flow cytometer used in this study requires polypropylene tubes.   
 
Blood Collection 
1.  Collect blood into K3EDTA Vaccutainer® (Lavender top) tube. 
2.  Keep anticoagulated blood at room temperature (20-25°C) until ready for staining.  Blood 
samples should be stained within 6 hours of collection.   
 
Preparation of Reagents 
Before performing the staining and fixing procedures below, some steps will need to be 
performed ahead of time.  These include a 1X dilution of the 10X FACS Lysing Solution and 
filtering of the PBS wash buffer.  See below for details. 
 
1.  Preparation of 1X dilution of the 10X FACS Lysing Solution (used in Step 8) 
 a.  Mix 10X FACS Lysing Solution with room temperature de-ionized 
water in a 1:10 ratio. For example, 10 mL of the FACS Solution can be mixed with 90 
            mL de-ionized water. 
 b.  Store prepared solution in a glass container at room temperature for up to 1 month. 
2.  Preparation of the PBS wash buffer (used in Steps 3-5, 11 and 13) 
 a.  Filter PBS solution through a 0.2 µm filter prior to use.  This can be 
            done in bulk (i.e., 250 mL at a time) and stored at room temperature. 
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Staining and Fixing Cells 
1.  Label test tubes as follows for each experiment: 
 Tube 1:  blood + CD3 antibody (single color control for FITC CD3) 
 Tube 2:  blood + CD16 antibody (single color control for PE CD16) 
 Tube 3:  blood + CD56 antibody (single color control for APC CD56) 
Tube 4:  blood + CD3 antibody + CD16 antibody + CD56 antibody  
              (the actual sample)* 
 
*Note that depending on how many different blood collections have been done, there will be 
multiple Tube 4’s (i.e., one for pre-exercise and one for each post-exercise time point).  For 
the single color controls, only one tube of each is needed, and it doesn’t matter which blood 
is used. 
 
2.  Add 100 µL of whole blood to each tube.  
3.  Add 8 µL of CD3 antibody and 12 μL of PBS wash buffer to Tubes 1 and 4. 
4.  Add 5 µL of CD16 antibody and 15 μL of PBS wash buffer to Tubes 2 and 4. 
5.  Add 8 µL of CD56 antibody and 12 μL of PBS wash buffer to Tubes 3 and 4. 
6.  Vortex tubes gently and incubate in the dark at room temperature (20-25°C) for 30 
minutes. 
7.   Prepare another tube with 100 μL of whole blood only.  This can be Tube 5.  It will serve 
as the unstained control for the experiment. 
8.  Add 2 mL of the 1X FACS Lysing Solution to each tube. 
9.  Vortex tubes gently and incubate in the dark at room temperature for 10 minutes. 
10.  After the tubes have finished incubating, centrifuge at 500 x g for 5 minutes.  Remove 
the supernatant. 
11.  Add 2-3 mL of PBS wash buffer to each tube. 
12.  Centrifuge tubes at 500 x g for 5 minutes.  Remove the supernatant. 
13.  Add 250 μL of the paraformaldehyde solution and 250 μL of the PBS wash buffer to 
each tube and mix thoroughly.  Let sit for 20 minutes. 
14.  Cap tubes and store in the dark at 2-8°C until ready to analyze on the flow cytometer.  
Samples should be analyzed within 24 hours. 
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APPENDIX F 
SAMPLE PREPARATION FOR NKCA ASSAY 
Materials 
1. Target Cells:  K562 cells (a NK-sensitive human Caucasian chronic myelogenous 
leukemia cell line) 
2. Effector Cells:  whole blood, collected into sodium-heparin Vacutainer® tubes 
3. Monoclonal antibody for labeling target cells:  FITC Mouse Anti-Human CD71 
Antibody (BD Catalog # 555536) 
4. Lysing Solution:  10X FACS Lysing Solution (BD Catalog # 349202), diluted to 1X 
concentration 
5. Test Preparation Tubes:  12x75 mm polypropylene test tubes (BD Catalog # 
352063)* 
6. Sodium Heparin Vacutainer® tubes 
7. Dulbecco’s PBS (pH = 7.2 ± 0.2; not containing calcium, magnesium, or phenol red 
(Invitrogen Catalog # 14190-136) 
8. Dilution Buffer:  GIBCO® RPMI 1640 w/Glutamax-1 + heat inactivated FBS + 
penicillin-streptomycin (Invitrogen Catalog # 61870-036, 16140-071, and 15140-148) 
9. Culture Medium for maintaining K562 cells:  Iscove’s Modified Dulbecco’s Medium 
(ATCC Catalog # 30-2005) + heat inactivated FBS + penicillin-streptomycin 
*The specific type of tube is of importance depending on which type of flow cytometer is 
being used.  The CyAn flow cytometer used in this study requires polypropylene tubes.   
 
Preparation of Dilution Buffer 
Mix 250 mL GIBCO® RPMI 1640 w/Glutamax-1, 25 mL heat-inactivated FBS, and 1.25 
mL penicillin-streptomycin.  To ensure that the mixture is sterile, filter through a 0.2 μm 
filter.  Store prepared Dilution Buffer at 2-8°C. 
 
Preparation of 1X dilution of the 10X FACS Lysing Solution 
Mix 10X FACS Lysing Solution with room temperature de-ionized water in a 1:10 ratio. For 
example, 10 mL of the FACS Solution can be mixed with 90 mL de-ionized water.  Store 
prepared solution in a glass container at room temperature for up to 1 month. 
 
Preparation of PBS Wash Buffer 
Filter PBS solution through a 0.2 µm filter prior to use.  This can bedone in bulk (i.e., 250 
mL at a time) and stored at room temperature. 
 
Maintenance of K562 Cell Culture 
1. Prepare the Culture Medium, which consists of 89% Iscove’s Modified Dulbecco’s 
Medium, 10% FBS, and 1% penicillin-streptomycin.  This can be made in bulk (i.e., 
quantities of 250 mL or 500 mL).  To ensure that the Culture Medium is sterile, filter 
through a 0.2 μm filter.  Store prepared Culture Medium at 2-8°C. 
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2. Maintain the K562 cells in the Culture Medium.  Cultures should be maintained at a 
density of 10
5
-10
6
 cells/mL and kept in an air incubator at 37°C in 5% CO2.   Fresh 
Culture Medium should be added every 2-3 days depending on cell density. 
Assay Protocol 
1.  Label test tubes as follows for each experiment 
Tube 1:  target cells only 
Tube 2:  target cells only 
Tube 3:  effector cells only* 
Tube 4:  target cells + effector cells* 
Tube 5:  target cells + effector cells* 
*Note that depending on how many different blood collections have been done, there will be 
multiple Tube 3’s, 4’s, and 5’s (i.e., ones for pre-exercise and ones for each post-exercise 
time point). 
 
2. Count freshly prepared K562 cells with a high viability (>95%) and adjust to a 
concentration of 2x10
5
 viable cells per mL. 
3. Add 500 μL of K562 cells to Tubes 1, 2, 4, and 5. 
4. Add 500 μL of Dilution Buffer to Tubes 1, 2, and 3. 
5. Add 500 μL of whole blood to Tubes 3, 4, and 5. 
6. Centrifuge tubes at 200 x g for 1 minute. 
7. Incubate tubes at 37°C in 5% CO2 for 2 hours. 
8. Add 10 μL of CD71 antibody to each tube.  Mix gently. 
9. Incubate tubes at room temperature in the dark for 15 minutes. 
10. Add 2 mL of 1X FACS Lysing Solution to each tube.  Mix gently. 
11. Incubate tubes at room temperature in the dark for 20 minutes. 
12. Centrifuge tubes at 500 x g for 5 minutes.  Remove the supernatant. 
13. Re-suspend cells in 500 μL PBS wash buffer.  
14. Cap tubes and and store in the dark at 2-8°C until ready to analyze on the flow 
cytometer.  Samples should be analyzed within 2 hours. 
 
Analysis of NKCA on the flow cytometer 
1. Use the same flow rate when acquiring data for each sample.  Additionally, each 
acquisition should last for the same amount of time for each sample so that the same 
volume is analyzed for each sample.  A 1 minute acquisition time is recommended. 
2. Use the side scatter (SS) vs. forward scatter (FS) plot to draw a region R1 around the 
targets as shown below: 
 
         Tube 1           Tube 2  Tube 3      Tube 4         Tube 5 
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3. Use this region to set a gate in the FL3 vs. FL1 plot.  Draw a region R2 around the 
CD71
+
 target cells (see below).  This will allow for separation of labeled target cells 
from unlabeled cells in the whole blood that may overlap the K562 region in the SS 
vs. FS plot.   
 
 
 
 
 
 
 
4. The numbers of cells in regions R2 are the ones that are used in the equation to 
calculate NKCA (% NK cytotox). 
 
% NK cytotox = 100*[target cells – (mixed cells – effector cells)] / target cells 
% NK cytotox = 100*[(Tube 3 + Tube 3 + Tube 1 + Tube 2 – Tube 4 – Tube 5) /  
                                     (Tube 1 + Tube 2)] 
 
        Tube 1           Tube 2  Tube 3      Tube 4         Tube 5 
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